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 1
 Abstract
 
The presented thesis describes the establishment of a cell culture model, which can serve as a 
screening tool in pharmaceutical research studying drug application to the lungs. It starts with 
a review, which gives an extensive overview on currently available cell culture models of the 
respiratory tract. 
Cells were isolated from porcine lung, grown as primary cultures on filter supports and 
identified as porcine alveolar epithelial cells (pAEpC). These cells grew to confluent 
monolayers with typical intercellular junctions. During the cultivation process, a change from 
heterogeneous morphology towards a monolayer predominated by type I and type II 
pneumocytes was observed. A maximal transepithelial resistance of about 2000 Ωcm² 
demonstrated the formation of a tight epithelial barrier. Permeation of marker compounds was 
reproducible throughout several cell preparations and the model proved successful in 
distinguishing between low and high permeable drugs. Based on these results quality control 
parameters were defined serving as threshold for the use of pAEpC monolayers in transport 
studies. Budesonide and triamcinolone acetonide were selected for permeation experiments, 
as examples for commercially available drugs, which are commonly administered to the 
lungs. Expression of P-glycoprotein (P-gp) was confirmed on protein level, although 
permeability studies revealed no polarity in transport of known P-gp substrates. 
The porcine alveolar epithelial primary cell culture shares major hallmarks of the mammalian 
alveolar epithelium and it is easily available and scaled up for drug screening. Filter-grown 
monolayers of pAEpC can be used to study drug transport across such artificial alveolar 
epithelium and may represent a suitable in vitro model for pulmonary drug absorption and 
delivery. 
 
 
Key words (max. 5): alveolar epithelial barrier, primary porcine lung pneumocytes, P-
glycoprotein, permeability studies, pulmonary drug absorption 
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 Kurzfassung
 
Die vorliegende Arbeit beschreibt die Etablierung eines Zellkulturmodells, das in der 
Pharmaforschung zum Studium pulmonal applizierter Arzneistoffe eingesetzt werden kann. 
Einleitend wird ein ausführlicher Überblick über weitere in vitro Modelle des 
Respirationstraktes gegeben. 
Aus der Schweinelunge isolierte Zellen wuchsen als Primärkultur auf Filtern und konnten als 
pulmonales Alveolarepithel (pAEpC) identifiziert werden. Sie entwickelten konfluente 
Monolayer mit typischen interzellulären Kontakten, wobei im Kulturverlauf aus einer 
zunächst morphologisch heterogenen Kultur eine Zellpopulation aus vornehmlich Typ I und 
Typ II Pneumozyten entstand. Ein elektrischer Widerstand von bis zu 2000 Ωcm² belegte die 
Ausbildung einer dichten Barriere. Permeations-Experimente über pAEpC Monolayer 
erlaubten eine Unterscheidung zwischen hoch- und niederpermeablen Arzneistoffen, auch bei 
Verwendung von Kulturen unterschiedlicher Präparationschargen. In diesem Rahmen wurden 
Parameter zur Qualitätskontrolle definiert, die als Grenzwert für den Einsatz von pAEpC 
Monolayern in Transportstudien dienten. Als Beispiele für kommerziell verfügbare 
Arzneistoffe, die über die Atemwege appliziert werden, wurden Budesonid und 
Triamcinolonacetonid untersucht. Die Expression von P-Glykoprotein wurde auf Protein-
Ebene bestätigt, obwohl der Transport bekannter P-gp-Substrate in Permeabilitäts-Studien 
keine Polarität zeigte. 
Alveolare Schweine-Epithelzellen in Primärkultur weisen typische Merkmale des 
Alveolarepithels von Säugetieren auf. Sie sind leicht und in größerer Menge verfügbar, wie es 
für eine frühe Selektion potentieller Arzneistoffe erforderlich ist. Auf permeablen 
Filtermembranen kultivierte Monolayer können zu Tansportstudien über solch ein künstliches 
Alveolarepithel genutzt werden und stellen ein geeignetes in vitro Modell für die 
Untersuchung pulmonaler Arzneistoff-Absorption und der Freisetzung am Wirkort dar. 
 
 
Schlüsselbegriffe: alveolare Epithelbarriere, Pneumozyten aus Schweinelunge, P-
Glykoprotein, Permeabilitäts-Studien, pulmonale Arzneistoff-Absorption 
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 Scope of the thesis
 
In context with pulmonary drug delivery there is an increasing demand for in vitro models, 
which imitate the mammalian lung. Due to a future drug delivery into the lungs for systemic 
action, transport processes across the pulmonary air-blood barrier come into focus. Thus 
current research concentrates on models for the distal lung region, which could serve as in 
vitro test system for systemically acting drugs. For the bronchiolar level characterized cell 
lines are already available, whereas alveolar epithelial models are prevailed by primary 
approaches. In view of ethical and logistical problems related to human tissue, the question 
raised what mammalian animal could serve as an alternative. Finally aiming at a commercial 
use favored aspects would be e.g. unlimited tissue supply, easy handling, low costs, 
robustness and validity. 
 
Since the pig closely resembles man in its anatomy and physiology as well as in histological 
and biochemical aspects [1], porcine cells and tissues have been widely used as models in 
studies investigating oral, ocular, transdermal, intestinal, buccal and nasal drug delivery [2-8]. 
However, porcine alveolar epithelium has not yet been characterized for its suitability in drug 
absorption studies. In comparison with diffusion models using nasal mucosa from other 
species, one essential advantage of porcine tissue is its availability, because animals intended 
for slaughter can be used (i.e. reduction of animal use for research purposes). Furthermore the 
morphology and physiology of porcine mucosa, as reflected by present cell types and 
electrophysiological results, seems to be comparable to that of man [8], at least concerning the 
nasal mucosa. In addition it is generally acknowledged that the enzymatic equipment of cells 
from these two species is very similar. 
 
Differences in the anatomy of human (panel A) and porcine lung (panel B) are illustrated in 
Figure 0-1. by comparing organs of these two species: The human lung is comprised by three 
lobes at the right and only two at the left hand side, whereas the porcine organ shows several 
lobes more. Despite of these obvious macroscopic differences in anatomy the microscopic 
and functional structures are very similar. 
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A B
 
Fig. 0-1. Anatomy of the lung: human versus porcine; A human lung [9]; B porcine lung, [10] 
 
Through the last years, at least two research groups concluded to select the pig as species. 
One of them isolated porcine primary airway epithelial (PPAE) cells from trachea [11], 
whereas other scientists used whole pig snouts for investigation on the nasal level [12]. 
 
Aim of this thesis is to establish an in vitro model based on porcine lung, which imitates the 
alveolar epithelium of the respiratory tract. In this context the development of an appropriate 
isolation procedure is followed by a basic characterization of resulting cell populations. 
Since such model is thought to represent a promising tool in the assessment of permeation 
characteristics of potential drug candidates in the near future, cells should be grown on 
permeable supports (filters), form confluent monolayers as well as functional tight junctions 
and generate transepithelial electrical resistances. Cultured cells should mirror relevant 
features of human respiratory epithelium in vivo (e.g., expression of characteristic proteins, 
presence of other functional structures) in order to justify its representation of in vivo 
conditions. 
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1. ABSTRACT 
 
The respiratory tract holds promise as an alternative site of drug delivery due to fast 
absorption and rapid onset of drug action, and with avoidance of hepatic and intestinal first-
pass metabolism as an additional benefit compared to oral drug delivery. At present, the 
pharmaceutical industry increasingly relies on appropriate in vitro models for the faster 
evaluation of drug absorption and metabolism as an alternative to animal testing. This article 
aims to provide a survey on the various existing cell culture systems which may be applied as 
in vitro models of the human air-blood-barrier, for instance, in order to enable the screening 
of large numbers of new drug candidates at low cost with high reliability and within a short 
time span. Apart from such screening, cell culture based in vitro systems may also contribute 
to improve our understanding of the mechanisms of drug transport across such epithelial 
tissues, and the mechanisms of how advanced drug carriers, such as nanoparticles or 
liposomes can help to overcome these barriers. After all, the increasing usage and acceptance 
of such in vitro models may lead to a significant acceleration of the drug development process 
by facilitating the progress into clinical studies and product registration. 
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2. INTRODUCTION 
 
Until today, oral application of drugs is the most preferred way to deliver a pharmaceutically 
active compound to its site of action. However, this first choice of delivery is not always 
possible, due to some restricting physico-chemical or pharmacological properties of the active 
compound. In this situation, alternative routes have to be looked for, such as e.g. drug 
delivery via the skin, which in the past few years has found excellent acceptance and where 
several registered drug products meanwhile are on the market. In a similar way, drug delivery 
by inhalation (via the lung) has also attracted much interest as another alternative route of 
drug administration. One of the main advantages favoring the pulmonary route lies in the 
rapid onset and the absence of first pass metabolism. The most commonly used aerosols, 
designed for local drug delivery in the therapy of lung diseases contain bronchodilators or 
glucocorticoids and are applied directly to the lung for therapy of obstructive airway and 
inflammatory diseases. For instance, in 1998 more than 20% of the drug delivery products 
sold worldwide target at the central regions of the lung for the treatment of asthma, chronic 
obstructive pulmonary disease (COPD) and other bronchial related diseases [1]. Delivering 
the drug directly to the place of action results in reduced side effects and immediate onset of 
drug action, the latter being absolutely necessary, e.g. in case of asthma attacks, which are 
associated with acute dyspnea. Recent improvements in the technology of new devices 
created much optimism when inhalation to the deep lung regions was taken into consideration 
as a new approach to systemic drug delivery. Particularly for drugs with poor oral absorption 
[2,3], such as peptides and proteins, the pulmonary route promises a progressive alternative 
way of reaching the systemic circulation (thereby avoiding painful injections). 
 
Current candidates for systemic delivery via the lung include insulin for diabetes, heparin for 
thrombosis as well as parathyroid hormone and calcitonin for treatment of osteoporosis or 
Paget’s disease of bone [4], with the latter being already on the market for nasal application 
(Karil®, Novartis) [5]. At present, an increasing interest in the development of aerosolized 
insulin for the substitution of subcutaneously delivered formulations may be observed. The 
conventional therapy for type I (insulin-dependent) diabetes mellitus requires multiple self-
injections a day; a treatment that due to its associated pain, inconvenience and disruption of 
lifestyle, often results in non-compliant patients [6]. Current clinical experience with inhaled 
insulin seems promising and represents the only viable non-invasive alternative to insulin 
injections at the moment. However long-term local tolerance of the pulmonary tissue is still a 
crucial issue. Moreover, since the lung-route allows bioavailability of insulin approaching 
10% without absorption enhancers [7], higher doses of inhaled insulin are required, making it 
less cost-effective than injected insulin [8]. Two different devices are mainly focused at 
present: i) the so-called AERxIDMS, a microprocessor-controlled aqueous mist inhaler for a 
liquid aerosol formulation developed by Aradigm Corp. and Novo Nordisk, which was proven 
to be well tolerated, i.e. no change in pulmonary function [9,10]. Similar results are obtained 
with the ii) Exubera device to deliver a dry powder formulation and designed by Nektar 
Therapeutics Inc., Aventis and Pfizer [10]. In this latter case phase II studies could reveal a 
similar efficacy to glycaemic control as by regular insulin injections. And apart from 
increased insulin antibodies after inhalation, the pulmonary function tests remained stable and 
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normal after 6 months of phase III trials. Another approach known as Alkermes project is 
based on large porous regular insulin of low mass density. Studies in normal human subjects 
showed similar pharmacokinetics as Exubera and AERx, respectively [7]. According to 
personal communication with Mr. W. Landgraf from Aventis, Exubera is expected to come 
onto the market not before end of 2005. 
 
Today’s technical knowledge meanwhile does allow efficient deposition of aerosol particles 
into the deep lung. However, our current understanding of what happens to aerosol particles 
after landing on the epithelial surface is still limited. In this context, in vitro models of the 
respiratory mucosa may be helpful to clarify interactions between drug compounds and carrier 
systems on the one hand and the biological air-blood barrier on the other hand. In parallel, the 
optimization of device technology and aerosol deposition still offers possibilities to further 
improve bioavailability. All in all, the interplay of three factors should be taken into account 
because they are finally decisive for good or bad bioavailability, they are: the efficiency of 
nebulization/aerosolization, the deposition, and permeability. 
Cell culture models of the respiratory tract may be expected to shorten time for the 
development of new drug products. In the pre-clinical stage they could be used as an 
alternative to expensive and time-consuming whole animal testing. Subsequently, the 
information on absorption mechanisms obtained from such in vitro experiments enables a 
better directed and more cost-saving performance of clinical studies as judgement on safety of 
new drugs and chemicals [11]. 
 
Aim of this article is to critically review the various cell culture models of the respiratory tract 
with respect to drug absorption and delivery. Various in vitro models and techniques, which 
have been described in the literature in the context of different bio-medical investigations, 
will be compared on the basis of their characteristic features, advantages and drawbacks from 
the view point of pharmaceutical sciences, keeping in mind their relevance for the faster 
development of new safe inhalation medicines. 
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3. EPITHELIAL BARRIERS OF THE RESPIRATORY TRACT 
 
 
3.1 Anatomy, histology and epithelial cell biology of the lungs 
 
The respiratory tract starts with the nasal epithelium or the oral cavity (mouth), followed by 
the pharynx and trachea, which discharge into the bronchial tree. The trachea or wind-pipe 
divides into the two main bronchi at the tracheal bifurcation, meets the bronchioles and then 
goes down to the distal lung. These so-called conducting airways get increasingly smaller in 
diameter while proceeding to the bronchioles and finally to the alveolar sacs, where the gas 
exchange takes place: they diminish in size from 2 cm diameter in the windpipe (with each 
branching) down to 200 µm in the alveolar ducts [12]. All in all, the serial dichotomous 
airway (Y)-branchings result in 23 airway generations with the upper part (conducting 
airways) mainly serving as air transport, whereas the alveolar region is more adapted to the 
needs of gas exchange. According to their respective functions (cleaning, mucus, surfactant) 
these parts are lined with epithelia of quite a different morphology. 
 
 
3.1.1 The airway epithelium 
 
The epithelial lining of the conducting airways in vivo is characterized by a pseudo-stratified 
columnar epithelium, which is comprised of three major cell types: ciliated cells, secretory 
(mucous, goblet, serous or Clara) cells and basal cells [13]. The overall thickness of this 
epithelial layer varies; tallest in the large airways and gradually decreasing in height to 2-
5 µm in the terminal bronchioles [14-16]. 
Ciliated cells constitute about 50% of the cell population in the human tracheal epithelium, 
whereas basal and secretory cells form the rest [14,17], causing regional differences between 
more secretory cells in the distal and fewer in the large airways. Together with mucous goblet 
and Clara cells, they cover almost the entire surface of the epithelium [1]. They are fairly tall 
with 20-60 µm and approximately 250 cilia on the apical surface of each cell, and their major 
function is the propulsion of mucus (in terms of mucociliary clearance) [13,18]. These ciliated 
cells are the most abundant cell type at all airway levels [19,20] and therefore, considering 
this distribution, it seems the most appropriate single cell-type upon which to model the 
airway epithelium. In the higher airways they are interspersed with secretory cells (mainly 
mucus secreting goblet cells), whereas at lower levels there are inserted, above all, Clara cells 
[1]. 
Secretory cells are characterized by an electron dense cytoplasmic region (due to the 
presence of secretory granules) and their function is the maintenance of a mucus blanket in 
the airway lumen [14,17], a protective mucus layer of about 5-10 µm in height, which coats 
the airway epithelium [15]. 
Basal cells reside near the basement membrane, interspersed between the taller ciliated and 
secretory cells and thus do not contribute to the epithelial surface [1]. Together with other 
intermediate cells, they show a more flattened or spindle-shaped appearance with rare 
cytoplasmic regions; moreover, they are suggested to be the progenitor cells for differentiated 
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ciliated or secretory cells [13,21]. The essential morphological features of the epithelium in 
the higher airways, the bronchiolar level and in the alveolar region are shown in Figure 1-1. 
 
 
Fig. 1-1. Morphology of epithelia lining the different regions of the human lung, 
characteristic for certain levels of the respiratory tract (lateral view). (Reprinted from Patton 
[22] with permission from Elsevier Science.) 
 
In contrast to the alveolar epithelium, which will be described below, cells localized in the 
conducting airways form a pseudostratified epithelial layer with overlapping cytoplasmic 
regions and the ciliated, non-ciliated, basal and secretory cells attain a cobblestone-like 
appearance [23-25]. When cultivated in vitro, some major factors that promote such 
differentiation of airway epithelial cells are the extracellular matrix (e.g. collagen-coating of 
filter supports), the composition of the growth medium (like supplemented with retinoic acid) 
and culture at an air-liquid interface [19,26,27]. The ultrastructure of the cell monolayers 
demonstrates cilia, microvilli and a glycocalyx on the apical membrane as well as tight 
junctions between the cells, while, however, the airway epithelium in general still appears to 
be more leaky than the alveolar epithelium [1]. Another feature of airway epithelial cells is 
the presence of desmosomes on the basolateral membrane [13]. Notably, the total surface area 
of the conducting airways with only 1-2 m² is relatively small, at least in comparison to the 
approximately 140 m² alveolar surface area [12,28]. Moreover, the airway epithelium is 
protected by a relatively thick and viscous mucus gel layer, which also features some peculiar 
mechanism of mucociliary clearance, while the alveolar epithelium is only covered by a thin 
film of lung surfactant [1]. 
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3.1.2 Lung surface lining (mucus and surfactant) 
 
The mammalian respiratory tract from the nasopharynx down to the respiratory region of the 
alveoli is continuously lined with an aqueous layer, which varies in its structure and 
composition depending on the particular epithelial function (conducting versus respiratory) 
[29]. The higher levels of the respiratory tract are covered by a mucus gel layer, which in the 
case of mammalian trachea and large bronchi, was observed to average 5-10 µm in thickness 
and is situated at the level of the tip of the cilia. The mucus layer consists of a fine fibrillar 
structure and appears ultrastructurally identical to the content of secretory granules of goblet 
cells [29]. It is conveyed upwards by epithelial cilia, an essential clearance mechanism that 
removes foreign material from the tracheobronchial tree, and as well, maintains the patency of 
small bronchi and bronchioles [29,30]. To warrant the function of the mucociliary clearance, 
the mucus blanket comprises two layers of differing physical properties: an upper gel layer 
consisting of mucus with a high viscosity and a lower sol layer at the place where cilia 
actually beat and recover, which is thin and watery with a low viscosity [31,39]. Down the 
airways, the thickness of the mucus blanket gradually decreases [32-34]. The bronchioles 
display a distinct surface layer [29,35], which seems to be partially derived from Clara cells 
[29,36]. 
The alveolar epithelium, finally, is covered by a very thin layer of fluid that averages about 
0.05-0.08 µm, but may be several microns thick in pooled areas and as thin as 15-20 nm in 
others [22,37]. While the mucus blanket covering the airways is a hydrogel formed by 
glycoproteins (mucins), the alveolar epithelium is covered by a thin lining fluid, the so-called 
surfactant. Its major function is to facilitate the “wetting” of the alveolar epithelium by the 
respiratory gases. This is achieved by an extremely low surface tension due to the presence of 
phospholipids and some specific surfactant proteins. The components of the pulmonary 
surfactant are secreted by type II pneumocytes [29,38,39]. Studies on synthesis, features and 
functions of lung surfactant and its proteins form a very sophisticated, complex and frequently 
addressed research topic, e.g., compare references [40-43], but a more detailed discussion 
would be beyond the scope of this article. Interested parties are referred to other recent review 
articles [44,45]. 
 
As a consequence of its higher attractiveness for drug delivery caused by a larger surface area, 
shorter diffusion pathway and less intensive clearance (mechanisms) or metabolism, emphasis 
will be laid on the alveolar distal lung region in the following. 
 
 
3.1.3 The alveolar epithelium 
 
The alveolar epithelium continuously lines the distal air space, covering more than 99% of the 
internal surface area of the lungs [12] and is composed of a monolayer of two 
morphologically distinct types of cells namely type I and type II cells [46]. 
Type I pneumocytes cover more than 90% of the surface of the alveolar air space, although 
they represent less than 10% of the total number of alveolar cells [47-50]. Alveolar type I 
cells exhibit protruding nuclei with extremely thin cytoplasmic extensions of 0.2-0.4 µm in 
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height [47,51,52]. This height is described as 2-3 µm perinuclear and 0.2 µm peripher, which 
means a sort of fried-egg-like morphology, in contrast to 5-10 µm of type II cells [53]. Thus 
providing a very short diffusion path, they are thought to be essential for normal gas exchange 
[13,48]. Human type I cells have a mean volume of 1764 µm3 and a very large surface area of 
5098 µm2 [47] compared to that of a human bronchiolar epithelial cell with 33 µm² [22]. In 
parallel, the cell density in the alveolar airspace is about 500 cells/mm² [22] versus 
approximately 20000 cells/mm² for the bronchial epithelium [53] or 55000 cells/mm² for the 
bronchi and 30000 cells/mm² for the bronchioles respectively [12]. 
Type II pneumocytes are more cubical in shape, with an intermediate size between the 
smaller endothelial and interstitial cells and the larger macrophages [13]. With their mean 
volume being half that of type I cells they comprise only 15% of all lung and 16% of the total 
alveolar cells (compared to 8% for type I) and cover 7% of the alveolar surface [47,54]. As a 
morphological hallmark they possess lamellar bodies [55] and during the recovery period a 
generation time of 3 days is calculated for type II cells [56]. These features hint to important 
functions including regulation of surfactant metabolism, ion and solute transport as well as 
alveolar repair, which are performed by alveolar type II cells within the lung [54]. They are 
able to produce and store lung surfactant, a mixture of phopholipids and surfactant-
apoproteins that is secreted to the alveolar lumen [57], thereby forming a 0.2 µm thick film or 
coating. This surface-active material serves to reduce the surface tension at the air-epithelium-
interface, thus preventing the pulmonary alveoli from collapse during exhalation [52,58,59]. 
In terms of alveolar repair, the observation of intermediate cellular forms between type II and 
type I suggests that replacement of injured type I epithelium is accomplished by proliferation 
of type II cells and their transformation to the squamous type of epithelium [56], in this way 
serving as progenitor pool for the renewal of the alveolar epithelium. If cultured on plastic or 
polycarbonate filter supports, they begin to flatten and exhibit type I cell-like morphology and 
functional characteristics that resemble the intact alveolar epithelium [60-62]. This ability to 
differentiate, as well as the capacity of type II cells in vitro to develop characteristics 
associated with type I cells in situ, as could be demonstrated by an acquired immunoreactivity 
to specific monoclonal antibodies [48], support their progenitor function. Nevertheless, there 
also exist hints to a direct formation of type I cells out of bone marrow-derived cells (after 
their engraftment in recipient lung parenchyma). Since a type I cell-like morphological and 
molecular phenotype could be detected without observing any engraftment of type II 
pneumocytes, these results challenge the current belief that adult alveolar type I epithelial 
cells invariably arise from local precursor cells [63]. In addition, type II cells seem to play a 
role in the regulation of immune defense processes, which is suggested by their expression of 
molecules of the class II major histocompatibility complex (MHC) and intracellular adhesion 
molecules ICAM-I [64-66]. 
Other cell types of relevance in this context are capillary endothelial cells, which amount up 
to 30% of all lung cells. They are significantly smaller in both size and average surface area 
than type I cells [47] and form a cell monolayer that makes up the wall of the microvessels. 
The surface area of a pulmonary endothelial cell is about one fifth the size of a type I cell and 
they build up capillaries, which lie under type I cells in the alveoli [22]. Moreover, there exist 
cells in the interstitial space, comprising 37% of the total cells, and alveolar macrophages, 
whose number shows great variability depending on biological parameters such as gender and 
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behavioral ones like smoking [47]. The latter occur on all epithelial lung surfaces with 
prevalence in the distal regions. Since the mucociliary escalator does not extend to the alveoli, 
they are said to patrol the extensive surface area of the extremely thin alveolar epithelium 
instead [1]. 
While the focus of this review is on the pulmonary epithelia and models thereof, it must be 
noted that also macrophages make an important contribution to the barrier function of the 
lungs. Drug targeting to macrophages as well as the prevention of particulate drug carriers 
from uptake by macrophages are separate topics of major interest to the pharmaceutical 
sciences. This includes the development of some specific cell culture models, which at least 
shall be briefly mentioned here. For instance, the continuous macrophage cell line NR8383 
(species: rat) has been proposed a model of alveolar phagocytosis by comparison with 
primary cultures. In order to achieve a closer modeling of the physiological lung environment, 
these cells even have been cocultured with the human alveolar epithelial cell line A549 [67]. 
Another even more complex approach describes a triple-cell culture system comprised of 
alveolar epithelial cells cultured on a permeable filter support, together with endothelial cells 
grown on the bottom side of the same filter insert and in addition including macrophages on 
top of the alveolar epithelial cells’ surface [68]. This attempt aims at a still more complete 
imitation of the native barrier with the endothelium being less important from the view point 
of transport studies but nevertheless essential with regard to immunological processes. 
 
 
3.1.4 Differentiation markers for alveolar epithelial cells 
 
In order to differentiate between the two types of alveolar epithelial cells and to distinguish 
them from cells of another origin, several biochemical or histological markers have been 
identified. They are also important tools for the characterization and evaluation of in vitro 
models, of which one feature is the identification of type I and/or type II cells respectively. 
A typical feature of alveolar type II cells is the secretion of lung surfactant and surfactant 
associated proteins. Alveolar type II cells carry out highly specialized functions that include 
the synthesis, secretion and reutilization of lung surfactant [69,70]. They are unique in their 
ability to produce lung surfactant and store surfactant lipids and proteins in lamellar bodies. 
Surfactant protein A (SP-A) is a major surfactant protein synthesized primarily by type II 
cells, and to a lesser extent by Clara cells. SP-C, another surfactant protein, is predominantly 
secreted from type II cells. Thus type II cells are characterized by staining of lamellar bodies 
and their visualization, by electron microscopic analysis of the ultrastructure or/and 
immunoblot analysis of SP-A, or expression of genes encoding SP-A, SP-B and SP-C. 
Enzyme activity may also serve as a cell marker because some enzymes are specifically 
associated with certain cell membranes. For instance, alkaline phosphatase is typically 
associated with the apical membrane of polarized epithelial cells, also including alveolar 
type II cells [64,71-73]. A typical marker for the basolateral membrane of polarized epithelial 
cells is Na+-K+-ATPase. This enzyme provides the driving force for active transport such as 
e.g., apical amiloride-sensitive Na-channels and basolateral Na-pumps, which are the primary 
pathways for transepithelial sodium transport across the alveolar epithelium [74]. 
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Moreover, specific membrane proteins such as RT140, a type I alveolar epithelial cell apical 
membrane protein detected in rats [75], or HTI56, an integral membrane protein specific to 
human alveolar type I cells [76], or the cellular and subcellular localization of Annexins (I 
and IV) in rabbits [77], indicate the alveolar nature of an epithelium. Another group of 
membrane proteins was discovered recently and is comprised of water channels, the so-called 
aquaporins (AQP). They facilitate water transport across epithelia and play an important role 
in normal physiology and disease (e.g. Sjogren's syndrome) in the human airways. Different 
sorts or protein types exist, named AQP1-5, and have been used to define certain airway 
sections by their occurrence. A study performed on mice demonstrated the presence of AQP1 
on the plasma membrane of microvascular endothelium and, to a lesser extent, on some 
pneumocytes. AQP5 was found on the apical membrane of type I alveolar epithelial cells. In 
contrast, AQP3 and 4 were allocated to the airways, with AQP3 found in basal cells of 
nasopharynx, trachea and large airways and AQP4 in the basolateral membrane (of airway 
epithelium) throughout the trachea and the small and large airways [78]. Other studies 
examined different human airway sections, starting with nose and bronchial epithelium, where 
AQP5 was observed at the apical membrane of columnar cells and submucosal gland acinar 
cells. AQP4 was detected in basolateral membranes of ciliated ducts and gland acinar cells 
and AQP3 was present on basal cells of both superficial epithelium and gland acinus. On the 
next level, the small airways, including proximal and terminal bronchioles, the AQP3 
distribution shifted from basal cell to surface expression (i.e. localized to the apical membrane 
of proximal and terminal bronchioles) and was the only AQP identified in this region of the 
human lung. Finally, regarding the alveolar epithelium, all three AQP’s were present, with 
AQP4 and AQP5 localized to type I pneumocytes and AQP3 to type II cells [79,80]. 
According to these results, species differences seem obvious and should be taken into 
consideration when it comes to the characterization of cell culture based in vitro models. 
 
A major part of current research on the alveolar epithelium concentrates on caveolae and 
caveolin, which likewise represent characteristic features of pneumocytes. Caveolae are 
morphologically identifiable as 50-100 nm small flask- or omega-shaped invaginations of the 
plasmalemma in endothelial and epithelial cells [81-84]. Caveolae are present in most cell 
types, but are particularly abundant in adipocytes, fibroblasts, lung epithelial cells (type I 
pneumocytes), endothelial and epithelial cells, as well as in smooth and striated muscle cells 
[84-86]. Biochemically, these structures are distinguished by the occurrence of caveolin, that 
forms the principal component of filaments constituting the striated cytoplasmic membrane 
coat of caveolae and is referred to as their major structural marker protein [82,83]. Caveolins 
are 18-24 kDa integral membrane proteins, which apart from their structural role in the 
formation of caveolae, are also suggested to have one in signal transduction [86]. An in vivo 
study with perfused rat lung sections proved that squamous alveolar epithelial type I cells 
possess numerous plasmalemmal invaginations and cytoplasmic vesicles ultrastructurally 
indicative of caveolae. By means of a novel application of confocal laser scanning and 
electron microscopy, caveolin-1 could be unequivocally localized in type I cells. However, an 
ultrastructural appearance of invaginations does not seem to universally imply the 
biochemical presence of caveolin, because coexistent with this, in both type I and capillary 
endothelial cells, membrane invaginations morphologically characteristic of caveolae were 
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observed, but lacked associated caveolin. The cubical alveolar epithelial type II cell also 
displayed specific label for caveolin-1 but with no ultrastructural evidence for the formation 
of caveolae [82]. The fact that these omega-shaped plasmalemmal invaginations found in 
type I cells were recently demonstrated to be biochemically indistinguishable from caveolae 
[82], suggests that they also could serve as potential markers for type I pneumocytes. 
More details and references on numerous lung epithelium-specific proteins, their 
characteristics and potential applications as markers can be found in a rather comprehensive 
review by Hermans et al. [87]. 
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3.2 Transport processes at the pulmonary epithelial barrier 
 
Following the order in which an aerosolized compound deposited in the peripheral lung has to 
face and overcome them, the more accurate structure of the so called air blood barrier is 
composed of a surfactant film, 50-80 nm in depth (the surface fluid), a type I cell monolayer 
and their basement membrane, subsequently meeting an endothelial cell before entering the 
blood vessel itself and being available and transported to various places within the system 
[22]. (see Fig. 1-1) From this point of view, the basic alveolar structure is the septum, which 
consists of capillaries sandwiched between two epithelial monolayers, all held together by 
numerous extracellular and intracellular fibers (e.g. collagen, basement membrane, actin and 
others) [22,88]. The main barrier function of this alveolar epithelium is the separation of 
alveolar air-spaces from vascular and fluid-filled interstitial spaces and therefore it might be 
expected to exhibit high resistance to fluid and solute movement [13,62]. This distal 
pulmonary epithelial barrier does not only restrict the passive flow of water and solutes 
[89,90], but contributes to the regulation of the removal of alveolar airspace fluid by active 
transport of solutes across the epithelium [91-93]. 
 
 
3.2.1 Ion transport 
 
From the physiological point of view ion transport is considered as an important function of 
the alveolar epithelium because of its capability to regulate volume and composition of 
surface liquids. Especially in terms of lung defense a proper homeostasis of these surface-
lining liquids is essential. The purpose of these ion-transport systems is seen in the need to 
regulate surface liquid volumes and composition relevant to the local environment: for 
instance, adjusting height and composition, which permits efficient function of the 
mucociliary clearance system in the airways, as well as the coordination of intrapulmonary 
surface liquid flow (i.e. so-called “axial” flow) between different pulmonary regions, e.g. 
alveolar and airway surfaces. A very detailed review by Boucher focuses on data derived from 
human subjects and introduces the various techniques that contributed to the characterization 
of this composite cell model. These are for instance: analysis of airway surface liquids, direct 
measurement of in vivo transepithelial electric potential differences, in vitro transepithelial 
bioelectric and ion flux studies, patch clamp studies or single cell fluorescence studies 
[32,94]. 
 
Focusing on the distal lung region in particular, various ion transport processes have been 
observed in alveolar epithelial cell monolayers; most relevant transporters are summarized in 
Table 1-1. Remarkably some of them are not equally distributed over the entire cell 
membrane but may be preferentially expressed at either apical or basolateral side, 
substantiating the polarization or polarized character of a functional epithelium and allowing 
substrate transport in only one (e.g. secretory or absorptive) direction. These alveolar 
epithelial ion transporters are also thought to be important factors in alveolar fluid 
homeostasis contributing to efficient gas exchange in the distal region of the lung [95]. 
Concurrently, it could be proved that type I pneumocytes express sodium pump and sodium 
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channel proteins, implicating a function in active transalveolar epithelial Na-transport [96]. 
New insights into the regulation of ion and fluid transport across distal pulmonary epithelia 
have been recently commented upon [97]. 
 
Table 1-1. Ion transport processes in alveolar epithelium 
 
Process Description 
apical amiloride-sensitive sodium 
channels 
active, distal Na+-absorption in apical-to-basolateral 
direction, from lumen to interstitium, localized on the 
apical surface, via amiloride-sensitive Na channels 
(ENa) with ATPase providing the driving force 
[95,98-100] 
basolateral sodium pumps ouabain-sensitive Na+-K+-ATPase on the basolateral 
surface, expressed in primary rat alveolar epithelial 
cells, upregulation of active ion transport by KGF 
(keratinocyte growth factor) [74,95,98-103] 
chloride transport passive chloride transport across (rat) monolayers 
under normal baseline conditions; 
induction of active Cl--transport by beta-agonists, 
concomitantly with stimulated Na+-absorption 
[13,99] 
basolateral sodium cotransport and 
exchange mechanisms 
basolateral sodium cotransport and exchange 
mechanisms, e.g. Na+-K+-Cl--cotransporter in rat 
alveolar epithelial cell monolayers [95,104-106] 
pH-regulating acid/base ion transport 
mechanisms 
[13,107] 
 
1. Na+-H+-exchange/antiport activity in type II 
alveolar epithelial cells [13,106,108] 
2. Cl--HCO3--exchange in rat type II alveolar 
epithelial cells, restricted to the basolateral 
surface [13,105,109] 
3. Na+-HCO3--symport, basolateral localization of 
Na+-HCO3--cotransporter activity in alveolar 
epithelial cells [13,104,110] 
4. Na+-H+-, Cl--HCO3--exchange and Na+-HCO3--
cotransport, basolateral in cultured rat alveolar 
epithelial cells [13] 
5. H+-ATPase: identification of a plasma membrane 
protontranslocating adenosintriphosphatase in rat 
alveolar epithelial cells [13,111] 
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3.2.2 Drugs and other small molecules 
 
In addition to specific mechanisms for ions, transporters enabling the passage of small 
molecules, such as compounds with nutritive functions or therapeutic drugs, are also found in 
the airway section of the respiratory tract. They may differ from each other in dependence on 
whether they are localized in the upper or lower respiratory tract (Table 1-2). 
In general, transport systems can be subdivided into two groups: 
a) Those situated in the cell membrane and which are responsible for the transport of 
small molecules, including ions such as sodium or chloride. In this context, the cystic 
fibrosis transmembrane conductance regulator (CFTR) is of scientific interest: as well 
as being a Na+-coupled glucose transport and organic anion transporter (Table 2-2) it 
has been identified in airway epithelia and is connected with the disease pattern of 
Cystic Fibrosis. This transmembrane protein belongs to the class of ABC-proteins 
(ABC = ATP-Binding-Cassette) and contributes to the physiology of airway surface 
liquid (ASL) metabolism and defense [112]. CFTR is described as a dual function 
protein in the airways and functions as a chloride(Cl-)-channel (which is defect in 
Cystic Fibrosis) and as a regulator of the epithelial sodium(Na+)-channel 
((ENaC)activity, apical) [113]. There has been evidence that active ion transport 
regulates ASL volume (height) and that a feedback exists between ASL height and the 
rate of ion transport and volume absorption. 
b) Vesicular transport systems for the translocation of large or macromolecules. 
 
Table 1-2 surveys these two groups of specialized transport processes thereby comparing 
airway and alveolar epithelium. 
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Table 1-2. Specialized transport processes in airway and alveolar epithelium 
 
 Airway Alveolar 
I. (Trans)membrane localized transporters and transport proteins, transport of small 
molecules 
organic anion transporter 
(OAT) 
different cellular localization,
probably related to species 
differences [13] 
not described/specified 
organic cation transporter 
(OCT) 
not described/specified in rabbits 
[95,114] 
CFTR (cystic fibrosis 
transmembrane conductance 
regulator) 
[112,113,115,116] 
not described/specified 
glucose transport Na+-driven, 
apical membrane, 
apical to basolateral direction 
[13,117] 
conflicting results in terms of 
Na-dependence, 
remaining/still unclear [13] 
amino-acid transport not described/specified carrier-mediated, 
in isolated and cultured (rat 
alveolar) type II cells [13] 
peptide transporter PEPT2 in rat [118] 
in human [119] 
in rat [95,118,120] 
in human [119] 
choline transport/uptake not described/specified energy-dependent, 
saturable, in cultured alveolar 
type II cells (choline = 
precursor of 
phosphatidylcholine, a major 
lung surfactant) [13] 
II. Vesicular transport systems, transport of large molecules 
caveolae/vesicle-mediated 
transport: 
not described/specified endocytosis, transcytosis, 
potocytosis [121,122]; 
macromolecular transcytosis 
[84,123-125]; 
internalization and 
transendothelial trafficking of 
solutes [86] 
vesicular pathway/transport or 
transcellular traverse/crossing 
endocytosis of 
macromolecular peptides, 
proteins and genes 
[13,126,127] 
endocytic and transcytic 
processes (besides 
paracellular transport) [13] 
transferrin mediated transport receptor mediated 
transcytosis, transferrin as 
carrier [13] 
transferrin-receptor mediated 
delivery of proteins 
[128] 
via surfactant [129], 
lectin-facilitated lipofection 
[130], 
acquired immune system and 
glycocalyx as barriers to 
overcome [131,132] 
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This second group including the caveolae- or vesicle-mediated transport of macromolecules is 
of particular interest, especially for the increasing number of newly developed 
Biopharmaceuticals, such as vaccines, monoclonal antibody-based products, nucleic acid-
based polymers, blood products, cytokines, hormones, therapeutic peptides as well as some 
alkaloids [133]. From a pharmaceutical point of view this class usually features huge sizes 
and poor permeability, thus complicating their delivery. 
 
 
3.2.3 Peptides, proteins and other macromolecules 
 
In the context of the promising but not yet fully understood pulmonary delivery of the afore-
mentioned Biologicals, caveolae and caveolins have attracted scientific interest. One reason 
for this focus may be the attribution of various functions to these cellular structures, in 
particular caveolae as potential macromolecule trafficking compartments within alveolar 
epithelium. Capable of pinching off (from the plasmalemma) and forming discrete vesicles 
within the cell cytoplasm, these specialized plasmalemmal microdomains are studied for their 
involvement in the transcytosis of macromolecules, as well as the internalization and 
transendothelial trafficking of solutes [82,86]. 
The existence of a numerical density of smooth-coated or non-coated plasma membrane 
vesicles or invaginations within the alveolar epithelial type I cell is widely accepted as 
putative function of these vesicles in macromolecule transport and in endocytotic and/or 
transcytotic trafficking of solutes [124]. Speculation about a model of caveolae vesicle-
mediated transport and a potentially significant role for alveolar caveolae in mediating the 
alveolar airspace to blood transport of macromolecules, is continuously gaining importance 
with respect to the development of more specific drug targeting approaches, more efficient 
gene delivery vectors, site-directed treatment of diseases and tissue specific drug delivery 
[124,125,134]. Cell culture models appear to present a suited tool in order to gain further 
knowledge on this speculation. As a matter of fact, scientists seem to rely predominantly on 
primary models for this field of research. Topic studies focus on the insulin receptor and the 
role of caveolae in signal transduction as well as their contribution to transport processes by 
dealing with albumin transport, the (intracellular) trafficking of sterol and cholesterol, and 
with the uptake or targeting of infectious agents and secreted toxins [122,134-138]. 
Nevertheless, unequivocal evidence proving that macromolecules such as insulin are really 
transported via caveolae is still needed. 
 
In the context of feasible transport mechanisms for macromolecular drugs, peptides and 
proteins across the alveolar epithelial barrier, several characteristics of the distal epithelium, 
such as the role of physicochemical properties of drugs (e.g., lipophilicity or molecular size) 
have been examined [139,140]. Since the 1980s permeability of a series of peptides and 
proteins was investigated. Some of the studied substances, as well as the corresponding 
models and experimental designs, are surveyed in Table 1-3. 
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4. IN VITRO APPROACHES TO MODEL THE EPITHELIAL BARRIERS OF 
THE RESPIRATORY TRACT 
 
 
4.1 Typology of in vitro models 
 
In general, there are three major in vitro approaches to mimic epithelial biological barriers. 
Ranked in order of diminishing complexity there are: isolated perfused organs, tissue explants 
and cell culture models (Fig. 1-2 A). Among the latter one can differentiate between primary 
cultures of a limited life span, and stable cell lines (transformed cells or carcinoma cell lines), 
which are immortal. A schematic overview of these is given in Figure 1-2 B. 
 
HIERARCHY OF IN VITRO MODELS IN PHARMACEUTICS 
 
 
 
 
   low          high 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
capacity complexity viability closeness 
to in vivo
reconstructed barriers
(epithelial cell cultures) 
isolated tissues
isolated perfused organs
 
   high           low 
 
Fig. 1-2. A Diagram representation of pharmaceutical in vitro models and their hierarchy. 
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tumor derivedtransformed 
primarylines 
cell culture models  
 
 
 
 
 
 
 
 
 
 
 
Fig. 1-2. B Further subdivision of cell culture models (reconstructed barriers). 
 
 
Isolated perfused organs (as ex vivo-models) usually possess a limited life span of only 
several hours. They imitate the in vivo situation very closely, but are simultaneously afflicted 
with a very high grade of complexity. Moreover, interpretation of results obtained in animal 
and tissue models is generally complicated by inter-species variation, imprecise drug delivery 
to the lung and concerns over preparation viability [1]. Finally, these very sophisticated in 
vitro models resemble, at least in terms of their complexness, the experimental design found 
with in vivo studies and are therefore not taken into consideration for screening processes. 
Nevertheless, isolated perfused lungs from the species rat, mouse, sheep and pig have been 
used for different purposes, such as the investigation of surfactant secretion, permeability 
measurements or the development of gene transfer methods [46,159-161]. They are not to be 
confused with organ cultures, which form an exception in this context because the intention in 
this case is to keep an organ alive outside a body, where it may even finish its differentiation, 
e.g., an artificial heart. 
In order to reduce the complexity of isolated perfused organs, sometimes only the concerning 
epithelium is mounted in an appropriate in vitro setup. This can be easily done in relation to 
the guts or skin, but turns out to be much more difficult in case of the lungs, because of their 
sponge-like morphology. These so called tissue explants or isolated tissue sheets also include 
amphibian Xenopus lung as another species, in particular with the complete organ standing 
for a single unit alveolus. In general, tissue sheets enable a reduction from a 3- to a 2-
dimensional model. Regarding their complexity, tissue explants bear a strong resemblance to 
the above-mentioned organ culture systems, in contrast to the far less complicated 
transformed or carcinoma cell lines or even primary cells. These latter cell culture models are 
focused in an attempt to reduce the barrier function to its major component, the epithelium. In 
comparison to the complex models they benefit from the feasibility of culture on filter inserts, 
their possible use in HTS (high throughput screening) processes and their comparatively cost 
saving maintenance. The fact that isolated perfused organs as well as isolated tissues feature a 
limited life span, finally lead to the idea of artificially generating epithelia, and resulted in the 
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so called reconstructed epithelia. The arrows in Figure 1-2 A illustrate the arguments 
speaking in favor and against the different approaches. 
Primary cells and cell lines principally distinguish from each other by the time span, during 
which they can be kept in culture, combined with the fact that primary cells have to be freshly 
isolated at certain intervals and thus each time descend from a different organism. Primary 
cultures face major limitations such as the lack of availability of normal human airway tissue, 
the limited number of cells, which is defined by the isolation yield, and a certain donor 
variation. But as cultures of mixed populations of human airway epithelial cells, they are said 
to provide the closest in vitro representation of the native epithelium. 
An advantage of transformed cell lines is that they are of known origin and their unlimited 
life-span enables prolonged studies. Moreover, they can be used as factories for production of 
large quantities of therapeutically effective, endogenous macromolecules [19]. Usually they 
are manufactured by transformation of primary cultured epithelial cells, and most commonly 
by constructs containing the large T antigen of the SV40 virus or human papilloma virus [13]. 
However, transformants frequently lose differentiated properties with increasing serial 
passage, particularly following crisis [162]. Although most of the SV40 transformed cell lines 
maintain their differentiated properties, at least in terms of ion transport, secretory processes, 
metabolic enzymes, and adhesion molecules similar to that of the native tissue, they tend to 
lose their ability to establish tight junctions (with time or passage number) [19]. In 
conclusion, drug absorption studies based on transformed cell lines should be interpreted with 
caution, due to their dedifferentiated characteristics such as lack of tight junctions and time-
dependent variation in morphological and physiological characteristics. These facts make 
them less suited for transport studies [13]. 
Carcinoma cell lines are derived from various lung tumors (e.g. A549) and their advantage 
over primary cultures of alveolar type II cells lies in the ease of cell culture and purity of cell 
types. On the other hand, they stem from excessively proliferating (tumor) cells, which may 
be not the only changed feature in comparison to normal healthy cells [163]. Nevertheless, in 
terms of reproducibility, they sometimes surpass primary cell cultures if the critical passage 
number (for drifting away) is known and taken into account. However, there also exist highly 
reproducible primary models. Cell lines normally afford easy maintenance and avoid several 
difficulties such as reproducibility or high costs, which often are associated with primary 
culture approaches [163]. Cell lines for research on pulmonary physiology that are available 
through ATCC (The American Type Culture Collection) have been surveyed [164]. 
 
 
4.2 Parameters characterizing the physical barrier of epithelia 
 
The ascertainment of tightness and permeability characteristics of a respective epithelium is 
essential for carrying out drug transport studies. The three most common techniques used to 
estimate the barrier properties of epithelial cells are: i) thin section electron microscopy, 
which provides a direct visualization of tight junctions; ii) transepithelial electrical 
measurements (TEER), which serve as an index for the paracellular flow of ions; and iii) 
permeability of compounds, which are transported across the cell layer exclusively by the 
paracellular route (i.e. flux measurements of hydrophilic non-electrolyte solutes) and serve as 
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an index of the functional restriction to solute transport through the tight junction, based on 
solute size, shape and charge [1,13]. Minimal assessment of tight junctional function requires 
the determination of both, the electrical resistance and the permeability of selected 
macromolecular solutes [13]. 
Recent studies dealing with these kinds of cell-cell interactions discuss the possible 
molecular architecture of TJ plaque structures and state that one functional role of the tight 
junctional zonula-occludens protein-1 (ZO-1) is to organize components of the tight junction 
and link them to the cortical actin cytoskeleton [165,166]. 
After a preceding histological and morphological characterization by microscopic techniques 
or the determination of certain marker proteins, the functionality of the passive physical 
barrier is mainly defined by two parameters, namely TEER and permeability. 
 
 
4.2.1 Transepithelial electrical resistance, TEER 
 
Since barrier properties and cell-cell-contacts form a central interesting aspect of in vitro 
models, the determination of connected parameters comes into focus. As a widely accepted in 
vitro culture technique, the performance of such a TEER measurement is illustrated in 
Figure 1-3. It demonstrates how a chopstick electrode has to be placed in order to measure the 
transepithelial resistance without damaging the surface of the cell monolayer. Since the 
measured values are usually referred to the corresponding surface area (=filter surface) the 
resulting unit is [Ωcm²]. 
 
 
 
apical compartment 
basolateral compartment 
cell monolayer 
filter
Fig. 1-3. Experimental set-up showing a transwell filter insert, covered by a cell monolayer on 
its permeable growth support, during measurement of transepithelial electrical resistance 
(TEER) using an electrical voltohmmeter (EVOM®) equipped with a chopstick electrode 
(STX-2) 
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4.2.2 Permeability coefficient, Papp 
 
The vast majority of cell culture models used to study drug absorption consists of epithelial 
cells, which are grown as confluent monolayers on semi-permeable supports. In principle, the 
polarized cells separate an apical from a basolateral compartment of a multifaceted diffusion 
chamber system (compare Fig. 1-3), and thus enable application of a test compound into the 
donor compartment (either apical or basolateral side), as well as monitoring and determination 
of the drug amount reaching the acceptor chamber subject to time [1]. These drug amounts are 
used to calculate the corresponding permeability coefficient for a certain compound. This 
parameter characterizes its ability to overcome the epithelial barrier and may serve as a first 
hint to its potential bioavailability in vivo. The apparent permeability coefficient (Papp) is 
calculated using the following equation with the resulting dimension being that of velocity, 
i.e. cm/sec: 
 
   Donorapp VAmdt
dQP ⋅⋅⋅= 11
0
; [cm/sec] 
 
where dQ/dt is permeability rate (steady state transport rate) obtained from the transport-time 
profile of the substrate, A is area of the exposed cell monolayer [cm2], m0 is the original mass 
of the marker substance in the donor compartment, and VDonor is volume of donor 
compartment [cm3]. 
 
The permeability of hydrophilic substances (i.e. predominantly paracellular transport), 
depends on the tightness of the epithelial monolayer and thus finally on TEER. This fact is 
confirmed in Figure 1-4, which compares different epithelial in vitro models (two bronchial 
and one intestinal cell line with a primary cell culture model) and culture conditions. The 
correlation of the calculated permeability coefficients with the corresponding TEER values 
results in a sort of cut off at more than 400 Ωcm² for each of the tested variations. 
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TEER [Ω•cm2]
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0,0
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Calu-3 LCC
Calu-3 AIC
16HBE14o- LCC
16HBE14o- AIC
Caco-2 LCC
HAEpC LCC
 
Fig. 1-4. Interdependence between permeability coefficient of the hydrophilic marker sodium 
fluorescein and the corresponding transepithelial electrical resistance. Comparison of different 
epithelial in vitro models results in a sort of “cut off” at more than 400 Ωcm². LCC, liquid 
covered culture/conditions; AIC, air interface culture; Calu-3, carcinoma lung, cell line; 
16HBE14o-, human bronchial cell line; Caco-2, carcinoma colon, cell line; HAEpC, human 
alveolar epithelial primary cells. (Reprinted from Ehrhardt [167] with permission.) 
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4.3 Metabolic enzymes and efflux systems representing biochemical barriers 
 
An important aspect of any in vitro model from a functional point of view is metabolism as 
part of the ADME-principle (Absorption – Distribution – Metabolism – Elimination). The 
epithelium lining the airways of the lung plays a key role in regulating the entry of inhaled 
foreign compounds or xenobiotics into the body and represents the primary defense against 
inhaled pollutants. There exist various mechanisms for dealing with inhaled pollutants as well 
as therapeutic agents: for instance, metabolism to forms which are less toxic or active and/or 
more likely to be excreted, or alternatively absorption and allowance of unchanged 
circulation, or at last promotion of excretion prior to absorption via the mucociliary transport 
system [168]. To predict the metabolic fate of a xenobiotic delivered to the lung, apart from 
physical factors (such as particle size or shape, hygroscopicity, flow rate, inhalation volume), 
the regional and cellular localization of enzymes will be important, because their activity may 
be influenced by genetic, physiological and environmental factors [1]. 
 
 
4.3.1 Metabolic enzymes 
 
The metabolic capacity of the lung is important for modeling barriers and there exists a 
review stating that most of the xenobiotic metabolizing activity is associated with two cell 
types: Clara cells and alveolar type II cells. Many other cell types in the lung do not contain 
cytochrome P-450, hence the amount of P-450 per mg of microsomal protein in the lung is 
much lower than that in the liver [169]. Currently, the cytochrome P450 enzymes of the lung 
are considered to be concentrated in specific cell categories, with the major activity in the 
lung attributed to Clara cells, type II pulmonary epithelial cells and alveolar macrophages 
[170-173]. 
The expression of phase I and phase II enzymes was evaluated by reverse transcription-
polymerase chain reaction (RT-PCR) as well as Western blot analysis. Results lead to the 
conclusion that the pulmonary system expresses numerous phase I enzymes, which catalyze 
the activation of environmental procarcinogens. Together with a low metabolic capacity of the 
pulmonary system compared to the liver, location and function of this organ suggests an 
important role in the aetiology of chemical-associated cancers [174]. 
Peptidases, as another class of enzymes, with their physiological function in the regulation of 
biologically active endogenous peptides (in healthy and diseased epithelium), certainly 
influence the pulmonary delivery of peptide based therapeutics as well [1,175]. Related to 
peptide hormones, these enzymes were studied in human bronchoalveolar lining fluid, 
macrophages and epithelial cells (BEAS-2B and A549). As a result, only aminopeptidase N 
and dipeptidyl (amino)peptidase IV activities were detected in extracts of bronchial epithelial 
and alveolar cells [176]. 
Thus the metabolism of inhaled pharmaceuticals seems to be a profound determinant for their 
pharmacokinetics and therefore indispensable for predicting the potential for presystemic 
metabolism. Nevertheless, the general significance of metabolism for the air-blood barrier still 
remains to be estimated. 
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4.3.2 Efflux systems 
 
Indeed these systems are the reason why molecules or drug substances are sometimes 
obviously not capable to overcome an epithelial barrier within an organism. Therefore, in 
context with the development of new drugs and chemotherapeutics in particular, the 
phenomenon, referred to as multidrug resistance (mdr), gains in importance. Studies have 
shown that cancer cells overexpress membrane bound proteins that efflux drugs out of the 
cells [177]. In order to be able to assess in vitro models with respect to their suitability for 
functional studies, the presence of such mechanisms is absolutely relevant. 
In principle, the mdr-phenomenon reveals itself as a polarized transport of substrates across a 
biological barrier (directional flux). For apically-localized efflux systmes the secretory 
permeation (i.e. from basolateral to apical, b Æ a) exceeds the absorptive one (a Æ b). Some 
of these efflux systems are identifiable by applying specific inhibitors. Calculating the 
permeability coefficient for both transport directions (basolateral to apical and the opposite 
way), their quotient Papp(ba)/Papp(ab) symbolizes the transport ratio. For no active transport or 
efflux this transport ratio is approximately 1, whereas in case of resistance, i.e. presence of an 
efflux system, a ratio of five and more is expected. In general: does the numerical value of 
this constant amount to >1, which means a prevailing transport from basolateral to apical 
direction, the result is a significantly reduced absorption caused by a resistance mechanism; 
this occurrence is referred to as mdr-phenomenon. 
 
During recent years, numerous studies have focused on the presence of efflux systems in 
various in vitro models, such as e.g. the intestinal Caco-2 cell line, MDCK cells, the blood-
brain-barrier, A549, Calu-3 and 16HBE14o- [167,178-187]. The following data illustrate the 
effect such secretory transport caused by mdr may have on transport ratio or directionality: 
The apparent permeability coefficients, determined by comparing two different in vitro 
models, show a transport ratio of 4.8 and 2.9 in case of the mdr-substrate rhodamine-123 for 
Caco-2 and 16HBE14o- respectively. This effect is leveled in presence of an efflux inhibitor, 
like verapamil, thereby reducing the ratio from 2.9 down to 1.02 in the 16HBE14o- model. In 
contrast, in case of the non-substrate sodium fluorescein no difference in transport ratio could 
be observed [163]. 
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Table 1-4. Comparative Papp values of permeation markers across 16HBE14o- and Caco-2 
cell layers cultured on Transwell Clear filter inserts 
 
Papp [×10-6 cm/sec]a  
16HBE14o- Caco-2 
solutes ±Verapamil absorption secretion absorption secretion 
Rhodamine 123 - 1.52 ± 0.24 4.48 ± 0.28 0.49 ± 0.19 2.35 ± 0.15b 
Rhodamine 123 + 1.43 ± 0.09 1.47 ± 0.11 ND ND 
Fluorescein-Na - 0.85 ± 0.03 0.82 ± 0.04 0.26 ± 0.07 0.34 ± 0.01 
Fluorescein-Na + 0.85 ± 0.03 0.84 ± 0.02 ND ND 
aMean ± S.D. (n = 12) 
bSignificantly (p > 0.05) from absorptive direction 
Data from previous research [163]. 
 
In parallel to the mere effect on substrate permeability, the occurrence and localization of the 
responsible membrane structures has also attracted scientific interest. CFTR (cystic fibrosis 
transmembrane conductance regulator), MDR1 (multi-drug resistance), and MRP1 (multidrug 
resistance-associated protein) are all members of the ABC transporter superfamily (ABC = 
ATP-binding cassette); they are attributed multiple functions, like Cl-, anion and glutathione 
conjugate transport and play a role in cell detoxification [112]. The multidrug resistance (mdr) 
genes encode P-glycoproteins (P-gp), or integral membrane proteins, which function as drug 
efflux transporters and whose effect is illustrated in Table 1-4. In the meantime several more 
efflux transporters, besides from the well known P-gp, have been discovered, identified and 
clearly localized in quite a lot of in vitro models as well as in native tissues. 
 
Apart from the possibility to identify substrates and non-substrates of efflux systems among 
new drug candidates, cell culture models offer promising perspectives in the development of 
new strategies to overcome resistance problems and to improve the efficiency of therapeutic 
drug substances. A recently published survey tries to classify a number of (about hundred) 
various compounds to categories like P-gp-substrate, Non-P-gp-substrate, mdr-inductor or 
borderline substrates (= contradicting results from different studies, no clear classification 
possible). Moreover, its author intends to establish a connection between structural elements 
and their capability to interact with P-gp [188]. 
A relatively new and intensely discussed point of interest is the involvement of caveolae and 
caveolins in the mdr phenomenon, brought about by the observed upregulation of caveolin in 
multidrug resistant cancer cells and connected functional implications. However, the 
molecular mechanisms by which caveolin-1 exerts its effects on cell proliferation, cell 
survival and multidrug resistance still remain to be fully elucidated [189]. 
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5. FEATURES AND APPLICATIONS OF SOME SELECTED CELL CULTURE 
MODELS OF THE LUNG 
 
The selection of the following models described in more detail is based on their acceptance in 
current research. Indicators are e.g. the frequency and incidence of publications or the number 
of projects and scientists dealing with their further characterization and evaluation. Moreover, 
their importance for certain fields of application as well as the aim to represent each level of 
the respiratory tract were taken into account. The tables that provide an overview of relevant 
in vitro models are subdivided into the different lung regions and the models arranged 
according to anatomical aspects as well as in consideration of complexity (starting with the 
most complex model and following the bronchial tree to the gas exchange or distal area). 
(Table 1-5 A, B, C). 
 
 
5.1 Tracheal epithelium 
 
As representatives of tracheal epithelial cells, two different in vitro models are focused, a 
primary one originating from rat, and a cell line, named SPOC1. 
Under certain in vitro culture conditions rat epithelial tracheal cells (RET) are able to 
differentiate in primary culture as to mucociliary, mucous or squamous phenotypes; the first 
one most closely approximating the tracheal epithelium in vivo. This expression of a 
mucociliary phenotype was demonstrated as requiring retinoic acid, collagen gel substratum 
and an air-liquid interface (i.e. removing apical medium and feeding only from the bottom 
compartment). If plated at a density of 1×104 cells/cm², cells will reach confluence from day 7 
onward [190]. 
SOPC1 stands for a rat tracheal goblet cell line, which is used as a mucus secreting drug 
absorption model of the airway epithelium and was spontaneously derived from secondary rat 
tracheal epithelial cell cultures by Doherty et al. about 8 years ago [191,192]. These cells are 
usually cultured at an air-liquid interface on Transwell-Col cell culture supports, resulting in 
transepithelial resistance of 112±14 Ωcm² for a plating density of 8×105 cells/cm². Transport 
experiments were performed at day 13 after plating and the permeability of mannitol was 
determined to be 6.56±0.58×10-6 cm/sec. As an addition to the range of applications, this 
model allows an evaluation of the effect of mucus layer on drug transport, since it features a 
mucus secretion that is under purinergic control and that can be stimulated by ANP-PNP 
(5’adenylyl imidophosphate) [192]. According to the authors report a doubling in thickness of 
the mucus layer (mucus secretion approximately three-fold) reduces transport rates of certain 
compounds, while others remain unaffected; therefore no consistent relationship between MW 
(molecular weight) and the effect of mucus on transport, as well as no apparent correlation 
between lipophilicity of compounds and effect of mucus on drug transport, could be identified 
[193]. 
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5.2  Bronchial (airway) epithelium 
 
Proceeding to the next “lower” level of the respiratory tract, i.e. the bronchi, the currently 
most popular human cell lines, Calu-3, 16HBE14o- and BEAS-2B, have been frequently 
used as models for the study of drug transport, drug metabolism and gene delivery at the 
bronchial (airway) epithelium. 
The Calu-3 cell line is of human origin, available from ATCC and features epithelial 
morphology as well as adherent growth [194]. It is a human sub-bronchial gland cell line, 
which was derived from a bronchial adenocarcinoma in a 25-year-old Caucasian male [1]. 
After screening for ultrastructure, levels of airway secretory proteins and mRNA, the Calu-3 
was found to be the only one out of 12 cell lines derived from human lung cancers, with the 
mRNA and protein content characteristic of the native epithelium [195], and thus identified as 
belonging to the better differentiated cell lines [19]. Due to its ability to form polarized 
confluent monolayers with tight junctions (TJ) [196], the cell line is supposed to constitute an 
appropriate tool for the study of TJ regulation in bronchial epithelium. Calu-3 cells have been 
shown to express the proteins of the major intercellular junctions, such as functional tight 
junctions, desmosomes and zonulae adherens [1]. Moreover, the TJ proteins occludin and ZO-
1 were found in continuous circumferential patterns suggestive of functional TJs. This 
observation is paralleled by the development of significant transepithelial resistances and a 
low paracellular permeability to solutes such as mannitol with a permeability coefficient of 
2.37×10-6 cm/sec measured on day 14 and 0.31×10-6 cm/sec on day 3 [197]. For the most 
commonly chosen plating density of 5×105 cells/cm² (growth on filter supports) the reported 
TEER values range from 100 Ωcm² [196] over 200 Ωcm² on day 6 and 500 Ωcm² on day 9 in 
culture [173] up to 1185 Ωcm² [198] or even 2500 Ωcm² [199]. Such discrepancies obviously 
reflect a relatively large lab to lab variability, which may be due to differences in culture 
conditions, the selection of individual (sub)clones or the different techniques employed to 
measure the TEER (Ussing chamber versus End-Ohm Chamber or STX-2 electrode); this is 
why care should be taken when comparing TEER values of different laboratories [173,199]. 
In terms of culture conditions, a recently published comparison of conventional liquid-
covered (LCC) with air-interfaced culture (AIC) resulted in different TEER values with 
1185 Ωcm² on day 16 and a slow decrease to 900 Ωcm² afterwards in the presence of an 
apical fluid lining (LCC). This is in contrast to AIC with about 500 Ωcm² after 10 days in 
culture and remaining at this level without any peak, although (in parallel) a regular 
appearance of the staining pattern for ZO-1 and E-cadherin could be found in both, LCC and 
AIC cells [198]. 
The fact that Calu-3 cells exhibit differentiated features and ion transport characteristics, 
including the presence of a functional CFTR (cystic fibrosis transmembrane conductance 
regulator) in cAMP-dependent Cl—secretion, and the capability of a chloride secretion that is 
sensitive to β-adrenergic stimulation, is just one more argument to speak in favor of this in 
vitro model. Furthermore, Ca-activated Cl--channels are absent from the apical membrane 
[13,196]. 
Due to their origin from sub-bronchial glands, as mentioned above, Calu-3 are able to produce 
mucus when grown as resistant monolayers under air-interface culture conditions [200]. They 
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also contain secretory granules and express mucus genes more typical of goblet cells or 
mucous gland cells [1,19,196,201]. 
Their potential as a drug absorption model is emphasized by quite a large number of 
published transport studies. Several compounds were investigated in this model, such as 
Lucifer Yellow, FITC-Dextran 3000, FITC-Dextran 70000, diltiazem, insulin, ciprofloxacin, 
mannitol, digoxin, vinblastine, flunisolid, sucrose, epinephrine, morphine, nicotine, cocaine, 
albuterol sulfate, salbutamol, and budesonid or triamcinolonacetonid [167,173,181,200,202]. 
Calu-3 also proved useful as a research tool for the development of more efficient gene 
delivery strategies, like lectin-facilitated lipofection, which is thought to enable a cell type 
specific gene targeting [130]. In order to assess the cell line’s potential as a metabolic and 
transport model, its metabolic capacity was also examined and two P450 isozymes (1A1 and 
2B) were determined to be functional but not inducible. Western Blots of Calu-3 microsomes 
revealed that the cells expressed several more CYP-enzymes, which were not inducible either 
[173]. 
In terms of functionality and multi drug resistance (mdr), evidence was given for an active 
apical to basolateral transport of flunisolid across Calu-3 cells. This was facilitated by MDR1-
P-gp, being located in the basolateral membrane [202]. Other studies demonstrating functional 
P-glycoprotein (P-gp) activity in Calu-3 cells were published the same year: for instance, the 
basolateral membrane localization of MRP1 (multi drug resistance related protein) compared 
to P-gp found on apical side of Calu-3 cells was shown by means of indirect 
immunofluorescent staining. It was also proven that Calu-3 cells possess MRP1 functional 
activity that is subordinate to P-gp efflux [187]. A similar study reports that Calu-3 express 
lower levels of P-gp than both, the intestinal epithelial cell line Caco-2 and the alveolar 
epithelial cell line A549 (see below), and that they actively efflux the P-gp substrate 
rhodamin 123 out of the cell, while mixed inhibitor studies demonstrated this efflux to be 
mainly P-gp mediated [203]. A subsequent study tried to find out whether or not P-gp efflux 
pump activity in Calu-3 is inhibited by glucocorticosteroids and β-ligands, and if formulation 
additives may affect P-gp activity. Results stated that both therapeutic classes inhibited 
rhodamin 132 efflux with increasing hydrophobicity, but steroidal P-gp substrates were non-
modulating. There was no effect of formulation additives on P-gp activity or on rhodamin 123 
accumulation respectively [204]. 
As a summary, the presence of tight junctions, together with additional secretory activity and 
the possibility of investigating formulation additives, underline the potential of this cell line as 
in vitro model for pulmonary drug absorption studies. 
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Another prominent bronchial epithelial cell line, designated 16HBE14o-, is a normal human 
airway epithelial cell line, which was obtained by transformation of cultured bronchial-
surface epithelial cells from a one-year-old male heart-lung (transplant) patient. It is a 
postcrisis large SV40 large T-antigen transformed epithelial cell line, derived from human 
bronchial epithelium, and only available as a gift from Dieter Gruenert at the Cardiovascular 
Research Institute at University of California, San Francisco, USA [1,162]. 
In culture 16HBE14o- cells form polarized cell monolayers [19] and particularly display 
many properties of bronchial basal cells; e.g., showing the same lectin-binding patterns and 
expressing the intercellular adhesion molecule (ICAM-1) [163,205,206] as do the basal cells. 
Confluent polarized monolayers show extensive tight junctional belts, which were identified 
as similar in appearance to those found in intact human tissue, and freeze-fracture electron 
microscopy of cultured 16HBE14o- cells revealed how well-formed they are [207,208]. The 
corresponding proteins, ZO-1 and occludin, were detected in continuous circumferential 
patterns suggestive of functional TJs [197,209]. Likewise, expression of E-cadherin and its 
importance for epithelial integrity was proved by Western Blot analysis [210]. By means of 
immunofluorescence stainings a recent study in this laboratory compared the influence of 
different culture conditions, AIC versus LCC, on the expression of proteins, contributing to 
the formation of cellular junctions, and their localization or cytosceletal organization. For ZO-
1, occludin, claudin-1, connexin43 and E-cadherin, a characteristic and more intensive 
staining pattern along the cell borders was found for liquid-covered cells in contrast to an 
irregular and incomplete appearance observed in cells grown under AIC conditions. These 
findings were confirmed by a parallel monitoring of transepithelial resistance, resulting in 
TEER values between 500 and 800 Ωcm² for cells cultured in the presence of an apical fluid 
lining (maximum on days 7-9) versus no peak development and only slow increase to 
127±20 Ωcm² (day 17) without (plating density 105 cells/cm²) [163]. Other TEER values 
reported for this cell line range from 160 Ωcm² [208], over 260 Ωcm² if cultured on vitrogen-
coated supports at an air-interface [211] and up to a maximum of 330 Ωcm² on days 6-8 
[197]. A higher plating density of 4.25×105 cells/cm² in combination with collagen (vitrogen) 
coated supports and AIC lead to similar TEER values between 150 and 240 Ωcm² [212]. In 
terms of paracellular integrity, a limit TEER value was defined as 270 Ωcm², with higher 
resistances not resulting in significantly decreased permeability coefficients, as determined for 
the anionic hydrophilic marker sodium fluorescein [163]. (Fig. 1-4). 
Apart from featuring basal cell like morphology, cells grown on collagen-coated supports at 
an air-liquid interface, retained important properties of differentiated airway epithelial cells, 
including apical microvilli and cilia [162]. Later on, electron microscopic studies revealed 
that microvilli were formed under each of the tested culture conditions AIC and LCC. 
Nevertheless, in the case of LCC conditions, the formation of a relatively thin layer of only 1-
5 cells in thickness with a high TEER (500-800 Ωcm²) was observed, whereas the epithelial 
barrier of air-interfaced cultured cells was rather thick, comprised of 10-16 cells in thickness, 
but nonetheless showed a relatively low electrical resistance (130 Ωcm²). (Fig. 1-5). As 
proved by light microscopy observations, LCC-grown cells possess a more flattened 
morphology and differ from the squamous metaplasia-displaying AIC-cultured cells, which 
appear more rounded [163]. 
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Fig. 1-5. Light micrograph of 16HBE14o- cells after 18 days of culturing either under 
(A) LCC throughout or (B) AIC conditions from day 1 onward. Cells were plated on 
Transwell Clear inserts at a density of 105 cells/cm². (Reprinted from Ehrhardt et al. [163] 
with permission from Springer-Verlag.) 
 
As another important characteristic of airway epithelial cells, 16HBE14o- show regulated ion 
transport, as they retain β-adrenergic stimulation of cAMP-dependent chloride ion transport 
[162]. Actually, the cell line was developed pursuing the aim of studying the chloride channel 
activity of the cystic fibrosis transmembrane conductance regulator (CFTR) in normal airway 
epithelial cells [162,213]. Moreover, the cells express both the CFTR mRNA and protein, 
readily detectable by Northern and Western hybridization analysis respectively, thus 
providing a valuable resource for studying the modulation of CFTR and its role in regulation 
of chloride ion transport in human airway epithelium as well as other aspects of human airway 
cell biology [162]. 
However, a great disadvantage of this in vitro model is that it does not have a mucus feature 
that protects the epithelium in vivo [1]; in contrast to Calu-3, 16HBE14o- do not secrete 
mucus [212]. 
Nevertheless, the 16HBE14o- cell line is assessed as a potential drug absorption model as 
proved by various transport experiments. Compounds, whose permeability in this model was 
determined, are e.g., mannitol, sodium fluorescein, FITC-dextran 4000, atenolol, propranolol, 
formoterol and salbutamol [1,163,197,211,212,214]. In vitro experiments with substances 
usually administered as therapeutic aerosols to the lungs, like salbutamol, budesonid, 
triamcinolonacetonid and insulin have been published recently [167]. In addition, studies exist 
which deal with the effect of drug delivery vehicles on epithelial permeability. They conclude 
that the physicochemical properties of inhaled formulations like pH and ionic strength, as well 
as osmolarity, may influence epithelial permeability [214]. Data thus obtained suggest that the 
physicochemical properties of inhaled formulations should be carefully controlled as e.g., the 
effect of buffer composition on mucus secretion shows that even the application of 
“physiological solutions” may affect the epithelium [212]. In addition, the model proved 
useful in questions addressed to gene delivery strategies [215,216]. These facts lead to the 
conclusion that this human bronchial epithelial cell line maintains cell polarity (tight junctions 
and directional ion transport) and serves as a model for studies of airway, disease, ion 
transport, secretion, viral infection, and cell-cell interaction properties of bronchial cells. 
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A similar, but less well characterized model, is 1HAEo-; these are normal human airway 
epithelial cells, SV40 transformed and obtainable as gift from Dr. Dieter Gruenert, University 
of California, San Francisco [162]. Like 16HBE14o-, they bind lectins in the same pattern as 
basal cells do in tissue [205], but far less attention is paid to their further examination, ending 
up in a rather low significance as current in vitro model. At least this transformed cell line has 
been shown to form tight junctions and together with the tracheobronchial 9HTEo- and 
56FHTEo- cells (also available from the Gruenert laboratory), serves as pulmonary tissue 
model [217,218]. 
 
For a decent relevant model, as judged by its frequent application, stands the human bronchial 
epithelial cell line BEAS-2B. It is derived from normal human (bronchial) epithelial cells 
(obtained from autopsy of non-cancerous individuals) and immortalized using the adenovirus 
12-simian virus 40 hybrid virus [219]. Cells are available from ATCC; they retain the ability 
to undergo squamous differentiation in response to serum and are recommended for screening 
of chemical and biological agents with respect to their ability to induce or affect 
differentiation and/or carcinogenesis [194]. They are also popular in studies of airway 
epithelial cell structure and function because of their phenotype, cytokine regulation, 
regulation of glucocorticoid receptors and response to challenges such as tobacco smoke, 
particles or hyperoxia. Although being amongst the most widely used cell lines for the study 
of cell biology, pathologic processes and drug metabolism, they have limited potential in 
modeling drug absorption, because they do not form tight junctions as readily as 16HBE14o- 
and Calu-3 cells do [1]. In parallel to the first, they also lack the secretion of mucus [212]. 
Since polycarbonate microporous cell culture inserts seemed unable to support cell growth, it 
was necessary to coat the inserts. Several coatings proved useful, including a combination of 
fibronectin, vitrogen and bovine serum albumin, which, together with Ultroser G serum 
substitute, exhibited a maximum resistance TEERmax of 70 Ωcm² when cultured at an 
air/liquid interface. Obviously it is not easy to generate resistances greater than 100 Ωcm² 
using BEAS-2B cells of intermediate passage [220]. On the other hand, they have been taken 
into consideration when studying the expression and activity of Xenobiotic-metabolizing 
enzymes [1,174]. In this context (metabolism), they have been shown to express peptidase 
activity in the form of neutral endopeptidase 24.11 and aminopeptidase M, whereas 
carboxypeptidase and dipeptidylpeptidase IV activity were not detected [175]. Recent case 
examples expanding this research field could e.g. demonstrate that Haemophilus influenzae 
stimulates expression of the adhesive glycoprotein ICAM-1 on the surface of respiratory 
epithelial cells (feature of basal cells) [221]. Furthermore, the BEAS-2B were used to study 
cell specific expression of secretory phospholipase A2 isotypes, suggesting them to provide a 
mechanism of pulmonary surfactant hydrolysis during lung injury [222]. 
 
Two more cell lines are of great interest from the therapeutic point of view, since they serve 
as model for the common airway disease cystic fibrosis (CF), the CF/T43 and IB3-1 cell 
lines. The first was derived from airway epithelial cells of a CF patient and transformed by 
SV40T gene [223] and is generously supplied by Dr. J. Yankaskas, University of North 
Carolina at Chapel Hill. It has been used to study PKC-δ-dependent activation (protein 
kinase C) of basolateral Na-K-2Cl cotransport in preserved CF cells and the cell line was 
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compared with tissue from non-CF tracheas and nasal polyp specimens from CF patients 
[224]. IB3-1 cells, also originating from a human CF patient, were examined in relation to 
infection models for the release of inflammatory mediators in CF [225,226]. Together with 
MDCK and T84, they serve as model systems for secretory epithelia that are intended for 
studying the effect of a synthetic peptide on the Cl--permeability in epithelial cells and the 
mechanism of its induction [226]. Moreover, the institute of D.C. Gruenert provides some cell 
lines especially for applications connected to CF (e.g. CFBE41o-, CFSMEo- and  
6CFSMEo-), which should be helpful in investigating the relationship between the CF defect 
and mucous secretion [218]. 
 
Finally, the cell line H441, which is interchangeably considered to model the alveolar or else 
the bronchial level, should be mentioned as an in vitro model for research topics that differ 
from drug transport (like BEAS-2B). It is a human airway epithelial cell line, which was 
derived by A.F. Gazdar in 1982 from the pericardial fluid of a patient with papillary 
adenocarcinoma of the lung. The cells expressed mRNA and protein of the major surfactant 
apoprotein (SP-A) and the cell line has been used as a transfection host for expression of 
pulmonary surfactant protein (SP-B) [194]. Since electron microscopy showed multilamellar 
bodies and cytoplasmic structures resembling Clara cell granules, they are referred to as a 
Clara-cell-like cell line [41,194,227]. They proved useful in evaluation and enhancement of 
gene expression as well as convenient for the qualitative assessment of gene incorporation 
into a host cell and expression of deficient protein; however, they seemed less suited for the 
quantitative assessment of drug or macromolecular transport [13,228,229]. Other research 
groups maintain that H441 feature a more type II like morphology, what would recommend 
them as a model for the alveolar level of the respiratory tract [230]. But in a recent 
publication, these cells are once more classified as a bronchiolar epithelial cell line [231]. 
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5.3 Alveolar (respiratory) epithelium 
 
Proceeding towards the distal lung regions, there also exist several models of interest: 
primary culture of epithelial cells isolated from rat or human lungs, and in terms of cell lines, 
the A549, L2 as well as AK-D cells, which will be described in more detail. 
Today, primary alveolar epithelial cells isolated from rat lungs, are one of the best-
established and most suitable in vitro models. They have been well characterized, and are 
concomitant with high reproducibility, convenient availability and economics of pathogen-
free animals [54]. The fact that rat alveolar epithelial cells are reported to share similar 
characteristics, such as phospholipid secretion similar to that of human type II cells, 
underlines their relevance [13,232]. In terms of morphology, freshly isolated type II cells 
exhibit lamellar bodies. These intracellular inclusions could be visualized in rat alveolar 
type II cells by means of tannic acid and polychrome staining [55,74]. Very detailed 
morphometric, morphologic and electron microscopic studies were performed with regard to 
parameters like cell density, surface area, arithmetic mean thickness (AMT), as well as 
aspects like differentiation. After five days in culture, cells in vitro exhibited morphological 
characteristics of type I pneumocytes with thin cytoplasmic extensions and protruding nuclei. 
This flattening, valued as a typical sign for differentiation, is confirmed by AMT 
measurements resulting in 3.3±0.5 µm on day 2, versus 0.5±0.2 µm after 6 days in culture. In 
parallel, the mean individual cell surface area increased from 476±14 µm² (2d) up to 
1268±21 µm² (6d). Whereas at the same time, cell density dropped from a mean of 
224±9 cells/mm² (2d) down to 114±15 cells/mm² (6d), what means a decrease in cell number 
[62]. Since more than 95% of the surface area in the distal airspaces of the lung is lined by 
type I cells, these observations (differentiation to type I-like cells) justify this model as 
particularly relevant for in vitro studies of transport phenomena [95]. Another qualifying 
feature with respect to transport experiments is the capability of generating transepithelial 
resistances sufficient in height. Two main plating densities of 1.0 and 1.5×106 cells/cm² 
respectively, result in TEER values of more than 2000 Ωcm² and in a potential difference of 
approximately 10 mV, reached between third and fifth day of culture [149]. As suggested by 
these measurements, the presence of several transport related proteins could be identified, 
including ion transport processes such as the polarized expression of sodium transporters 
(Table 1-1) and specialized transporters (Table 1-2). During the last decade, numerous drug 
transport studies benefited from this primary model. Some of them focused on passive 
permeation, e.g. of lipophilic solutes, dextrans and osmotic water flow [95,139,233,234]. 
Others were interested in active and passive permeation of amino acids, peptides and proteins 
[120,144,149,235]. Finally, primary cultured pneumocyte monolayers also proved useful in 
the investigation of other cell biological characteristics e.g., expression of caveolae or 
caveolins [83]. Trying to confirm the in vivo result of caveolae being present in alveolar 
epithelial type I cells, but absent in its progenitor (type II cell), it was demonstrated that 
freshly isolated rat type II cells lack caveolae and expression of caveolin-1 (a critical caveolae 
structural protein). But as type II cells acquired a type I-like phenotype in primary culture 
caveolin-1 expression increased, with caveolin-1 signal at 192 h postseeding up to 50-fold 
greater than after 60 h; caveolae were morphologically evident only after 132 h. In parallel, 
maintenance of a differentiated type II cell morphology with time, i.e. by culture upon 
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collagen with an apical interface of air, a temporal increase in caveolin-1 expression was not 
observed and only very faint signals evident even at 192 h postseeding; in addition these 
cultures did not display any caveolae at all [83]. 
A similar model, derived from the same species, is the so-called FDLE (primary rat fetal 
distal lung epithelial cells). According to the isolation method described recently, cells are 
plated onto Transwell Col membranes at a plating density of 1.5×106 cell/cm², where they 
form coherent epithelial layers with transepithelial resistances >200 Ωcm². First change of 
medium and concomitant removal of debris takes place about 18-24 h after plating. 
Approximately 48 h after isolation cells are ready for studies [236]. This fetal model 
contributed to clarify the effect of PO2 on these cells, and was studied in order to understand 
processes taking place shortly before and after birth, when PO2 changes and liquid has to be 
removed from the lungs enabling the newborn infant to breath. This process is driven by the 
active absorption of sodium from the lung lumen. The removal is done while the distal lung 
epithelium ceases to secrete liquid and begins to absorb the fluid already present. As was 
proved, raising ambient PO2 from its fetal level evoked increased Na+ absorption [236]. A later 
work addressing this special model examined the role of nuclear factor κB activated 
transcription of genes encoding the subunits, which form the Na+ channel (ENaC) in O2-
evoked Na+ transport [100]. 
 
An approach very close to the in vivo situation uses primary alveolar epithelial cells 
derived from human lungs (hAEpC) after surgery [232,237]. Alveolar type II cells of 
human origin are isolated from resected lung and their maintenance in culture was described; 
they were shown to secrete phospholipids, a characteristic of pulmonary surface-active 
material [232]. Subsequent development led to the establishment of a primary model, which 
appears to be a valuable in vitro model for pulmonary drug delivery and transport studies, 
since cells in culture spread to confluent monolayers with peak TEER of 2100 Ωcm² and PD 
of 13.5 mV. In addition, they exhibit tight junctions as well as desmosomes, show cell 
specific lectin binding and follow a differentiation process. Transport studies with hydrophilic 
macromolecular FITC-dextrans across cell monolayers revealed an inverse relation between 
permeability and molecular size [237]. 
In terms of differentiation, they show the characteristic flattening of cells and transition from 
a more round sectioning profile (type II) in early culture stages into type I morphology with 
flat extensions, as is clearly illustrated in Figure 1-6. 
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Fig. 1-6. Cross sections through cultured human alveolar epithelial cells (hAEpC) at different 
times of culture (A-E), visualized by scanning electron microscopy. Bar = 10 µm. (Reprinted 
from Fuchs et al. [238] with permission from Springer-Verlag.) 
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Nevertheless, in cultures at the age of 8 days, round cells are still occasionally found 
interspersed in the monolayer and they also contain the typical multilamellar bodies. By 
means of various techniques such as flow cytometry, immunofluorescence, immunoblotting 
and reverse transcriptase polymerase chain reaction (RT-PCR), a shift in the synthesis of 
important marker proteins could be proven: the protein biosynthesis switches with time in 
culture from low caveolin-1 and high surfactant protein C (Sp-C) to high caveolin-1 and low 
Sp-C levels. Moreover, electron microscopy revealed the presence of omega-shaped 
invaginations in apical and basal plasma membranes of those extensions in flat type I cells. 
The distribution of these flask-like sectioning profiles in ultrathin monolayer sections 
(referred to as caveolae) correlates with that of small, concentric and uniformly sized holes, 
which could be observed on the surface of cultured hAEpC via scanning electron microscopy 
(Fig. 1-7) [238]. 
 
 
 
      
      
 
 
 
 
 
 
 
 
 
 
 
Fig. 1-7. Formation of caveolae. D Donor lung tissue used for primary cell culture of human 
alveolar epithelium type I (ATI) cells, visualized by transmission electron microscopy 
(scale bar = 0.2 µm). G Scanning electron microscopy of hAEpC at the age of day 10 
(scale bar = 0.5 µm). (Reprinted from Fuchs et al. [238] with permission from Springer-
Verlag.) 
 
Due to the demonstrated similarity between human alveolar epithelium and the primary cell 
culture, these data suggest that hAEpC is a suitable and useful tool in the study of epithelial 
transport and cell biological processes. 
Nevertheless, there exist some disadvantages, which weaken the favored position of this 
human model, and because of ethical considerations, commercial use will hardly be accepted. 
Moreover, it should be kept in mind that as the material is mainly derived from lung surgeries, 
i.e. from tumor patients, which are often elderly people, some tumor cells might eventually 
contaminate this biopsy material. Another drawback to be faced is the risk of some variability, 
e.g. smokers versus non-smokers as well as the incidence of lung or hereditary diseases. 
Finally, these primary cells have turned out to react very sensitively to environmental 
conditions (like e.g. temperature, change from culture medium to buffer solution). In addition 
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to a quite complex isolation procedure the sources for tissue material are limited, thus 
confining the availability of this model and not recommending it for first stage high 
throughput screening. 
 
In contrast to primary cells, cell lines are often preferred, because of the ease of cell culture 
and the purity of cell types. 
The cell line A549 belongs to the group of well characterized and widely used in vitro 
models. As it is also available from ATCC, this human lung carcinoma cell line was initiated 
through explant culture of lung carcinomatous tissue from a 58-year-old Caucasian male. 
Unfortunately, A549 cells do not express sufficient phenotypic characteristics of alveolar 
epithelial cells to allow determination of their cell of origin, but they have many important 
biological properties and exhibit features of alveolar type II cells [1,13,239]. 
Today, the cell monolayer phenotype of A549 is commonly accepted to be primarily type II in 
nature (compared to type I-like differentiated characteristics of primary cultured rat or human 
alveolar epithelial cells), although they differ from isolated or cultured primary alveolar 
type II cells in several aspects: in terms of lipid content, the phosphatidylglycerol, which is 
one of the characteristic phospholipids of pulmonary surface-active material in primary 
isolated rat (10% of total phospholipids) and human type II cells (8.9%) as well, is nearly 
absent in A549 cells (0.1-0.2%), which comes close to the phospholipid content of fibroblasts 
[240]. Moreover, a direct cholinergic effect on phospholipid secretion occurs in A549 cells 
[241] in contrast to the lack of any direct cholinergic effect in both, rat and human type II 
cells [13,232]. Further distinctive marks are that A549 do not express detectable levels of 
surfactant protein A (SP-A) nor of its mRNA [242,243], and that they lack the formation of 
domes (indicating active transepithelial ion transport), whereas rat and human type II cells do 
[232]. Finally, monolayers of A549 do not undergo differentiation into cells showing type I-
like cell morphology [13]. The apparent permeability coefficients of FITC dextrans (4400-
150000 Da) turned out to be more than 100-fold higher than that found in primary cultured 
alveolar epithelial cells [140,244]. Accordingly an equivalent pore radius of about 17 nm was 
calculated from passive solute transport data from flow across A549 cell monlayers [244], 
which is three times greater than that estimated for primary rat alveolar epithelial cell 
monolayers [233]. In agreement with this result, the number of equivalent pores per unit area 
for A549 monolayers is even a thousand-fold higher than that estimated for primary rat 
alveolar epithelial cell monolayers [95]. 
Contradicting results have been published on the capability of this cell line to generate 
transepithelial resistance. For culture on collagen-coated permeable filters, the development 
of transmonolayer TEER values of 600 or 745 Ωcm² was reported, but conflicts with the 
simultaneously determined very high diffusion rates for hydrophilic solutes. Another research 
group, using the same culture approach, reported TEER values close to zero for A549 
monolayers even after six days of culture to confluence. This absence of any significant 
electrical resistance in monolayers of immortal cell lines is most likely caused by a lack of 
functional tight junctions [95,245]. The difference to the 2000 Ωcm² exceeding TEER values 
for primary cells may be explained by different intercellular junctions between type II-like 
cells alone (=A549), type I-like cells alone or type I and II cells (=primary culture) [244]. 
Differences in the expression of tight junctions between A549 and primary cells are 
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confirmed by a comparative immunostaining for the tight junction protein ZO-1 in primary 
human cells hAEpC and the A549 cell line alike. As demonstrated in Figure 1-8 the protein 
itself seems to be present in both models. But in case of the hAEpC, it is located along the cell 
borders showing the characteristic circumferential pattern, whereas the cell line reveals a quite 
more diffuse picture. The obvious gaps in protein expression and cell-cell contacts support the 
resulting different TEER- and Papp-values found for these two in vitro models. 
 
BA 
 
Fig. 1-8. Different shape of tight junctions compared for two in vitro models. A Primary 
human alveolar epithelial cells on day 9 in culture, hAEpC. B Filter grown monolayer of 
A549, a human alveolar epithelial cell line, 8 days after plating. Both are immunostained for 
ZO-1 protein (green fluorescence). Cell nuclei are counterstained with propidiumiodide (red 
fluorescence). Scale bar = 50 µm. Observation by confocal laser scanning microscopy. 
(Panel A reprinted from Elbert et al. [237] with permission from Kluwer Academic/Plenum 
Publishers, and panel B from Elbert [52] with permission.) 
 
Further studies revealed, that in terms of proteolytic activity, A549 cells exhibit very low 
aminopeptidase activity compared to primary cultured alveolar cell monolayers, but they are 
also reported to synthesize, store (in lamellar bodies), and secrete phospholipids as do alveolar 
type II cells [13,239]. Expression of the adhesive glycoprotein ICAM-1 on the surface of 
respiratory epithelial cells, could be stimulated by Haemophilus Influenzae [221]. In reference 
to multidrug resistance, no P-gp or MRP was detected in A549, since Western Blot analysis 
proved that anti-P-gp and anti-MRP antibodies did not immunoreact with proteins in wild-
type A549 cells [186]. 
Moreover, since – despite of the greater number of type II cells present in the alveoli – 
approximately 95% of the alveolar epithelial surface area is composed of type I pneumocytes, 
its usefulness as a drug absorption model appears questionable [1]. The outlined differences in 
morphological and biochemical characteristics indicate that though there is potential for A549 
as a model for assessment of drug efficacy, toxicity and rapid evaluation of drug permeability, 
its suitability as a predictive tool for alveolar drug transport in vivo is not clear [244,246-248]. 
Overall, the low values for transepithelial resistance make it difficult to interpret transport 
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data (including drug trafficking) obtained from such cell line [95]. Nevertheless, it has in fact 
been used to study alveolar drug absorption [244], metabolism [245] and gene delivery [130] 
and is widely accepted as a valuable model for studies in pulmonary toxicity with widespread 
use even in recent years [249-253]. 
 
Another cell line representing the alveolar region of the respiratory tract nominated L2, was 
cloned from an adult female rat lung, where it was actually derived from lung tissue of adult 
Rattus norvegicus and shows epithelial morphology as well as adherent growth properties 
[194,254]. Cells are supplied by either Dr. W.H.J. Douglas, (W. Alton Jones Cell Science 
Center, Lake Placid, NY) at population doubling level 27 [240], by ATCC with passage 24 
submitted [194] or other L-2 cells (CCL 149) at passage 26 can be obtained from Dr. R. Hay, 
(ATTC, Rockville, MD) [240]. At the very start, diploid clones were isolated from an 
enzymatic dispersion of normal adult rat lung, thereby gaining four clones with epithelial 
morphology and with two of them appearing to be of type II alveolar cells’ origin, according 
to electron microscopic observations. The in-detail reported ultrastructure demonstrated 
characteristics similar to type II cells. In phase-contrast microscopy clone L-2 showed 
evidence of epithelial morphology and granules in the cytoplasm; the latter, on the 
ultrastructural level similar to osmiophilic lamellar bodies, are present in type II pneumocytes 
of intact rat lung. In comparing lamellar body fractions isolated from intact rat lung as well as 
from clone L-2, it was substantiated that the cytoplasmic inclusion bodies of clone L-2 are 
indeed surfactant containing osmiophilic lamellar bodies. The cell line was grown in a 
stationary perfusion culture system, where it formed multilayers of eight layers in thickness. 
In suspension culture L-2 cells assumed a spherical shape, but cell viability declined to 80% 
after 48 h and they lost the lamellar substructure characteristic of osmiophilic inclusion 
bodies. Nevertheless, return to monolayer culture proved this process to be reversible. 
Moreover, a second cell type appeared during suspension culture that is similar to type I 
alveolar pneumocytes of pulmonary epithelium in vivo, and suggesting a possible conversion 
of type II cells into type I cells under certain environmental conditions [254]. The main 
application of this cell line is in transfection studies with the objective to identify the Rat 
Type I Vasoactive Intestinal Polypeptide (VIP) Receptor Gene, which is highly expressed in 
the lung [255]. Further usage is given in adhesion and cytotoxicity studies e.g., focusing on 
interactions between polymorphonuclear neutrophils (PMN) and the alveolar epithelium 
[256]. 
 
AK-D cells form another in vitro model for the distal lung area; they were cloned from feline 
fetal lung at 55 days gestational age [240] and feature characteristics similar to type II cells as 
underlined by ultrastructural observation [257]. They can be obtained from Dr. A. Kniazeff, 
(University of California, San Diego, CA) [240]. Cell cultures were initiated by trypsinization 
of lung tissues from 55-day-old fetuses of Felis catus. After a period of cultivation, cells were 
cloned, and several clones were established. But only four clones with an epithelial 
morphology were selected for further study and designated AK-A, -B, -C and -D. In early 
stages, cultures were composed of a mixture of fibroblast-like and epithelial cells and 
proliferated comparatively slowly; on further transfer there was a progressive shift to an 
epithelial morphology with a concomitant increase in growth rate. This growth rate decreased 
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again at passage 55 when cells were going into senescence [257]. These clonal isolates, 
derived from fetal cat lung, featured properties in common with type II alveolar pneumocytes: 
As well as being epitheloid, the cells contain lamellar inclusion bodies similar in appearance 
to those observed in feline lungs in situ, and can still be observed after 40 passages in culture. 
But these inclusions are more numerous and heterogeneous in size than commonly observed 
in type II cells in vivo [257]. 
In a comparative study, considering the cell lines A549, L2 and AK-D, their phospholipid 
composition was compared to that of fibroblasts grown under similar conditions. Since the 
lipid content of these cultured cells was very different from that of freshly isolated rat type II 
cells, their suitability as model cell systems for type II cells seems questionable [240]. 
Examination of confluent cultures by phase-contrast microscopy revealed, that all three 
epithelial cell lines grew as typical monolayers of flattened, polygonal cells. But staining with 
phosphine 3R gave only a few intensely fluorescent pin-point-like inclusions for L-2 and AK-
D and none of these inclusions could be stained with the modified Papanicolaou stain 
[55,258]. In contrast, A549 cells grown in serum showed numerous small phosphine-positive 
inclusions but lacked Papanicolaou-positive inclusions. However, if A549 were cultured 
without serum for two days, they showed an increased number and size of the inclusions 
visible with phosphine and in addition, could be stained by the Papanicolaou method [240]. 
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6. POTENTIAL AND LIMITATIONS OF AVAILABLE CELL CULTURE 
MODELS 
 
Numerous studies deal with the suitability of primary cultured airway and alveolar 
epithelium as in vitro models. In this context it is very important to ascertain to what extent in 
vitro and in vivo situations resemble each other and if the artificial model is able to imitate 
real life conditions. For instance, it was shown that primary cultured airway epithelial cells 
exhibit strikingly similar characteristics to the epithelial cell lining in vivo like mucus-
glycoprotein secretion [13]. It was also reported that rat alveolar epithelial cells share similar 
characteristics, such as phospholipid secretion, with that of human type II cells [232]. 
Moreover, an interspecies comparison of characteristics of cells from the alveolar regions of 
normal lungs (from humans, baboons and rats) showed relatively constant proportions of cells 
in the alveolar region and in their average thickness, size and surface areas [47]; this result 
may justify the use of animal derived in vitro models. As well, cancer cell lines have been 
screened for their suitability to serve as in vitro models [196,259]. There also exists research 
work comparing six different lung carcinoma cell lines (A549, Calu-3, NCI H292, Calu-6, 
RPMI 2650 and A427 cells) with regard to their expression of MUC genes, which are known 
to be normally expressed in upper and lower respiratory tract tissues [201]. 
 
As illustrated in Table 1-5, there exist numerous in vitro models able to imitate different 
regions of the respiratory tract, but which are still limited in reference to certain aspects. The 
decision on, whether a model is suited or not, depends on the respective scope or question 
addressed in a study. 
Toxicity studies for instance, represent an important research topic, since airway epithelial 
cells are localized at the very interface with the external environment and are the first to be 
exposed to inhaled irritants, allergens and noxious stimuli. As well as having their barrier 
function, pulmonary epithelial cells also serve as a part of the local immune system. Their 
morphology and development, as well as their function in host defense have been reviewed 
recently. Moreover, this work covers alterations of the epithelium associated with airway 
diseases and potential therapeutic implications for the treatment of respiratory diseases [260]. 
In lung periphery type II cells are the ones usually investigated, because of their antioxidant 
defense, synthesis of lung phospholipids and local immunomodulation. In addition, they are 
the stem alveolar epithelial repair system after lung injury and during normal turn over 
[249,261]. The great majority of studies within this scope used the A549 cell line as in vitro 
model. Other cell culture systems investigated in this context were the BEAS, BEAS-2B and 
H292 cell lines; but primary cultures of nasal epithelial cells, of the upper airways, NHBE 
(normal human bronchial) cells and rat alveolar cells were also included. 
The use of cell culture models for drug transport studies requires the formation of tight 
polarized monolayers as an essential precondition. Thus it is necessary to ascertain the 
tightness of the monolayer by parameters like TEER and PD (potential difference). In order to 
use in vitro results as a predictive tool to estimate in vivo absorption, the utility and validity of 
such a model should be proven and optimized [13]. That means, that acceptance, as a valid in 
vitro drug absorption model, is justified by the establishment of a robust correlation between 
data obtained in vitro and pulmonary drug absorption in vivo. Unfortunately comparison with 
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data from literature is often complicated by discrepancies in methodology such as dosing 
methods or species variation. However, using collected data [262] as a standard for in vivo 
pulmonary availability, a good correlation was observed with data obtained in Xenopus 
pulmonary membranes [1,263]. An earlier review comes to the same conclusion of a generally 
close agreement in transport characteristics of both hydrophilic and lipophilic diffusion 
markers, with those in vivo [13]. Ideally, a good in vitro model should accurately correlate 
with observations of transport and biological phenomena in vivo [95]. 
As for primary cultures, it is likewise important for cell lines that their biological properties 
mirror those of epithelial cells in vivo. 
Cell culture conditions and the time in culture, i.e. age of cells, are two parameters, which are 
thought to affect the expression of drug-metabolizing enzymes and active transport 
mechanisms [212]. For instance, it could be demonstrated that interleukin-9 upregulates 
mucus expression in the airways and regulates the expression of mucin genes in lung cells 
both, in vivo (transgenic mice) and in vitro (NCI-H292 and human primary lung cultures) 
[264]. This result represents another argument in favor of valued in vitro models based on cell 
lines or primary cells. Cell lines are indeed regarded as valuable tools for the determination of 
transport mechanisms and pathways. In addition, further analysis of apical to basolateral 
transport may help to elucidate absorption pathways [1,265]. 
 
 
Keeping in mind the ease of cell culture and other advantages of cell lines over primary 
models, many case studies focus on pulmonary cell lines as representatives of primary 
culture and thus contribute to create a basis for the discussion on which approach is 
preferable: 
For instance, while studying the efficacy of liposomes and polycationic gene transfer systems 
and at the same time comparing 16HBE14o-, Cos7 cells and porcine primary airway epithelial 
cells as models, a recent research work proved the effect of lung surfactant on transfection 
efficiency to be similar [129]. A comparison between 16HBE14o- and MDCK in testing the 
sensitization and allergic responses of house dust mite, showed both models to be affected in 
a similar way, (tight junctions and desmosomes) [197,209]. Another group evaluated MDCK 
versus primary excised human airway epithelial cells in terms of adenovirus vectors for 
transfection and found that the basolateral membranes in both cell culture systems resembled 
each other [131]. In addition, the alveolar epithelial cell line A549 is quite frequently taken 
into account as an in vitro model to answer various questions of that kind: for instance, when 
compared to primary nasal cells, they showed substantial similarity in the release of 
proinflammatory cytokines and morphological changes in response to various fungal extracts 
[251]. In parallel with cultured human bronchial cells, a comparable mucin expression and 
secretion in response to neutrophil predominant airway inflammation could be demonstrated. 
Moreover, they were analogous in expression and mechanism of induction [266]. A more 
complex work confronting A549 and 16HBE14o- on one side with primary human bronchial 
and nasal epithelium on the other, revealed a similarity in interleukin-5 mRNA expression 
upon exposure to ozone (as a sign of toxicity) for all the four different models [267]. Similar 
interleukin expression was also observed while examining the BEAS-2B cell line versus 
primary culture of human and monkey tracheobronchial epithelial cells [268]. 
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This very broad agreement in results and data obtained from pulmonary cell lines and primary 
cultured cells in parallel justifies the interchangeability of these two categories of in vitro 
models (for the bronchiolar and conducting airway zone of the respiratory tract and depending 
on the addressed topics). But proceeding to the deeper lung regions, these two alternatives do 
not always exist. For imitation of the alveolar lung region, one still has to rely on primary 
cultured pneumocyte monolayers. Currently existing cell lines (such as A549, L2, AK-D) 
do not form functional tight junctions, thus making it very difficult to interpret transport data 
(including drug trafficking) obtained from experiments with these immortal cell lines. 
Although exhibiting some phenotypic features of alveolar epithelial cells, they generally do 
not appear capable of replicating the transepithelial transport properties of intact alveolar 
epithelium sufficiently to justify their use for in vitro study of pulmonary drug delivery design 
and targeting [95]. Instead, primary cultures appear to be the only reasonable alternative at the 
moment, especially for studying alveolar epithelial transport processes and cell biology, since 
many of the characteristics present in a primary culture model are likely to be representative 
of those in the respiratory epithelium lining the distal region of intact lung. Moreover, they 
feature phenotypic transition into type I-like cells, thereby recommending this in vitro 
approach as more attractive for identification and characterization of alveolar epithelial 
transport processes. 
 
 
In spite of the encouraging progress, which was made during the past few years in developing 
improved cell culture based in vitro models, it is certainly necessary to be still aware of their 
limitations. These limitations include the fact that such a model – except co-cultures - is often 
based on a single cell type (i.e. cells of monoclonal nature and therefore perhaps not able to 
imitate the complexity of the native tissue or organ), and also that it may have tight junctions 
or cell cycles being less representative for the target tissue, but capable of affecting transport 
and metabolism mechanisms. Another shortcoming may be that adenocarcinoma-derived cell 
lines often show untypical phenotypes [1]. For example, gene transfer to lung cells in vivo is 
discussed as an attractive technique for the possible treatment of both inherited and acquired 
lung diseases like cystic fibrosis, pulmonary inflammation or lung cancer. In this context, in 
vitro respiratory epithelial cell cultures may serve as convenient models to investigate the 
feasibility of in vivo gene delivery. But since the efficiency of gene transfection may differ in 
vivo and in vitro, as shown by Fortunati et al. [269], the extrapolation of in vitro data to the in 
vivo situation should be examined with caution. 
In terms of immunology, the great majority of available in vitro models does not include the 
occurrence or at least some characteristics of macrophages, which play an important role in 
this functional barrier. In parallel, the comprising or not comprising of a mucus layer or 
surfactant film may also affect the result of an experiment depending on being carried out in a 
certain model. 
The various models presently in use illustrate the great variability in the presence or absence 
of relevant anatomic, morphologic, biochemical or functional features. The main problem is 
that there is seldom one model, which unites all the characteristic features and capabilities. 
That is why a model should be selected carefully with consideration given to the subject of 
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interest. And it must be taken for granted that the chosen model will fulfill the respective 
requirements. 
 
With regard to the effort needed to set up and validate a cell culture model, the ideal of the 
future would be a human cell line; preferentially grown under AIC conditions. Apart from 
sufficiently copying relevant anatomic, biochemical and functional features of the alveolar 
epithelium in vivo, it should offer facilities and test settings for the qualitative assessment of 
aerosols. That is why the development of devices for pulmonary application increasingly 
concentrates on adaptations to cell culture models: for instance, the so-called CostarTM 
Horizontal Diffusion Chamber System is a combination of a resistant epithelial cell 
monolayer, mucus and continual perfusion on the basolateral side that mimics lung 
physiology by generating sink conditions [200]. Some solutions recently applied in order to 
place aerosolized microparticles onto a cell monolayer, were the use of an impinger [198,270] 
or a cascade impactor, enabling simulation of tidal breathing patterns [271]. Another setting, 
designed as a cylindrical perfusion cell, was optimized to allow a quantitative dosimetry of 
fine and ultrafine aerosol particles during in vitro exposure of cell cultures [272]. 
Nevertheless, further improvements are necessary and thus the question of how to realize 
quantitative drug dosing without harm to the exposed epithelium is still a challenge. Other 
promising approaches pursue the establishment of a co-culture between different cell types 
e.g., alveolar epithelial cells with migrating macrophages on their top and with an endothelial 
cell monolayer on the upside down filter surface [68]. Both strategies aim at a closer imitation 
of in vivo conditions. 
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7. OUTLOOK 
 
One of the best examples to demonstrate the value of epithelial cell culture in the field of 
biopharmaceutics and drug delivery is the well-known Caco-2 cell line as an in vitro model 
for the gastrointestinal (GI) tract. This cell culture model has been widely used in high 
throughput screening programs in order to predict oral bioavailability [273,274] and 
moreover, to generate data for regulatory purposes. This fact evenly prompted the U.S. 
Pharmacopoeial Division of Standards Development to introduce standard methods for drug 
permeability assessment based on Caco-2 cell monolayers [275]. According to the 
Biopharmaceutics Classification System (BCS), whose theoretical basis was first described in 
1995 [276], drug substances can be classified as belonging to one of four classes: class 1 = 
high solubility and high permeability, class 2 = low solubility and high permeability, class 3 = 
high solubility and low permeability or finally, class 4 = low solubility and low permeability. 
In this context, both the US FDA and the European agency EMEA recommend the use of 
suitable epithelial cell monolayers in classifying the permeability of drug compounds 
[277,278]. This reaction clearly lays emphasis on a new trend in pharmaceutical development 
and on the increasing significance of cell culture models. 
Validation and standardization of these models attract scientific attention not only in terms of 
the oral route across the intestine but also for alternative applications for instance facing a 
pulmonary or blood-brain barrier [279]. Numerous laboratories rely on cell culture models of 
intestinal permeability such as, Caco-2, HT-29 and MDCK. In an attempt to increase the 
throughput of permeability measurements, several physicochemical methods such as 
immobilized artificial membrane (IAM) columns and parallel artificial membrane permeation 
assay (PAMPA) have been explored. More recently, much attention has been paid to the 
development of computational methods for the prediction of drug absorption. However, it 
seems clear that no single method will suffice for studying drug absorption; but in all 
probability a combination of systems will be needed. Accurate methods are necessary to 
understand absorption mechanisms (like efflux-limited absorption, carrier-mediation, 
intestinal metabolism), which may limit intestinal drug absorption. This information could be 
extremely valuable to medicinal chemists in the selection of favorable chemo-types. A review 
article, which describes different techniques that are used in evaluation of drug absorption by 
indicating their advantages and disadvantages, was published two years ago [280]. 
 
For the respiratory tract, with Calu-3 and 16HBE14o- there are currently some cell lines 
available, which have been proven to satisfactorily model the airway epithelium [95]. As 
immortal cell lines they call for easy maintenance and avoid several difficulties, including 
reproducibility or high costs, which are commonly associated with primary culture 
approaches [163]. In contrast, there has been only limited success in generating cell lines 
representing the distal alveolar epithelium of the lung, which is the preferred target area for 
systemically acting drugs. Therefore primary cultured pneumocytes still take priority over cell 
lines [95], to which the hAEpC [237] and primary rat alveolar cells represent promising 
approaches. 
In addition to the aforementioned publicly available cell lines there already exist some 
commercially available in vitro approaches, such as e.g. the so-called EpiAirwayTM Tissue 
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Model, distributed by the Mattek Corporation [281]. Although these commercial models still 
need to be better characterized and validated, the fact that they start to appear on the market 
represents a milestone in this area of science. 
 
Even though still far from being perfect, the presently available models, which have been 
discussed in this review do represent an important step forward in predicting drug transport 
across the respiratory epithelium as well as bioavailability from the lung [1]. Certainly there 
exist numerous limitations connected with today’s in vitro models and it is still a long way to 
reach this final aim. In contrast to animal experiments, they offer the opportunity to simulate 
already known characteristics of a diseased state, regardless of ethical aspects and thus enable 
the development of a more precise and individual treatment or therapy schedule. Moreover, in 
vitro models hold promise with regard to HTS (high throughput screening) and the screening 
of large numbers of new synthesized potential compounds within a short time, while 
estimating their ability to overcome the barrier faced within the body and to finally reach their 
site of action. An essential disadvantage is that cell culture models often do not exhibit all the 
differentiated and functional characteristics of the corresponding native epithelium or entire 
organ. Therefore a model for a certain development problem or scientific question should be 
selected carefully, considering limitations and taking them into account for experimental 
design or interpretation of results. 
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1. PREPARATION OF ALVEOLAR EPITHELIAL CELLS FROM PORCINE 
LUNG 
 
This chapter describes the isolation of primary alveolar epithelial cells of porcine lung origin, 
referred to as pAEpC in the following, the actual method as well as the required materials, 
reagents and tools. The aim was to gain these cells in large yield and high purity and to 
establish an in vitro model, which closely imitates the in vivo situation. For that purpose an 
isolation procedure developed for human alveolar cells (hAEpC) as reported by Elbert et al. 
[1,2] and later refined by Fuchs et al. [3,4] was slightly modified and adapted to larger 
amounts of tissue. The original method was described by Bingle et al. [5], Dobbs et al. [6,7] 
and Cunningham et al. [8-10]. In this context the use of another species required the 
adjustment of at least some steps of the original isolation procedure. 
 
Isolation of primary alveolar epithelial cells subdivides into different steps: A mechanical 
mincing of the tissue at the beginning is usually followed by a proteolytic enzyme digestion, 
in order to dissociate the (type II) cells from each other. Subsequent purification of alveolar 
epithelial from other lung cells is referred to as one of the most crucial steps, because type II 
and other lung cells overlap in both size [11,12] and density [13]. That makes it difficult to 
separate them from a mixture of lung cells by usual techniques, such as differential 
sedimentation or straining over filters. Alternative methods are differential sedimentation, 
centrifugal elutrition and flow cytometry, as well as the less complicated and higher recovery 
yielding lectin agglutination or antibody panning [14]. There also exist hints to a direct 
formation of type I cells out of bone marrow-derived cells (after their engraftment in recipient 
lung parenchyma). For instance a type I cell-like morphological and molecular phenotype was 
detected without observing any engraftment of type II pneumocytes. These results challenge 
the current belief that adult alveolar type I epithelial cells invariably arise from local precursor 
cells [15]. Indeed, isolation procedures for type I cells have been described, e.g. by Dobbs et 
al. [16], but this approach concentrates on modification of the refined method for isolation of 
human alveolar epithelial cells. Thus the study follows the presently most common method, 
which is to isolate primary type II cells, because they are more robust and able to differentiate 
into type I cells during culture. 
 
Tissue dissociation 
In terms of tissue dissociation there exist various possibilities to use single enzymes in 
different concentrations or combinations. With regard to isolation of type II cells in special 
nearly all methods described rely on calcium chelation, enzymatic treatment or both. The 
most common enzymes used to release type II cells from lung tissue are trypsin, pancreatic 
elastase and collagenase, as well as different enzyme cocktails, which proved effective in 
isolating type II cells [7]. For instance, according to Finkelstein et al. addition of small 
amounts (2.5 – 25 µg/ml) of trypsin to elastase (0.3 mg/ml purified) could improve cell yield 
[17]. Moreover, elastase is more selective in dissociating alveolar cells than trypsin or 
collagenase: After instillation into the lung the alveolar epithelium is selectively loosened or 
removed from the underlying basal lamina. At the same time, the interstice remains 
remarkably intact, although elastic fibers in the interstitial and perivascular spaces are 
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disrupted or degraded. In contrast trypsin or collagenase liberate interstitial and endothelial as 
well as alveolar cells, but unfortunately there is no easy method of separating type II from 
interstitial and endothelial cells. Thus elastase offers a significant advantage over trypsin and 
collagenase, because it reduces the number and types of contaminating cells [7]. 
Besides the enzyme itself, the manner in which it is delivered to the alveolar surface may 
influence cell yield, as e.g. instillation via trachea seems more effective in liberating cells than 
incubation of minced lung tissue [7]. Another important question to consider is whether 
enzymatic treatment alters certain cellular functions or not. A fact that was underlined by a 
study, in which the use of trypsin rather than elastase caused a dramatic reduction in dome 
formation and thus in ion transport: Even after 8 days in culture distinct changes in dome 
function were observed and speak in favor of an influence on cell functions for prolonged 
periods [18]. Since a combination of trypsin and elastase already proved successful in 
isolation of hAEpC without significant damage and with respect to similarities between the 
species man and pig this method was continued. 
In variation to the method described by Elbert et al. and Fuchs et al. [1-4] there was a pre-
incubation preceding the actual digestion, which took place at 37°C vital temperature. The 
idea was to give the enzyme enough time, 1.5 h at 4°C, to soak the agitated tissue without 
damaging cells situated on the outer surroundings [19]. This measure enabled a more 
homogeneous digestion process: not only from outer to inner parts of tissue residues, but in a 
regular way from all directions, thereby preventing outer cells from being exposed for a 
longer period and therefore more likely to be affected. 
Differential adherence 
Adhesion on plastic surfaces (Petri dishes) serves to remove macrophages from a 
heterogeneous collective of cells. The separating principle is based on the fact that alveolar 
epithelial cells need (between 48 h and) up to 60 h to adhere in contrast to macrophages, 
which are quite fast in making contact with an untreated growth support. This discrepancy is 
used for depletion of macrophages. 
An additional step to select macrophages from a cell suspension by means of magnetic beads 
- as performed during isolation of hAEpC - was dropped in case of pAEpC, due to possible 
species differences and high costs: Those magnetic beads are coupled to a human antibody 
and thus do not necessarily bind to macrophages of another species. 
Coating 
In order to offer alveolar epithelial cells more in vivo-like conditions, growth supports are 
often pre-treated and covered with components from native matrix. Such a coating proved 
necessary for attachment of isolated pAEpC. For the primary human model a coating with 
fibronectin and collagen was successful and adopted because of known similarities between 
those mammalian species. 
Cryopreservation 
Current conservation methods for pAEpC still need further improvement, since there was 
little success in defrosting and subsequent culture of these primary cells. Reducing the 
DMSO-content in the cryo freezing solution from 10 to 5% may possibly lead to more 
promising results. Likewise attempts to subculture those primary cells did not succeed till 
today, thereby confining the time span of their use in research studies up to 2 weeks. 
 
 
Isolation of pAEpC, problem of infection, optimization of culture conditions Chapter 2
 
All the necessary materials and reagents used for isolation of pAEpC are listed in an appendix 
at the end of this chapter. 
 
 
1.1 Tissue supply and transport 
 
Tissue was provided by an abattoir in Zweibrücken, the experimental surgery of the Medical 
Faculty, Homburg (mini pigs) and another slaughterhouse (Egidius Braun) in Konken 
(suckling pigs). For the selection of an appropriate lung organ attention is to pay for features, 
which could indicate pneumonia or other infections, such as tissue lesions, sticking together 
or dark colored tissue areas. On this decision advice should be searched with the personnel 
and present veterinarian. The recommended starting amount of tissue material for the 
performance of an isolation procedure is one pulmonary lobe for pigs typically slaughtered at 
the age of 6 months or the whole organ in case of a 2-3 months-old suckling or mini pig. 
Hands of the operator should be protected with double hand gloves and disinfected with 
ethanol when handling with the tissue. The fresh organ is transferred immediately into sterile 
phosphate buffered saline (transfer buffer) and kept on ice during transport to the laboratory. 
A filled container is important to guarantee a nearly complete coverage of the swimming 
organ by buffer solution and to prevent it from air contact (drying). Time between collection 
of tissue and preparation procedure should be kept as short as possible (and not exceed 
4 hours). 
 
 
1.2 Isolation – Selection and mechanical reduction to small tissue pieces 
 
In a first step the elastic pleura visceralis (white thin skin, Fig. 2-1 A,B), that is surrounding 
the organ like a second skin, was removed by means of scalpel and tweezers. The pre-selected 
(approx. 1 × 1 × 2 cm³) tissue pieces were preferentially taken from the diaphragmal and 
cranial regions of the organ. During this dissection of tissue fragments the organ was fixed on 
a sterile support by artery forceps and surgical scissors. Visible airway (white color) and 
blood vessels (red color) were removed. Dissection tools were cleaned and stored in (70%) 
ethanol or isopropyl alcohol. Resulting pieces of tissue were collected in approximately 
300 ml of BSSA/B and kept cool on crushed ice (Fig. 2-1 C). They were shortly stirred to 
wash out blood cells and potential pathogenes. 
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A B C 
   
 
Fig. 2-3. A Device to wash tissue over a 100 µm pore-sized nylon net filter; B transfer of 
washed tissue pieces into a tared flask for digestion; C pre-incubation at 4°C for 90 min in a 
refrigerator and subsequent enzymatic digestion, incubation at 37°C for 30 min in an 
incubator, agitated 
 
 
1.3 Isolation – Enzymatic digestion 
 
The minced tissue was weighed to determine the amount of enzyme required for the trypsin-
elastase-digestion. Components of the solution used in this digestion process were trypsin, 
elastase and BSSB, at a temperature of 4°C. According to an experience based directive 1 g of 
tissue needs 0.5 ml of trypsin solution (2.5%). For instance 20 g of tissue were mixed with 
10 ml trypsin solution (250 mg), 1 elastase aliquot (2.5 units) and BSSB completing the total 
volume to 40 ml. Tissue amounts of 30 g or more required 2 elastase aliquots (5 units). This 
digestive mixture should cover the tissue and avoid a drying up. A compromise has to be 
found between sufficient coverage by fluid and minimal dilution of the enzyme solution. 
Enzymatic tissue dissociation started with a pre-incubation preceding the actual digestion at 
37°C vital temperature. Within 1.5 h at 4°C the digestive enzymes were given enough time to 
soak the agitated tissue without damaging cells situated on the outer surroundings. During the 
following incubation at 37°C for 30 min the flask was placed in an incubator and the 
suspension slightly mixed on a magnetic stirrer (Fig. 2-3 C). 
Considering lot-based variations of the used enzymes a first optic control of the digestion 
progress after 25 min is recommended (phase contrast microscopy). Figure 2-4 illustrates the 
stage in which the process should be stopped: Observation of numerous released single cells 
in parallel to just a few cell clusters (0-1 per field of view) indicates a sufficient digestion. In 
contrast, several large cell agglomerates or very few single cells speak in favor of a prolonged 
digestion (5 min) and repeated control. 
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A B 
  
 
Fig. 2-4. Phase contrast microscopic images of pAEpC after enzymatic digestion; A cell 
cluster, lens magnification 10x; B released cells, lens magnification 10x 
 
Digestion was stopped by adding an enzyme-inhibiting solution, which contained fetal calf 
serum (10-20 ml), DMEM/Ham’sF12/10%FCS (30 ml) and DNase-aliquots (10,000-
15,000 units each); all solutions were kept at 37°C. The enzyme DNase was added to prevent 
the cells from clumping together and forming cell clusters via deoxyribonucleic acid (DNA), 
which is released from mortified cells [20]. 
 
 
1.4 Trituration and filtration 
 
After adding the enzyme-inhibiting solution into the flask the tissue suspension was triturated, 
i.e. subjected to a certain shear stress for 8-10 min while pipetting up and down (Fig. 2-5 A). 
This trituration process subsequent to the digestion served to increase the number of cells 
loosened (from the tissue) by mechanical forces. Afterwards the tissue mass was filtrated over 
nylon gauze as demonstrated in Figure 2-5 B. This step was repeated once with the slimy 
digested tissue that remained on the gauze. It was sucked up by a pipette, triturated for 
another 4-5 min in 30 ml BSSA/B and subsequently also filtrated over gauze. The remaining 
tissue was disposed, whereas the filtrate was purified in the following. In order to remove 
large cell clusters, cell debris or tissue pieces the resulting cell suspension was filtrated over 
cell strainers with 40 µm in pore size as illustrated in Figure 2-5 C. A deeply red cell pellet 
(erythrocytes) as depicted in Figure 2-6 A was obtained after centrifugation of the filtrate for 
10 min at 300 g. 
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Fig. 2-5. Trituration process after digestion, higher yield by mechanical stress; B filtration 
step using gauze filter; C filtration over 40 µm-pore-sized nylon cell strainer, removal of cell 
debris 
 
 
1.5 Differential adherence 
 
The cell pellets out of the aforementioned centrifugation step were each resuspended in 3 ml 
medium for adhesion, unified and subdivided onto Petri dishes (10 cm in diameter). The 
number of dishes depended on the amount of tissue entering the digestion process: as a rule 
4 g require 1 Petri dish. Every single tissue culture dish was filled with 8 ml medium for 
adhesion (containing 50 ml DMEM/Ham’sF12/10%FCS and one DNase-aliquot). Cell 
suspension was added in a special way: The tip of the pipette was vertically pressed to the 
bottom of the Petri dish with constant pressure. The shear stress isolated single cells out of the 
clusters. Slight rotation of the dishes led to an even spreading of cells; blistering should be 
avoided because of the loss in adhesion area. After 90 min of incubation at 37°C, 5% CO2 
[20] the supernatant with non-adherent cells was collected with caution and unified in tubes. 
Each Petri dish was washed with 4 ml BSSB (added slowly) and the washing fluid collected 
as well. Both steps should be performed quite carefully so as to avoid detachment of already 
adhered cells (hold dishes slanting). Figure 2-6 B pictures those adhered cells left behind on 
the bottom of the dishes. An almost complete covering of the plastic support was achieved 
during this time span (1.5 h); panel B shows predominantly small cells, probably erythrocytes, 
and cells larger in diameter, which belong to the group of alveolar macrophages. After 
another centrifugation of the cell suspension (10 min, 300 g) deeply red cell pellets were 
obtained again. 
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Fig. 2-6. A Cell pellet before adhesion, red colored by erythrocytes; B cells (macrophages) 
adhered on untreated plastic surfaces after incubation for 90 min, lens magnification 20x 
 
 
1.6 Discontinuous percoll density gradients 
 
Since the different cell types composing the cell suspension at this stage, overlap in size but 
differ in density, a density gradient centrifugation was used for further purification and 
enrichment of alveolar epithelial cells. The resulting supernatant from the previous 
centrifugation was layered on discontinuous density gradients of percoll with upper and lower 
solutions featuring densities of 1.040 and 1.089 g/ml respectively [20]. 
Each 50 ml centrifugation-tube was filled with 15 ml of the high-density percoll solution 
(σ=1.089 g/ml) and overlaid with 15 ml of the low-density percoll solution (σ=1.040 g/ml). 
Every 5 g of tissue mass requires 1 gradient. Solution was added slowly and carefully in order 
to avoid turbulences. Cell pellets from the previous centrifugation were resuspended in 3 ml 
DMEM/Ham’sF12/10%FCS (37°C) each, unified and cautiously layered in equal shares on 
top of the percoll (Fig. 2-7 A). During centrifugation for 30 min at 300 g the centrifuge brake 
was switched off. Cell debris should remain on top of the fluid column, blood cells collect in 
the cone end (Fig. 2-7 C) and alveolar epithelial cells should accumulate as an interface 
between the percoll solutions. 
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Fig. 2-7. A Loaded percoll gradient: cell suspension on top, subsequently low- and high 
density solution; B percoll-density gradient after centrifugation with alveolar epithelial cells 
accumulated as an interface; C erythrocytes in the cone end of the tube after percoll-density 
gradient centrifugation 
 
Visible cells were removed from the interface with a pipette, subdivided in two tubes and 
washed by adding BSSA/B to fill the tubes, mixing and subsequent centrifugation (10 min, 
300 g). The obtained cell pellet was of a white to slightly red color in contrast to the deep red 
observed in previous stages (Fig. 2-8 A). 
 
 
1.7 Counting and plating 
 
The two light-colored cell pellets were resuspended each in 5 ml cell culture medium (see 
appendix) and unified to give a total amount of 10 ml cell suspension, from which the sample 
for cell counting was drawn. A Fuchs-Rosenthal-Chamber was used to count the cells: 100 µl 
of the cell suspension were diluted at 1:20 or 1:200 by addition of buffer and 100 µl of a 0.4% 
trypan-blue-solution. During an incubation of 10 min at room temperature the dye was given 
enough time to enter dead cells, to stain them and so to detect their vitality. Only the middle-
sized unstained cells were counted, in contrast to the very small contaminating erythrocytes. 
Figure 2-8 B shows a typical view of the counting chamber: pAEpC tend to form clusters 
what makes counting rather difficult. 
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Fig. 2-8. A White shaded cell pellet out the interface of density gradient (used for plating); 
B sector of Fuchs-Rosenthal-Chamber with cell suspension diluted at 1:20 for counting, dark 
trypan-blue crystals 
 
After an additional washing step in BSSA/B (10 min, 200 g) cells were plated onto Transwell 
Clear filter inserts, which had been coated with fibronectin/collagen as described below (point 
1.8.). Figure 2-9 gives an idea of the used plating density of 8×105 cells/cm². Obviously there 
were still macrophages in the cell suspension, but since known to patrol the alveolar epithelial 
surface in vivo (as part of the local immune system), their presence should contribute to a 
close imitation of in vivo conditions. Since alveolar epithelial cells need quite a long time for 
adhesion, a first replacement of cell culture fluid and concomitant removal of debris and 
blood cells should not take place within the first two days. 
 
BA 
  
 
Fig. 2-9. pAEpC plated on A Transwell Clear filter inserts at 8×105 cells/cm², lens 
magnification 10x; B 12-well plates at 8×105 cells/cm², lens magnification 20x 
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1.8 Coating of growth supports 
 
The standard covering procedure described by Elbert et al. was changed from 6 µg/cm² 
human fibronectin and 30 µg/cm² type-I rat tail collagen [1] to 2 µg/cm² human fibronectin 
and 8 µg/cm² rat tail collagen type-I respectively. 
Growth supports should be coated either during the enzymatic digestion, or adhesion or 
alternatively on the day before a planned preparation: 100 µl of each fibronectin- and rat tail 
collagen type I solution were added to 10 ml of cell culture fluid, which was cooled on ice, 
and mixed by slowly overturning in a tube. Immediately afterwards approx. 250 µl of this 
mixture were added onto 1.13 cm² area of a single filter membrane. Slight agitation of 
Transwell plates served to distribute the fluid on the filter surface and should result in its 
complete coverage. After an incubation of at least 2 h or over night at 37°C, humid 
atmosphere and 5% CO2, the fluid was removed and the supports were dried under the 
laminar air flow. Dried and shrink-wrapped plates can be stored up to 6 weeks at RT. 
 
1.9 Culture maintenance 
 
First change of cell culture fluid is not recommended within 48 h after plating (point 1.7). 
From this time cell culture fluid should be replaced at least every second day (36-48 h 
intervals). As pAEpC turned out to react very sensitive to air contact as well as changes in 
temperature, not more than 6 filters should be refreshed in one working step. As a rule the 
removal of used-up culture medium starts with the basolateral fluid, whereas fresh cell culture 
medium is added to the apical compartment first. 
 
 
1.10  Cryopreservation 
 
The cell suspension obtained at the end of the isolation process was centrifuged (10 min, 
200 g) and cell pellets resuspended in FCS (4°C). Sterile solution of DMSO (dimethyl 
sulfoxide) kept at RT served as cryoprotectant and was added to 10% in the resulting mixture. 
The volume of FCS was adjusted to obtain a suspension of 20-50 million cells/ml, which was 
distributed to 1 ml per cryo-vial. The vials were placed into an ethanol-filled freezing device 
pre-cooled at -20°C. The device was stored for min. 6h up to max. 3d at a temperature of –
86°C, the cryo-vials were then transferred into liquid nitrogen. 
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1.11  Flow chart: isolation of pAEpC from porcine lung 
 
tissue supply: abattoir 
intact lung organ 
tissue pieces taken from diaphragmal and cranial regions of a pulmonary lobe
 
 
 
 
       removal of pleura visceralis 
       mincing, washing 
       removal of visible bronchioles 
 
tissue cubes of approx. 5 mm edge length 
fine cutting process to enlarge surface for digestion process 
 
 
 
       repeated washing and 
filtration over 100 µm pore-sized nylon 
gauze 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
 
    
    
    
    
 
 
 
 
deenzymatic digestion: trypsin-elastase-incubation 
pre-incubation at 4°C for 1.5 h 
incubation at 37°C for 30 mintrituration 
filtration via nylon gauze 
filtration over 40 µm cell strainer 
centrifugation 
differential adherence 
on plastic surfaces to partly remove macrophages 
incubation at 37°C for 90 min 
   removal of cell suspension 
rinsing of Petri dishes 
centrifugation 
discontinuous percoll density gradients 
dissociation from blood cells and cell debris 
   collection from the interface 
   washing step 
   centrifugation 
   counting plating on fibronectin-collagen-coated transwell filters 
nsity 8×105 cells/cm², cell culture fluid SAGM, 1% serum 
confluent monolayers after 5-10 days
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1.12  Collected data 
 
In total 46 preparations were performed till today, thereby starting from different supplies as 
concerning age or gender of donor animals. The first 7 isolation procedures served to further 
optimize the method with regard to plating density, coating, incubation times, material of 
growth supports, addition of antibiotics, as well as supplementation or choice of cell culture 
medium and frequency of its replacement. From preparation number 8 upwards the isolation 
method remained unchanged so as to allow a comparison of results. The nomenclature 
thought to distinguish respective cell isolations from each other uses the abbreviation 
“pAEpC” (porcine alveolar epithelial cells), followed by a number indicating successive 
preparation counts: “pAEpC-n”. Tissue amounts entering the isolation process varied from 
15.8 g to 43.7 g and the respective yields from 1.00 million to 37.62 million cells/g tissue, i.e. 
an average of 24.1 (±5.0) g starting tissue mass and a mean yield of 9.50 (±6.89) ×106 cells/g. 
This variation in isolation yield may be explained by varying tissue quality in dependence on 
age, gender or state of health of the respective donor animals. 
 
Focusing the usefulness of obtained cell cultures for transport studies a successful isolation 
was defined by its capability to form confluent and tight monolayers. A level of acceptance in 
terms of TEER (transepithelial electrical resistance) was determined later (chapter 4). 
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2. THE PROBLEM OF INFECTION AND APPLIED SOLUTIONS 
 
In an early phase of model establishment infections were observed, which caused neither 
adherence nor growth of cells. 
Due to a certain donor variation infections are a frequently occurring topic in context with 
primary cell cultures. In general, a compromise is searched between cell protection and 
damage or potential alteration of their features and functions. In order to understand certain 
risks of infection as well as the measures introduced to suppress their occurrence, some 
background knowledge about the slaughtering process should be helpful and is described in 
the following. 
 
 
2.1 The process of slaughtering 
 
The slaughtering process starts with anaesthetization by electric shock treatment. Afterwards 
the animals are left to bleed out while hanging. In order to ease the following removal of the 
bristles, swine bodies are bathed in water of 62-64°C temperature for 5-6 min. The loosened 
bristles are scraped off by means of knifes, rollers or brushes. After opening the abdominal 
wall, the organs out of chest and stomach are removed. Subsequently, animal bodies are 
divided lengthwise into two halves. In general the slaughtered pigs are about six months old 
and all female. As about 1000 pigs a day pass the aforementioned bathing solution, it presents 
a critical factor in terms of hygiene. It is mainly contaminated with spores of bacteria, because 
vegetative forms of microbes are unlikely to survive this temperature. Although the pigs are 
already dead when dived into the water, their autonomic nervous system may still be working 
and thus cause inhalation; in this way the contaminated fluid may reach the airways. For this 
reason a sample of the bathing solution was analyzed and showed a mixture of different 
streptococci (but not Streptococcus suis) and other bacteria (Fig. 2-10 A). As characteristic 
for streptococci they showed the typical chain formation and spherical shape. Such an organ, 
designated as “scaled water lung” is also pictured in Figure 2-10 B, with frothy water leaking 
from the bronchial tubes (arrow). 
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Fig. 2-10. A Sample from bathing water (Methyleneblue-staining): typical chain formation 
and spherical shape of different streptococci (Bacto Control); B “scaled water lung”, cutting 
face from a porcine lung organ featuring open bronchi filled with foaming water (arrow); 
taken from reference [21] 
 
 
2.2 The infectious organisms 
 
As a precondition to introduce measures, which should avoid infection in primary cell 
cultures, methods for detection and identification of infectious pathogens were developed. 
The following observations were interpreted as signs of an infection: i) within less than 12 h 
the violet color of a test solution (DMEM-Ham’s F12 plus 100 µl cell suspension obtained at 
the end of isolation process) changed to yellow, ii) measured TEER values did not differ from 
that of a blank filter, and iii) light microscopy revealed that no adhesion took place and that 
the cells kept their spheroid morphology. In addition an increasing vacuolization and 
degeneration of cells with development of large vacuoles hinted to a serious infestation. 
Those vacuoles contained moving objects (visualized by phase-contrast microscopy), which 
were suggested to be streptococci. 
Several test samples taken from the supernatant of cultivated cells the day after the 
preparation were examined by Bacto Control GmbH (Saarbrücken, Germany): By means of 
Gram-, Giemsa- and Methyleneblue-staining they were able to identify the infectious 
pathogen as Streptococcus suis. They observed formation of chains and a positive Gram-
staining as a typical feature for cocci in general, as well as a lancet-like shape as a special 
characteristic of Streptococcus suis (Fig. 2-11). The assumption to find a pneumococcal 
infection was not confirmed: Since these bacteria are capsulated by mucus, this should have 
been visible as a light blue border surrounding the germs in the Methyleneblue-staining, but 
was not detected. 
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Fig. 2-11. A Giemsa-staining: residues of some cells with stained nuclear plasma; 
B Methyleneblue-staining: lancet-shape as special feature of Streptococcus suis, but lack of a 
blue cell surrounding border as characteristic for pneumococci 
 
The identified pathogen, Streptococcus suis, causes mainly in piglets meningitis, pneumonia, 
arthritis, endocarditis and septicaemia. It is normally localized in the tonsils of pigs, but also 
able to cause meningitis in man. Today it is accepted as an occupational disease, because 
people with exposition to pigs or the raw meat, i.e. abattoir staff, veterinarians, cooks, 
breeders, housewives and so on, have a 1500-times higher risk to get infected. 
Communication is possible through little injuries of the skin or via droplet infection. There 
are reports on herds of swine with an 80%-rate spread of this infection, but nevertheless 
clinically healthy [22]. According to Seol et al. [23] four different serotypes of this pathogen 
are currently known. One of them, Streptococcus suis type II, causes pneumonia in young 
pigs with large amounts of froth in the trachea and bronchi as characteristic for the 
corresponding clinical picture. In addition, an immunoperoxidase test could show the 
bacterium’s presence in the alveoli [24]. 
 
 
2.3 Selection of antibiotics to supplement the cell culture fluid 
 
In spite of resistances against penicillin and doxycyclin in porcine species, as well as against 
makrolids and tetracyclins the pathogen, Streptococcus suis, is sensitive for penicillin and 
ampicillin. Thus high doses of either penicillin or ampicillin are recommended for therapy of 
human beings [22]. A screening of 522 Streptococcus suis isolates proved the vast majority of 
them susceptible to both ampicillin (83%) and penicillin (78%). Despite the resistant isolates 
the beta-lactam antibiotics were the most active drugs against this pathogen [23], suggesting 
them as hopeful candidates for additives aiming at the protection of cell cultures. 
Penicillin G and V show very similar antimicrobial activity for aerobic, gram-positive 
microorganisms. Penicillin G is active against a variety of gram-positive and gram-negative 
cocci, although many bacteria previously sensitive to the agent are resistant in the meantime. 
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In general, aminopenicillins like ampicillin, amoxicillin and their congeners, comprise similar 
antibacterial activity and a broader spectrum than penicillin G, V and the penicillinase-
resistant penicillins. All of them can be destroyed by β-lactamase and hence are ineffective 
against most staphylococcal infections. Nevertheless they are bactericidal for both gram-
positive and –negative bacteria with meningococci and monocytogenes reacting sensitive to 
these drugs. The fact that aminopenicillins are somewhat less active than penicillin G (against 
gram-positive cocci) may be compensated by their broader spectrum. In addition concurrent 
administration of clavulanate or sulbactam markedly expands the spectrum of activity. 
Comparing the two aminopenicillins ampicillin and amoxicillin, their antimicrobial spectra 
are essentially identical [25]. As a matter of fact there exist differences concerning absorption 
of these compounds from the gastrointestinal tract, subsequent different peak concentrations 
in plasma and oral doses as an impact [25]. But these are less important for their suitability as 
cell culture fluid additives. 
The aminoglycosid antibiotic gentamicin belongs to the widely accepted supplements, which 
are routinely used in today’s cell culture media. Its spectrum comprises mainly gram-negative 
bacteria as well as enterobacteriaceae [25]. But it is useless in antagonizing streptococci. 
Gentamicin features a bactericidal type of action and due to its hydrophilicity the compound 
is not able to enter a cell. Instead it distributes only in the extracellular region and thus 
exclusively influences pathogens localized there [26]. 
 
All these facts helped to decide upon a selection of antibiotic compounds for this special 
model and led to the following conclusion: Being aware of the relatively high incidence of 
infections caused by streptococci (within this species), its good activity against gram-positive 
cocci recommended penicillin G, whereas the broader spectrum and a less high resistance rate 
spoke in favor of ampicillin. Complementing to those the common gentamicin was included 
to cover the extracellular zone and to prevent contamination by mycoplasms. Table 2-1 gives 
a short survey on the three finally chosen substances and on some of their relevant features. 
 
Table 2-1. Selected antibiotics and their characteristics according to references [25,27] 
 
Antibiotic Group Mechanism Effect Spectrum 
gentamicin aminoglycoside interference with 
protein synthesis, 
translation of 
mRNA 
 
bactericidal 
gram-positive 
and -negative 
bacteria, 
mycoplasms 
penicillin G β-lactam antibiotic gram-positive 
bacteria 
ampicillin aminopenicillin 
inhibit synthesis of 
peptidoglycan wall 
(last step), i.e. 
transpeptidase 
inhibitors 
 
both of them 
bactericidal similar but 
broader spectrum 
than Penicillin G
 
 
 115
Isolation of pAEpC, problem of infection, optimization of culture conditions Chapter 2
 
2.4 Control of success and applied analytical methods 
 
Different combinations and concentrations of the above listed compounds were tested and 
finally resulted in an antibiotic protection realized by 50 µg/ml of each gentamicin and 
ampicillin plus 200 IU/ml penicillin G. In order to minimize the initial number of infectious 
agents, these substances were added not only to the growth medium but also to all solutions 
used within the isolation procedure. The number of washing steps applied to the mechanically 
dissected tissue pieces was increased, to further reduce the concentration of potential 
contaminating organisms or bacteria. 
Point of interest was the existence and extent of an infection in the cell suspension obtained at 
the end of the preparation process in comparison to that of the starting point, represented by 
the transfer solution. For control purposes samples of both (resulting cell suspension and 
corresponding transfer buffer) were subjected to a shock-freeze and thaw process as well as 
treatment in distilled water, with the aim to release possible intracellular localized bacteria via 
lysis of cells. In addition the supernatant of plated cells as natural habitat of extracellular 
contaminants was also used for sampling. 
 
Hycon dip analysis of those aforementioned samples was performed by means of Hycon dip 
slides for fluids (Biotest Diagnostics AG, Dreieich, Germany). After dipping the slide into the 
sample, subsequent incubation and analysis enable detection and monitoring of microbial 
levels in liquids. Dip slides have a paddle coated with two different agar media permitting the 
simultaneous determination of two tests in one step (Fig. 2-12): determination of the total 
count of microorganisms and the selective detection of yeasts and moulds (GK-HS) or 
coliform bacteria (GK-C) respectively. In dependence on the used agars the required 
incubation times varies from 3-5 days for GK-A/HS (at room temperature or at 30°C) to 1-
2 days at 30°C for GK-C. An optical chart, which is delivered together with the slides, allows 
the determination of CFU/ml (CFU = colony forming unit). Obtained results are summarized 
in Table 2-2. 
 
 
 
Fig. 2-12. Biotest Hycon 
Dip Slides: a ready to use 
system for detection and 
monitoring of microbial 
levels in liquids; paddle 
coated with two different 
agar media; photograph 
taken from reference [28] 
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Table 2-2. Contamination throughout cell preparations pAEpC-6, 7 and 8 (analysis results) 
 
 GK-A GK-HS GK-C 
pAEpC-6 cell suspension 10² - 10³ CFU/ml 10³ CFU/ml 10² - 10³ CFU/ml 
pAEpC-7 cell suspension none none none 
pAEpC-8    
transfer buffer 104 CFU/ml 10² CFU/ml 10² CFU/ml 
cell suspension none none none 
 
Cells out of both cell isolations pAEpC-6 and 7 did not generate measurable TEER-values. 
This observation verified that this failure was not necessarily caused by an infection. 
Nevertheless comparison of transfer solution with the resulting cell suspension in case of 
pAEpC-8 proved, that the measures taken to reduce the number of contaminants during the 
preparation process (washing steps, antibiotics), worked effectively: Despite present 
infectious agents in the transfer solution, none were detected in the final cell suspension. 
 
To confirm these results the microbiological examination of further cell suspensions was 
outsourced for extern analysis to L+S AG (“Gesellschaft für Mikrobiologie und biologische 
Qualitätsprüfung”, Bad Bocklet-Großenbach, Germany). For sampling approximately 
30 ×106 cells were lyzed by suspension in 10 ml antibiotic-free, distilled water and subjected 
to a shock-freeze and thaw process. Afterwards the solution was brought to a total volume of 
50 ml by adding DMEM/Ham’s-F12 (Biochrom KG, Cat. F4815, Berlin, Germany) and 
stored at 4°C. Analysis was realized by count determination according to Ph. Eur. 3rd edition, 
surface procedure (spiralometer) and after a dilution at 1:10 in case of pAEpC-11. Cell 
isolation pAEpC-15 was also tested by means of count determination according to Ph. Eur. 3rd 
edition as well, but subsequent to prior enrichment via membrane filtration (increased 
sensitivity of the method). The result expressed as total count in CFU/g was identical for both 
samples with less than 100 in case of bacteria, yeasts and moulds respectively, i.e. below the 
detection limit. In brief the two analyzed isolations did not show detectable signs of an 
infection, proved successful in the formation of tight monolayers and generated TEER-values 
as expected. 
 
Primary tissue material is usually attributed a certain donor variation and probability of 
infection in the individual donor animal. Nevertheless, the results described above show that 
the measures taken in order to prevent or at least to minimize this residual risk of 
contamination, were able to guarantee an appropriate protection. 
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3. OPTIMIZATION OF CULTURE CONDITIONS 
 
The tested variations included plating density, growth supports (material characteristics, 
size/area and coating), the cell culture fluid itself, as well as the frequency of its change. 
Moreover, culture under conventional liquid covered conditions (LCC) was compared to 
culture at an air liquid interface (AIC). Transepithelial electrical resistance (TEER), as a 
reliable and accepted bioelectrical parameter in the characterization of various in vitro 
models, was chosen as criterion: Throughout those experiments the decision on which method 
or condition should be preferred, was based on its development (in dependence on time in 
culture). 
 
 
3.1 Plating density 
 
For the (human) hAEpC in vitro model an optimum plating density of 4×105 cells/cm² was 
determined and resulted in confluent monolayers with functional barrier properties in terms of 
TEER [1]. In case of the pAEpC model the tested plating densities ranged from 2×105 to 
1 million cells/cm². 
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Fig. 2-13. Transepithelial electrical resistance (TEER) monitored for different plating 
densities, tested for cell isolations pAEpC-1 (A) and pAEpC-10 (B); plating density 
2×105 (¡); 4×105 (■); 6×105 (U); 8×105 (○); 9×105 cells/cm2 (¼) 
 
Experimental data obtained for cell isolation pAEpC-1 (Fig. 2-13 A) did not allow a reliable 
statement, because the number of monitored filters (n=2) was to low. But subsequent repeats 
confirmed this first trend as demonstrated for cell preparation pAEpC-10 (n=5): Lower 
plating densities resulted in insufficient monolayer tightness (no confluence), where 
monolayers generated transepithelial resistances around zero (2×105 cells/cm²) or about 
300 Ωcm² (4×105 cells/cm²) respectively. In contrast densities of 6×105 cells/cm² and more 
led to significantly higher TEER values of about 1500 Ωcm². The very similar parameter 
(TEER) development observed in case of the two higher plating densities, 6×105 and 
8×105 cells/cm², (Fig. 2-13 B) indicated that further increase in plating density may not result 
in higher resistance values. This assumption was confirmed in experiments with 
1×106 cells/cm² plating density (not shown). For further evaluation several cell isolations 
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were plated at 6×105 and 8×105 cells/cm² in parallel but featured almost identical TEER 
developments. 
Since pAEpC cultures were characterized by a low proliferation rate and seemed to reach 
confluence rather by spreading out and extending cell surface, a high plating density was 
favored. In addition higher densities were known to force back the contaminating fraction of 
fibroblasts, which proved to spread out wherever offered enough space. For these reasons 
8×105 cells/cm² was finally chosen as routine plating density. 
 
 
3.2 Growth support (material, size/area) and coating 
 
Published methods dealing with growth and maintenance of cells on tissue culture plates or 
filter membranes, offer a great spectrum of supports, extracellular matrices, culture media and 
supplements, such as growth factors, hormones and others. Combinations of these conditions 
allow the development of several in vitro models for the study of different aspects in alveolar 
epithelial cell biology. Coating of the growth support with laminin for instance, permits long-
term maintenance of type II cell properties [29-31], whereas collagen [32] and fibronectin 
[29] have been shown to promote adhesion and cell spreading [14]. 
In order to assure that observed differences were not caused by variations in preparation 
quality, the experiments described in the following were all performed using monolayers of 
one single cell isolation (pAEpC-11). Cells were plated at 6×105 cells/cm² and cultured in 
SAGM (Small airway growth medium) as described previously (point 1.9). The number of 
filters for each test condition was at least n=3 (-6) (exceptions indicated). 
As observed by phase contrast microscopy, porcine primary cells preferred permeable growth 
supports: They did adhere on coated cell culture flasks or Multiwell-dishes, but started to 
form vacuoles and began to detach from the support at days 3-4 in culture. This is why 
Transwell filters were used instead; due to their permeable structure they imitate the 
epithelium’s native surroundings more closely. 
 
Size 
Transwell Clear filter inserts of 0.33 cm² surface area proved successful in culture of primary 
human alveolar epithelial cells. After initial use in the porcine model they were replaced by 
the more common 1.13 cm²-filters (12 mm in diameter), which seemed suited as well and 
easier in handling. Due to the nearly unconfined supply with porcine lung tissue (in contrast 
to human organs), there was no need to switch to smaller units so as to improve capacity. 
Testing filter inserts of different surface areas revealed a slower increase in TEER during time 
in culture for the smallest (area). Compare Figure 2-14. 
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Fig. 2-14. Comparison of different filter sizes: transepithelial resistance as a function of time 
in culture observed for cell isolation pAEpC-11, if plated at 6×105 cells/cm² on Transwell 
Clear filter inserts of varying area. 
 
Apart from the marked plateau (advantageous with regard to future transport studies) as 
observed in case of 1.13 cm²-filter inserts, practical reasons were decisive for selection of this 
filter area in routine use. Although highest maximum resistances were monitored for 4.7 cm²-
filter inserts, they simultaneously consumed large volumes of cell culture fluid. As another 
disadvantage just 6 filters (i.e. sample compartments) per plate require a great number of cells 
for a comparatively low throughput rate. Since test compounds, e.g. potential drug candidates, 
often feature a limited availability, the reduced throughput capacity would mean that less 
conditions (combinations, concentrations, inhibitors, enhancers, temperatures) could be tested 
within one batch of cell monolayers. 
 
Coating and membrane material 
Due to the fact that no cell adhesion took place on untreated supports, a certain imitation of in 
vivo surroundings seemed necessary. For hAEpC a combination of fibronectin and collagen 
(both components of the native extracellular matrix) already proved successful and was 
adopted. The standard covering procedure was defined as 2 µg/cm² human fibronectin (Fn) 
and 8 µg/cm² type-I rat tail collagen (Col). This method was compared to vitrogen (VIT), a 
pepsin-solubilized bovine dermal collagen, which can be used as gel, film or monomeric 
coating for covering cell culture surfaces (Fig. 2-15). 
As an alternative to the polyester (PE) membrane material of the so far used Transwell Clear 
filters, polycarbonate (PC) membranes were tested. Apart from the synthetic material all other 
characteristics were maintained, i.e. the same coating (Fn/Col), cell culture fluid and plating 
density. 
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Fig. 2-15. Comparison of different coatings fibronectin/collagen (Fn/Col) versus vitrogen 
(VIT) and membrane materials polyester (PE) versus polycarbonate (PC): TEER was 
monitored depending on time in culture as observed for cell isolation pAEpC-11, plated at 
6×105 cells/cm² (n=3, except “PC Fn/Col” with n=2 from day 11 on) 
 
Those pAEpC monolayers cultured on vitrogen coating did not succeed in developing 
appropriate transepithelial resistances (maximum 360 Ωcm²), whereas those grown on 
Fn/Col-coated filters achieved resistances between 1700 and 2200 Ωcm². Highest TEER 
values were monitored for the combination of polycarbonate membrane with Fn/Col-coating. 
But the “non clear” polycarbonate material did not allow light microscopic observation; as a 
consequence the clear polyester membranes were preferred as standard growth support. 
 
 
3.3 Culture media and supplements, frequency of replacement 
 
The high costs of the cell culture fluid, which was recommended for cultivation of hAEpC 
and used so far, raised the question for less expensive alternatives. The fact that in case of 
Dulbecco’s minimum essential medium (DMEM) no adhesion or further development of cells 
was observed (not shown), suggested both primary models to require a growth medium 
optimized for alveolar or airway epithelial cells. Nevertheless besides the SAGM 
manufactured by Clonetics (distributed by Cell Systems) there existed an alternative offered 
by a company named PromoCell. Table 2-3 compares the composition of these two different 
cell culture fluids and underlines the similarity of both approaches in terms of 
supplementation. 
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Table 2-3. Contents of the tested cell culture fluids in comparison 
 
 Cell Systems, Clonetics 
SAGM BulletKit 
PromoCell 
AGM BulletKit 
Basal medium SABM (small airway 
epithelial cell basal medium)
Cat.No. CC-3119 
500 ml 
ABM (airway epithelial cell 
basal medium) 
Cat.No. C-21260 
500 ml 
BPE (Bovine Pituitary 
Extract) 
0.03 mg/ml (0.4%) 0.4% 
hEGF (human Epidermal 
Growth Factor) 
0.5 ng/ml 0.5 ng/ml 
Insulin 5 µg/ml 5 µg/ml 
HC (Hydrocortison) 0.5 µg/ml 0.5 µg/ml 
Epinephrine 0.5 µg/ml 0.5 µg/ml 
T3 (Triiodthyronine) 6.5 ng/ml 6.7 ng/ml 
Transferrin 10 µg/ml 10 µg/ml 
RA (Retinoic Acid) 0.1 ng/ml 0.1 ng/ml 
FCS (Fetal Calf Serum) 1% 1% 
BSA-FAF (Bovine Serum 
Albumin-Fatty Acid Free) 
0.5 mg/ml -- 
Gentamycin 50 µg/ml 50 µg/ml 
 PRÄP*  
Ampicillin 50 µg/ml 50 µg/ml 
Penicillin G 200 IU/ml 200 IU/ml 
*PRÄP = SAGM plus ampicillin and penicillin G 
 
Apart from DMEM, three further culture media were tested. Two of them, designated as 
SAGM and PROMO, featured almost identical supplement concentrations and according to 
product sheet data (Table 2-3) differed only in the content of T3 and BSA-FAF. The third 
alternative, PRÄP, differed from SAGM by supplementation with two additional antibiotic 
substances: ampicillin and penicillin G. Both antibiotics were also contained in PROMO. 
Cells of preparation pAEpC-11 were used to compare the three culture fluids; two different 
plating densities were simultaneously studied. 
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Fig. 2-16. Comparison of varied cell culture fluids: TEER as a function of time in culture was 
observed for pAEpC-11 plated at A 8×105 cells/cm² (n=3) or at B 6×105 cells/cm² (n=4) 
 
Out of three test media PROMO obviously proved not suitable as concluded from its negative 
influence on the development of pAEpC (Fig. 2-16). Independent of plating density, filter 
area or even membrane material, the result was always identical, i.e. no development of 
confluent monolayers or measurable resistances (not shown). Even plating of cells in SAGM 
and subsequent switch to the alternative medium (concurrently with the first replacement of 
cell culture fluid) did not change this result. Cells plated directly in PROMO-medium did not 
adhere at all, whereas the procedure of a later replacement led to detachment of already 
adhered cells. 
In parallel the two test media based on Clonetics basal medium and distinguished only by 
antibiotic additives (SAGM and PRÄP) influenced the TEER development in approximately 
the same way. This observation was confirmed in several other cell isolations (Fig. 2-17). 
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Fig. 2-17. Different antibiotic supplementations of cell culture fluids: SAGM versus PRÄP. 
Development of TEER as a function of time in culture, monitored in pAEpC-10 plated at 
8×105 cells/cm² (n=6) 
 
Reported data revealed a significant difference in porcine cell development, if plated and 
grown in either of the manufacturers offered cell culture fluids (PromoCell versus Clonetics) 
despite an almost identical supplementation. From this result was concluded that the basal 
media, optimized for small airway and airway epithelial cells respectively, were responsible 
for this effect. Precise contents of both basal media were not available and pAEpC obviously 
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required conditions adapted to small airway epithelial cells. In this context they showed the 
same behavior as reported for hAEpC [33]. 
With respect to occurring infections in donor animals the variant of Clonetics SAGM 
BulletKit supplemented with two additional antibiotics was chosen as routine cell culture 
fluid for the porcine model. 
 
 
In case of hAEpC a replacement of cell culture medium every second day was found 
insufficient for an optimal nutrition of cells. A feeding interval of two days led to repeated 
amplitudes in TEER with a decline every second day after refreshment, alternating with a new 
increase on the day after replacement [1]. 
According to a similar test of pAEpC monolayers, there was no significant difference between 
daily change of culture medium and replacement every second day (Fig. 2-18). In terms of 
model comparison this result underlines the better robustness of the animal model. 
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Fig. 2-18. Daily replacement of cell culture fluid versus every second day: TEER as a 
function of time in culture measured for pAEpC-13 plated at 6×105 cells/cm² and cultivated 
either in SAGM or PRÄP medium (n=5) 
 
The fact that a longer feeding interval led to slightly higher maximum resistances 
(1229±55 Ωcm² versus 988±37 Ωcm²), suggested a better growth and barrier development of 
pAEpC monolayers if not disturbed too often. In addition, this diagram (Fig. 2-18) proved 
once more that SAGM and PRÄP were equivalent: no difference except for the better 
protection against possible infections. 
Later experiments using already standardized culture conditions, i.e. 8×105 cells/cm² plating 
density, PRÄP as routine cell culture fluid and a higher number of test filters (n=12) led to 
similar results (not shown). 
The total of these data suggests that it did not matter whether the cell culture medium was 
refreshed daily or not and with respect to the rather expensive Clonetics medium an interval 
of 32-48 h (1.5-2 d) was determined as optimum for sufficient supply with nutrients, growth 
factors and hormones. 
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3.4 Culture conditions: AIC versus LCC 
 
Culture at an air-interface is a frequently discussed approach to more in vivo like culture 
conditions of lung epithelial cells. For this purpose the cell culture medium is removed from 
the apical cell surface at a certain time, e.g. 24 h after plating; concurrently the volume in the 
basolateral compartment is adjusted in height [34-36]. These air-interface conditions have 
been shown to improve differentiation in primary cultures of human airway epithelia [37,38], 
whereas their suitability in case of primary alveolar cells or lung epithelial cell lines, is still 
controversially discussed. 
To study the influence of these culture conditions on pAEpC monolayers, isolated cells were 
plated as usual. After an adhesion phase of at least 48 hours the apical fluid was removed and 
the basolateral volume adjusted to 500, 600 and 800 µl respectively. This measure should 
prevent a hydrostatic pressure from causing detachment of cells. Since a periodical flooding 
of monolayers was necessary for TEER-monitoring via chopstick electrode, an appropriate 
equilibration time (subsequent to the flooding) had to precede each measurement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-19. Comparison of conventional liquid-covered (LCC) to air-interface culture 
conditions (AIC); parameter TEER monitored for pAEpC-1, plated at either 6×105 or 
9×105 cells/cm² (n=2) 
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AIC-cultured cells (broken lines) revealed a higher data scattering, what could be an impact of 
varying equilibration times ranging from 10-45 min (Fig. 2-19). A fairly parallel development 
of TEER was observed if focused on one of the respective culture conditions. In case of AIC 
different plating densities did not affect growth curves, whereas for LCC monolayers TEER 
was in positive correlation with a higher plating density. 
Studies performed in bronchial cell lines observed an acceptable development of mucus 
producing Calu-3 cells under air-interface conditions; alongside a rather bad influence of 
apical air contact on cell-cell junctions was reported for monolayers of the mucus lacking 
16HBE14o- cell line [36,39]. Native alveolar epithelium is also not covered by a mucus layer 
and the rather thin film of surfactant obviously does not offer a comparable protection. Due to 
the higher scatter of the data culture at an air-interface turned out to be a less stable system. 
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Concluding from these findings and due to the unfavorable influence of repeated flooding on 
cell monolayers, this culture method was not recommended as routine for porcine primary 
alveolar epithelial cells. 
 
 
3.5 Isolation procedure 
 
The intention was to shorten and simplify the complex isolation method for pAEpC and to 
find out whether similar results could be obtained. In general, every single change in the 
isolation procedure could influence the resulting model. Possible consequences may be an 
altered cell population, a different number or kind of cell types or modified features, such as 
protein expression or formation of cell-cell contacts. A parallel preparation following the 
original method (as described above) should guarantee that modifications in the isolation 
procedure represent indeed the only reason for potential differences in the subsequent culture. 
 
One idea was to skip the most time consuming step, i.e. the manual removal of visible airway 
vessels (tracheae, bronchi, bronchioles). Furthermore the density gradient centrifugation was 
advanced and followed by a differential adhesion extended from 1.5 h to approximately 20 h 
over night. 
Some differences already occurred during the preparation: In case of the modified method the 
unpurified tissue was harder to cut by scalpels and minced pieces were more difficult to 
handle throughout the subsequent isolation. The density gradient centrifugation was 
performed the next day (adhesion over night) and featured a diffuse interface. In addition the 
resulting yield of 1 Mio cells/g tissue was less than half that of the original method. 
Subsequent culture demonstrated that cells obtained via the modified version did not succeed 
in the formation of a confluent monolayer. Microscopy revealed differences in morphology: a 
longish expanded shape of cells (actually characteristic for fibroblasts) instead of the typical 
type I and type II-cell-like appearance. Parallel monitoring of transepithelial resistance 
(Fig. 2-20), phase contrast microscopy and transport of marker compounds (not shown) 
confirmed these findings. 
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Fig. 2-20. Original and modified (shortened and simplified) isolation method compared by 
TEER development of resulting cell cultures; pAEpC-33 plated at 8×105 cells/cm² (n=12) 
 
As proven by illustrated TEER-data in Figure 2-20, the tested changes did shorten the 
preparation (distribution over two days), but quality of gained cells was insufficient: Original 
and modified procedure did not result in equivalent cell populations with similar 
characteristics. 
 
 
3.6 Summary and definition of standards 
 
On the way to establishment and characterization of a new in vitro model it is important - 
starting from an optimized level - to maintain a selected method for isolation and purification 
of cells, which enter the subsequent culture process. Such constant preconditions allow 
comparison of results in series of trials and enable assessment of a models reproducibility or 
robustness. 
According to the presented data in terms of isolation method and culture conditions, the 
following procedures were recommended as current optimum: 
- isolation of primary porcine alveolar epithelial cells according to the method described 
in point 1 
- plating density: 8×105 cells/cm² 
- coating: 2 µg/cm² human fibronectin and 8 µg/cm² rat tail collagen type-I 
- growth support: Transwell Clear (PE) filter inserts of 1.13 cm² surface area 
- culture: liquid covered conditions 
- medium: SAGM supplemented with three antibiotics (gentamicin, ampicillin, 
penicillin G) 
- feeding interval: replacement not within first 48 h (adhesion), then at least every 
second day 
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4. APPENDIX 
 
Materials and reagents 
 
Material 
 
a) Unsterile 
- Cold box/cooler 
- Gloves 
- Safe-Lock Micro Test Tubes of 1 and 2 ml volume 
- Fuchs-Rosenthal counting chamber 
- Glass slides, cover glasses 
- Cover slips 
- Nylon gauze 
- Aluminium foil 
 
b) Sterile 
- Serological pipettes of 5, 10 and 25 ml-volume 
- Eppendorf pipettes and tips 
- Glass pipettes 
- Transwell Clear (Corning Costar, Cat. 3460, 3470 and 3450, Bodenheim, 
Germany) 
- 12-well plates (Corning Costar, Bodenheim, Germany) 
- Cell culture flasks of 25 cm² area (Corning Costar, Bodenheim, Germany) 
- Nylon net filters of 100 µm pore size (Millipore GmbH, Schwalbach, 
Germany) 
- Sucking flask, connecting piece and receiver (Millipore GmbH, Schwalbach, 
Germany) 
- Petri dishes (plastic) 10 cm in diameter (Corning Costar, Bodenheim, 
Germany) 
- Duran glass bottles of different volumes (100, 250, 500 and 1000 ml) 
- Plastic tubes of 15 and 50 ml volume with screw cap for centrifugation 
(Greiner Labortechnik, Frickenhausen, Germany) 
- Cell strainers of 40 µm pore size (Falcon Biocoat, Fisher Scientific GmbH, 
Schwerte, Germany) 
- Metal plate for surgical work (30×40 cm²) 
- Glass plate for surgical work (30×30 cm²) 
- Instrument case for surgical devices (Medica, Dudweiler, Germany) 
- Tweezers (surgical and anatomical) (Medica, Dudweiler, Germany) 
- Artery forceps (Medica, Dudweiler, Germany) 
- Surgical scissors (Medica, Dudweiler, Germany) 
- Scalpels (Medica, Dudweiler, Germany) 
- 1 Glass with screw cap and at least 2 l volume for organ transport 
- Glass beakers of different volumes (50, 100, 200, 400 and 800 ml) 
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- 1 Glass beaker of 400 ml volume with gauze on top 
- 1 Glass flask with screw cap and magnetic stir bar (Fisher Scientific GmbH, 
Schwerte, Germany) 
 
 
Reagents and required solutions 
 
a) Reagents stored at room temperature 
- HEPES dry substance 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid) 
(Biochrom KG, Cat. L1603, Berlin, Germany) 
- PBS, Instamed 9.55 g/l PBS Dulbecco 
(Biochrom KG, Cat. L182-50, Berlin, Germany), w/o Ca2+, Mg2+ 
- DMSO, Dimethylsulfoxide, Hybri Max, Cell Culture 
(Sigma, Cat. D-2650, Deisenhofen, Germany) 
5x 5 ml or 5x 10 ml, 1 ml-aliquots recommended 
 
b) Reagents stored at 4°C 
- Rat Tail Collagen, Type I, sterile, in 0.01 N acetic acid of 3-5 mg/ml 
(Becton Dickinson, Cat. 354236, Heidelberg, Germany) 
- Percoll, 100% sterile stock solution 
(Sigma-Aldrich GmbH, Cat. P1644, München, Germany) 
- Trypan Blue Solution 0.5% (in physiological sodium chloride solution) 
(Biochrom KG, Cat. L6323, Berlin, Germany) 
to dilute with water to 0.4% solution 
- SAGM Bulletkit (=SABM, 500 ml basal medium, stored at 4°C and SAGM 
SingleQuots, stored at –20°C) 
(Cell Systems, Cat. CC-3118, St. Katharinen, Germany) 
- DMEM/Ham’s F12, liquid medium without L-Glutamin, (Dulbecco’s MEM) 
(Biochrom KG, Cat. F4815, Berlin, Germany) 
- Medium 199 dry substance, (M199), 
Instamed 9.62 g/l, Medium 199 Earle, w L-Glutamin, w/o NaHCO3 
(Biochrom KG, Cat. T061-05 or T061-10, Berlin, Germany) 
- Ampicillin-Na-salt (Biomol, Cat. 01503-1, Hamburg, Germany) 
- Gentamicinsulfate-solution 10 mg/ml (Biochrom KG, Cat. A2712, Berlin, 
Germany) 
- Penicillin G-Na-salt (Biochrom KG, Cat. A321-42, Berlin, Germany) 
- Fibronectin, human, lyophilisate (Cell Systems, Cat. 2003, St. Katharinen, 
Germany) 
- Deoxyribonuclease I, DNase type IV (bovine pancreas) 
(Cell Systems, Cat. LS 02139, St. Katharinen, Germany) 
- Elastase (porcine pancreas) 
(Cell Systems, Cat. LS 02292, St. Katharinen, Germany) 
- Hycon dip slides for fluids (Biotest Diagnostics AG, Dreieich, Germany) 
- DMEM (Biochrom KG, Berlin, Germany) 
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c) Aliquots stored at –20°C 
- Ampicillin stock solution (SL), dilution 1:100 before use 
1000 mg Ampicillin-Na-salt are weighed into a 200 ml-glass beaker and under 
stirring solved in 150 ml PBS (pH 7.4), afterwards transferred into a 200 ml-
volumetric flask and filled up to the mark with PBS. After mixing the solution 
is filtrated via a 0.22 µm-bottle top filter; 5, 10 and 40 ml-aliquots are 
recommended and stored at –20°C. 
- Gentamicin stock solution (SL) 
Concentration of 10 mg/ml in PBS, aliquots of 5 and 10 ml are recommended 
and stored at –20°C; dilution of 1:200 gives a final concentration of 50 µg/ml. 
- Penicillin G stock solution (SL), dilution 1:100 before use 
Amount of Penicillin G-Na-salt corresponding to 4 million IU is weighed into a 
200 ml-glass beaker and prepared in analogy to Ampicillin-SL. 
- Fibronectin, human 
Reconstitute to 1 mg/ml with sterile distilled water and aliquote in 100 µg-
portions. In a first step the vial containing the lyophilisate (1 mg) as well as the 
solvent are equilibrated to room temperature. Afterwards the lyophilized 
fibronectin is resuspended in 1000 µl sterile distilled water, which is added into 
the delivered substance vial. Allow the material to dissolve (30 min without 
any agitating or swirling). The resulting solution is pipeted into 100 µl-aliquots 
and stored at –20°C. 
- Deoxyribonuclease I, DNase 
The delivered amount of lyophilized powder is to dissolve in an appropriate 
volume of sterile BSSA, to resuspend in its vial and to aliquote in portions of 
10000-15000 units. These are stored at –20°C. 
- Elastase 
The lyophilisate is solved in sterile BSSB (add directly into the delivered vial) 
and subdivided into aliquots of 2.5 units, which are stored at –20°C. Note: 
Reconstituted solutions with a concentration over 1 mg/ml may become 
viscous upon storage for 1-2 days. Therefore the enzyme should be 
resuspended to give a solution of 1 mg/ml or less. 
- Trypsin (1:250) 2.5% in PBS w/o Ca2+, Mg2+ 
(Biochrom KG, Cat. L2133, Berlin, Germany) 
6 ml of this solution correspond to 150 mg Trypsin type I. Aliquots of 6 and 
12 ml respectively are stored at –20°C. 
- Fetal Calf Serum, FCS 
(Greiner Labortechnik, Cat. 758075, Frickenhausen, Germany) 
Aliquots of 5, 10 and 50 ml are stored at –20°C. 
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d) Required solutions stored at RT or 4°C 
- PBS (10x) for transfer buffer 
95.5 g/l Instamed PBS Dulbecco are dissolved in 1 l distilled water, pH 
adjusted to physiological pH 7.4 and filtrated via a 0.22 µm-bottle top filter in 
a sterile glass bottle. Store for about 6 months at room temperature. 
- Transfer buffer, PBS (1x) 
After dilution of PBS (10x) with sterile distilled water antibiotic stock 
solutions are added: 1 l requires 5 ml Gentamicin-SL and 10 ml of each 
Ampicillin- and Penicillin G stock solution. Transfer buffer can be stored at 
4°C for 3 weeks. 
- BSSA, balanced salt solution A 
The following substances are weighed and subsequently dissolved in distilled 
water (molarities given refer to 1 l): 
8.0 g/l  NaCl   (136.9 mM) 
0.40 g/l KCl   (5.4 mM) 
0.125 g/l Na2HPO4x2H2O (0.7 mM) 
2.38 g/l HEPES  (10 mM) 
1.0 g/l  glucose  (5.6 mM) 
pH is adjusted to 7.4 by means of 1 N NaOH and antibiotic stock solutions are 
added as follows: 
5 ml/l  Gentamicin-SL (final concentration 50 µg/ml) 
10 ml/l  Ampicillin-SL (final concentration 50 µg/ml) 
10 ml/l  Penicillin G-SL (final concentration 200 IU/ml). 
The resulting mixture is sterilized by filtration via a 0.22 µm-bottle top filter in 
a sterile glass bottle and to store at 4°C for max. 3 weeks. 
- BSSB, balanced salt solution B 
This buffer solution is almost identical to the aforementioned BSSA, but 
contains two salts in addition (molarities given refer to 1 l): 
0.29 g/l MgSO4x7H2O  (1.2 mM) 
0.394 g/l CaCl2x6H2O  (1.8 mM) 
- Cell culture medium 
SAGM is mixed according to the manufacturers recommendation (i.e. 
subsequent addition of the following supplements, delivered as SAGM 
SingleQuots, to 500 ml SABM basal medium) but without addition of 
Gentamicin and Amphothericin-B; the concentration in brackets gives the final 
concentration in the completed medium: 
7.5 mg/ml BPE (Bovine Pituitary Extract)            (0.03 mg/ml) 
0.5 mg/ml Hydrocortisone     (0.5 µg/ml) 
0.5 µg/ml hEGF (human recombinant Epidermal Growth Factor) 
         (0.5 ng/ml) 
0.5 mg/ml Epinephrine      (0.5 µg/ml) 
10 mg/ml Transferrin      (10 µg/ml) 
5 mg/ml Insulin       (5 µg/ml) 
0.1 µg/ml Retinoic Acid      (0.1 ng/ml) 
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6.5 µg/ml Triiodthyronine     (6.5 ng/ml) 
50 mg/ml BSA-FAF (Bovine Serum Albumin-Fatty Acid Free) 
         (0.5 mg/ml) 
Antibiotic stock solutions are added as listed below: 
5 ml/0.5 l Ampicillin-SL     (50 µg/ml) 
5 ml/0.5 l Penicillin G-SL     (200 IU/ml) 
2.5 ml/0.5 l Gentamicin-SL     (50 µg/ml) 
The mixture is sterilized by filtration via a 0.22 µm-bottle top filter into a 
sterile glass bottle and after addition of 5 ml FCS (to give a final serum 
concentration of 1%) stored at 4°C for max. 2 weeks. Repeated warming and 
cooling of the medium should be avoided. Thus just the required volume for a 
single procedure is transferred to a sterile secondary container and warmed up 
to physiological 37°C before use. 
- Medium for differential adherence 
225 ml  DMEM/Ham’s F12 liquid medium 
25 ml  Fetal Calf Serum (FCS)    (10% serum) 
2.5 ml  Ampicillin-SL     (50 µg/ml) 
5 ml  Penicillin G-SL     (200 IU/ml) 
2.5 ml  Gentamicin-SL     (50 µg/ml) 
Storage at 4°C is possible for 3 weeks. 
- PBS (10x) for Percoll solution high density 
The following substances are weighed and subsequently dissolved in distilled 
water (molarities given refer to 1 l): 
75.0 g/1 l NaCl       (130.3 mM) 
4.0 g/1 l KCl       (5.4 mM) 
4.6 g/1 l Na2HPO4x2H2O     (2.6 mM) 
25.3 g/1 l HEPES      (10.6 mM) 
19.8 g/1 l glucose      (11 mM) 
pH is adjusted to 7.4 and after filtration via a 0.22 µm-bottle top filter, the 
sterile solution is to store at 4°C for max. 6 months. 
- M199 (10x) for Percoll solution low density 
9.62 g/100 ml Medium 199 dry substance are dissolved in distilled water, pH 
adjusted and after filtration via a 0.22 µm-bottle top filter the sterile solution 
can be stored for about 6 months 4°C temperature. 
- Percoll solution low density (σ=1.040 g/ml) 
50 ml  M199 Earle (10x) 
136 ml  Percoll, 100% sterile stock solution 
314 ml  sterile distilled water 
Storage at 4°C is possible for 6 months. 
- Percoll solution high density (σ=1.089 g/ml) 
50 ml  PBS (10x) for Percoll solution high density 
324.5 ml Percoll, 100% sterile stock solution 
125.5 ml sterile distilled water 
Storage at 4°C is possible for 6 months. 
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1. ABSTRACT 
 
Purpose. The purpose of this study was to establish a primary culture of porcine lung 
epithelial cells as an alternative to the currently existing cell cultures from other species, such 
as e.g., rat or human. Primary porcine lung epithelial cells were isolated, cultivated and 
analyzed at distinct time points after isolation. 
Materials and Methods. The main part of the work focused on the morphology of the cells 
and the detection of alveolar epithelial cell markers by using electron microscopy, 
immunofluorescence microscopy and immunoblotting. Regarding a later use for in vitro 
pulmonary drug absorption studies the barrier properties of the cell monolayer were evaluated 
by monitoring bioelectrical parameters (transepithelial resistance and potential difference). 
Results. Epithelial cells isolated from porcine lung grew to confluent monolayers with typical 
intercellular junctions within a few days. Maximum transepithelial resistance of about 
2000 Ωcm² was achieved and demonstrated the formation of a tight epithelial barrier. The cell 
population changed from a heterogeneous morphology and marker distribution (caveolin-1, 
pro-SP-C, surface sugars) towards a monolayer consisting of two cell types resembling type I 
and type II pneumocytes. 
Conclusions. The porcine alveolar epithelial primary cell culture holds promise for drug 
transport studies, because it shares major hallmarks of the mammalian alveolar epithelium 
and it is easily available and scaled up for drug screening. 
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2. INTRODUCTION 
 
Inhalation of systemically acting drug substances into the lung (pulmonary drug delivery), as 
an alternative to injection, is a frequently addressed topic in modern drug development. In this 
context transport processes across the pulmonary air-blood barrier came into focus and the 
demand for in vitro models, which imitate the mammalian lung, increased. Since whole organ 
models are very complex and difficult in handling, in vitro reconstructed epithelia are 
preferred as models. For the bronchiolar level characterized cell lines are available, whereas 
alveolar epithelial models are prevailed by primary cell culture. Isolation and culture of 
primary alveolar epithelial cells is possible e.g. in case of rat [1] and man [2,3]. However, 
because of ethical and logistical problems related to human tissue or the small amount of 
tissue gained from small mammalian species like rat, alternative models should be developed, 
especially for high-throughput drug screening. 
 
The pig closely resembles man in its anatomy and physiology as well as in histological and 
biochemical aspects [4]. These are the main reasons for considering xenotransplantation from 
pig to man to overcome organ shortage for transplantation [5]. Porcine cells and tissue have 
been widely used as models in studies investigating oral, ocular, transdermal, intestinal, 
buccal and nasal drug delivery [6-11]. However, porcine alveolar epithelium has not yet been 
characterized for its suitability in drug absorption studies. One essential advantage of porcine 
tissue is its availability, because animals intended for slaughter can be used (i.e., reduction of 
animal use for research purposes). Furthermore the morphology and physiology of porcine 
mucosa seems to be comparable to that of man [11]. In addition it is generally acknowledged 
that the enzymatic equipment of cells from these two species is very similar. For instance 
similarities between man and pig are evident with regard to the overall metabolic status of the 
two species, the structure and function of the gastrointestinal tract, pharmacokinetics of 
compounds, and the relative size and properties of mucin glycoproteins from mucus 
secretions of human and swine trachea epithelium [12,13]. 
 
Cell culture based models for drug absorption studies frequently use epithelial cells, which are 
grown to confluence on permeable cell culture supports. To prove the tightness of the 
intercellular junctions and to study the permeation characteristics of such an artificial 
epithelium is an essential pre-requisite for their use in transport studies. Moreover, the 
epithelium formed in vitro should possess all other essential morphological, biochemical and 
biophysical characteristics of the epithelium in vivo. In this study alveolar cells (mainly 
type II pneumocytes) of porcine lung were isolated and cultivated up to 13 days. Cells were 
characterized morphologically and by measuring general epithelial and alveolar marker 
molecules using immunocytochemistry and immunoblotting. In order to identify the barrier 
properties of the epithelium formed in vitro, bioelectrical measurements (i.e. transepithelial 
resistance and potential difference) were conducted. Results prove that porcine alveolar 
epithelial cells in primary culture (pAEpC) develop a tight epithelium, which resembles the 
alveolar epithelium in vivo and other cell culture models in many aspects. Therefore the 
porcine cell culture provides a good alternative for rat and human cell culture models. 
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3. MATERIALS AND METHODS 
 
 
3.1 Cell isolation and culture conditions 
 
Primary porcine alveolar epithelial cells 
Primary porcine alveolar epithelial cells were isolated according to a procedure originally 
developed for human alveolar epithelial cells (hAEpC) and published by Elbert et al. [2] as 
well as recently by Fuchs et al. [14] or Ehrhardt et al. [3]. This method, originally described 
by Bingle et al. [15], Dobbs et al. [1] and Cunningham et al. [16], was slightly modified and 
adapted to larger amounts of tissue. In this context the use of another species required the 
adjustment of at least some steps of the original isolation procedure [17]. 
Porcine lung organs from female, 6 months old pigs were obtained from an abattoir. The 
recommended starting amount of tissue material for a preparation is one pulmonary lobe of 
such a slaughtered animal. The fresh organ was transferred into sterile phosphate buffered 
saline and kept on ice during transport to the laboratory. Time between collecting the tissue 
and starting the isolation procedure was between 1 and 2 hours. The mechanical mincing of 
tissue pieces from diaphragmal and cranial regions of the pulmonary lobe was followed by 
washing and the removal of visible bronchioles. Tissue cubes of approx. 5 mm edge length 
were subjected to a fine manual cutting process to enlarge the surface for enzymatic digestion. 
Resulting tissue pieces underwent several washing steps and filtration over 100 µm pore-sized 
nylon gauze. In contrast to the isolation of human alveolar epithelial cells/human protocol [2] 
there was a pre-incubation at 4°C for 1.5 h before entering the enzymatic digestion by a 
trypsin-elastase-combination at 37°C for another 30 min. Cell strainers were replaced by 
nylon filters combined with a glass device (Millipore GmbH, Schwalbach, Germany), which 
could be connected to a pump and contained greater amounts of tissue. Subsequent to the 
enzymatic treatment the resulting tissue mass got triturated (mechanically stressed), filtrated 
via nylon gauze and finally over 40 µm cell strainers. Differential adherence on plastic 
surfaces served to remove macrophages (incubation at 37°C for 90 min) and dissociation from 
blood cells and cell debris was done by a discontinuous percoll density gradient 
(σ = 1.089 g/ml and σ = 1.040 g/ml). Cells collected from the interface were washed and 
plated at a density of 8×105 cells/cm². Further removal of macrophages with magnetic beads, 
as described and published for human alveolar epithelial cells, was omitted in view of high 
costs and, because it was unclear if this antibody-based technique would work with porcine 
cells. However, satisfactorily results were obtained without this additional depletion of 
macrophages. An average of 24.1 (±5.0) g starting tissue mass yielded 
9.50 (±6.89) ×106 cells/g. Variances in this yield may reflect differences in age, gender or 
state of health of the respective donor animals which was, however, not further investigated. 
Isolated cells were cultured on permeable fibronectin(2 µg/cm²)/collagen(8 µg/cm²) coated 
Transwell Clear filter inserts (12 mm diameter, pore size 0.4 µm, Corning Costar, Bodenheim, 
Germany). Cells were plated at a density of 8×105 cells/cm² and grown under liquid covered 
conditions (i.e. 500 µl apically and 1500 µl basally) using small airway growth medium, 
SAGM, (Cell Systems, St. Katharinen, Germany) supplemented with gentamycin, ampicillin 
(50 µg/ml each) and penicillin G (200 units/ml). Fetal calf serum (1% (v/v), FCS) (Greiner 
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Labortechnik, Frickenhausen, Germany) was added in order to reduce fibroblasts. Cultivation 
temperature was 37°C in a 5% CO2 atmosphere and the cell culture medium was replaced at 
least every second day. Subsequent isolation batches are referred to as “pAEpC-n” (porcine 
alveolar epithelial cells) with n indicating the batch number. 
 
Other cell culture models, such as Caco-2 and Calu-3, were cultivated according to 
established protocols [18,19]. 
 
 
3.2 Electron microscopy 
 
Fixation 
Porcine alveolar epithelial cell layers cultured on Transwell filters were quickly washed two 
times in phosphate buffered saline (PBS) and fixed in a mixture of 4% (w/v) 
paraformaldehyde (freshly depolymerized) and 1% (v/v) glutaraldehyde in 0.1 M cacodylate 
buffer. After 5 min at room temperature (RT) under agitation, the fixative was replaced twice 
by fresh fixative for another 30 min (RT, agitation) and then for about 12-24 h (4°C). 
Afterwards cells were washed three times using PBS and stored at 4°C. 
After the initial fixation cells were postfixed with 2% (w/v) osmium tetroxide in 
0.1 M phosphate buffer and dehydrated in a series of acetone (50, 70, 80, 90, 96, 100, 100%; 
each for 15 min at RT). Cells were then prepared for transmission or scanning electron 
microscopy according to the following protocols. 
 
Transmission electron microscopy of ultrathin sections 
Cells were infiltrated with an Epon resin (EMbed 812, Science Services International, EMS, 
Fort Washington, USA) according to Luft et al. [20] using acetone/resin mixtures (3:1, 1:1, 
1:3) and pure resin. For embedding the Transwell filters were cut into pieces, placed into 
fresh resin and polymerized at 60°C for at least 2 days. Ultrathin sections were taken 
perpendicular to the filter surface (60-80 nm thick) and inspected with a transmission electron 
microscope EM10C (Zeiss, Germany) after staining with uranyl acetate and lead citrate for 
more contrast. In total, two randomly collected samples were analyzed for each time point. 
Scanning electron microscopy of the resin block face was done as described by Laue et al. 
[21]. 
 
Scanning electron microscopy of cell surfaces 
After dehydration, cells were dried by critical point drying. Subsequently Transwell filters 
were mounted on aluminium stubs and sputter coated with platinum. Two samples were 
inspected and analyzed for each time point/age of cells. 
Analysis of the filter area covered by cells was based on two randomized samples. Digital 
images were taken at a magnification of 800 x and overlaid with a lattice-grid (2.5 × 2.5 µm). 
The number of points lying over free filter surface was determined (point-counting method of 
basic stereology) and related to the total number of points. 
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3.3 Determination of bioelectrical parameters: transepithelial electrical resistance and 
potential difference 
 
Bioelectrical parameters were measured using an electrical voltohmmeter (EVOM, World 
Precision Instruments (WPI), Berlin, Germany) equipped with STX-2 “chopstick” electrodes. 
Transepithelial electrical resistance (TEER) was estimated relative to the corresponding 
surface area (=filter surface) and given in Ωcm². The potential difference (PD), defined as an 
open circuit membrane potential, was measured in millivolt (mV). All measurements were 
corrected for the value measured with a coated cell-free Transwell filter. 
 
 
3.4 Immunocytochemistry 
 
Antibodies 
The following primary antibodies served for qualitative detection of tight junction proteins 
ZO-1 (zonula occludens protein-1) and occludin: mouse anti ZO-1 antibody with species 
reactivity human and mouse monoclonal anti occludin antibody (both Becton Dickinson (BD) 
Transduction Laboratories, Heidelberg, Germany), as well as rat anti ZO-1 including porcine 
species reactivity (Chemicon, Hofheim, Germany). Localization of the adherent junction 
protein E-cadherin was examined by means of mouse anti E-cadherin (BD Transduction 
Laboratories, Heidelberg, Germany). Furthermore, mouse anti-cytoceratin antibody 
(Transduction Laboratories, Heidelberg, Germany) and mouse monoclonal LRP-56 (lung 
resistance protein) antibody (Sanbio, Beutelsbach, Germany) were used as primary 
antibodies. Caveolin-1 expression was analyzed using a rabbit polyclonal cav-1 (BD 
Transduction Laboratories, Heidelberg, Germany) antibody, which recognizes both the α- and 
β-isoforms of caveolin-1. Surfactant protein-C (SP-C) was detected by means of a rabbit 
polyclonal proSP-C anitbody (Chemicon, Hofheim, Germany), which recognizes the SP-C 
proprotein as well as processing intermediates. 
Mouse IgG1κ (Sigma, M 5284, Deisenhofen, Germany), IgG rabbit serum (Dako, X0903, 
Hamburg, Germany) and rat IgG1, Clone DD9 (Chemicon, CBL 604, Hofheim, Germany) 
were used for isotypic controls and diluted to the protein content of the primary antibodies 
listed above. Fluorescence visualization of bound antibodies was done by incubation with 
secondary FITC-labeled (FITC = fluoresceinisothiocyanate) goat anti-mouse F(ab’)2 
fragment, goat anti-rabbit F(ab’)2 fragment or FITC-conjugated rat-immunoglobulins (Dako, 
F 0479, F 1262, F 0234, Hamburg, Germany). 
 
Immunofluorescence 
Filter-grown pAEpC cell layers were washed three times in PBS, fixed on Transwell filter 
inserts with 2% (w/v) paraformaldehyde in PBS and blocked for 10 min in 50 mM NH4Cl, 
followed by permeabilization for 8 min with 0.1% (w/v) Triton X-100. Subsequent to the 
fixation cells were incubated with a primary antibody diluted 1:100 in PBS plus 1% (w/v) 
bovine serum albumin (BSA), pH 7.2, anti-pro-SP-C was diluted 1:40. After a 60-min 
incubation with 100 µl of the diluted primary antibody, the cell monolayers were washed 
three times with PBS before incubation with 100 µl of a 1:100 dilution in PBS containing 1% 
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(w/v) BSA of the respective FITC-labeled secondary antibody. Propidium iodide (PI; 
1 µg/ml) was then added to counterstain cell nuclei. After 30 min incubation, the specimens 
were washed three times with PBS and embedded in FluorSave anti-fade medium 
(Calbiochem, Bad Soden, Germany). 
 
Lectin binding 
For cytochemical detection of cell-specific lectin binding, Ricinus communis agglutinin 
(RCA) and Maclura pomifera agglutinin (MPA) served as differentiation markers for type I 
and type II pneumocytes respectively, a modified Krebs-Ringer buffer (KRB) (glucose 
replaced by manitol) was used instead of PBS. After three washing steps in modified KRB 
cell monolayers were fixed with 2% (w/v) paraformaldehyde and blocked in 50 mM NH4Cl. 
Cell layers were incubated with lectin at a concentration of 50 µg/ml each, for 1 h at 37°C in a 
water-saturated 5% CO2 atmosphere. The incubation was performed with either vital or fixed 
cells. In the first case cells were subjected to three washing steps, incubated and mounted in 
FluorSave or else fixed as described above, followed by incubation and subsequent mounting. 
The type I cell-specific lectin Ricinus communis agglutinin (RCA) was used in its rhodamine-
labeled, the type II cell-specific Maclura pomifera agglutinin (MPA) in its FITC-labeled form 
(Vector Laboratories, Burlingame, CA, USA over Boehringer Ingelheim Bioproducts, 
Ingelheim, Germany). Freshly plated cells (1 day) were air-dried instead of fixation and 
examined the following day. Cell nuclei were not counterstained. Cells at the age of 4 or 
7 days were subjected to both, single- and co-incubation. 
 
Images were obtained with a confocal laser scanning microscope (MRC-1024, Bio-Rad, 
Hemel, Hempstead, UK) with the instrument settings adjusted so that no positive signal was 
observed in the channel corresponding to the green fluorescence of the isotypic controls. 
 
 
3.5 Staining for alkaline phosphatase 
 
Expression of alkaline phosphatase, as another marker of differentiation, was tested 
comparing pAEpC immediately after plating, with those cultured for a period of 6 days. A 
Sigma Diagnostics test kit (Sigma, kit 86R, Deisenhofen, Germany) was used for 
histochemical detection of phosphatase activity. Cells were plated onto 
fibronectin/collagen(Fn/Col)-coated glass cover slips, which were placed on the bottom of 12-
well plates. Freshly isolated cells (1 day) were air-dried, whereas cultured cells were washed 
twice with PBS and fixed with methanol (4°C, 30 min). After three more washing steps 
400 µl of the staining solution was added into each well and incubated at RT for 10-30 min 
under protection from light. Staining was performed according to the instructions of the test 
kit. Stained pAEpC were examined under an inverted light microscope (Leica Microsystems 
Wetzlar GmbH) connected to a Nikon coolpix990 digital camera for documentation of 
micrographs. 
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3.6 Western blot 
 
Detection of proteins by Western blot analysis served to check the specificity of the used 
antibodies and to compare pAEpC in primary culture with cell lines (Calu-3, Caco-2). 
Different cell isolations of pAEpC were examined at 0, 2, 4 and 7 days in order to obtain at 
least semi-quantitative knowledge about changes in protein expression in dependence on 
cultivation time of cells. Caco-2 and Calu-3 cells were cultured for one week before they were 
analyzed in Western blot studies for comparison with the primary cells. 
Detection of individual proteins was performed according to Roche’s Manual [22] and current 
literature as referred in Table 3-1. 
 
Protein extraction 
Cells either cultured on Transwell Clear filter inserts or freshly isolated pAEpC (day 0) were 
washed twice with PBS (4°C) and lysed in sodium dodecyl sulfate (SDS) sample buffer for 
approximately 5-10 min while cooled on ice. This buffer contained 50 mM TRIS/HCl, (pH 8), 
1% SDS and 50 µM Dithiothreitol (DTT) (Carl Roth GmbH, Karlsruhe, Germany). Lysates 
were clarified by centrifugation at 16000 g for 2-5 min, the resulting supernatant was boiled at 
95°C for 10 min (denaturation) and stored at –20°C. 
Total protein determination of samples was performed by means of MicroBC-Assay protein 
quantitation kit (Uptima, Montlucon, France) using bovine serum albumin as standard [23]. 
 
Gel electrophoresis 
Lysate supernatants were diluted 2:1 (to give a total protein concentration of 1 µg/ml) with 
2x electrophoresis sample buffer (1x = 150 mM TRIS/HCl (pH 6.8); 1.2% SDS; 30% 
glycerol; 15% β-mercaptoethanol and 18 mg/l bromophenol blue); all reagents obtained from 
Carl Roth GmbH, Karlsruhe, Germany. Aliquots equivalent to 15 µg total protein per sample 
were loaded and resolved in a 8-15% SDS/polyacrylamide gel (SDS-PAGE) according to 
Laemmli [24] using a Minigel-Twin (Whatman Biometra, Göttingen, Germany). A full-range 
rainbow prestained molecular weight marker (Amersham Biosciences, Freiburg, Germany) 
was concurrently electrophoresed. 
 
Immunoblotting 
Gels were electroblotted to Roti-PVDF (polyvinylidene difluoride) Transfer Membrane (Carl 
Roth GmbH, Karlsruhe, Germany) in a Tank Blot (Whatman Biometra, Göttingen, Germany) 
filled with Towbin blotting buffer (25 mM TRIS/HCl, 192 mM glycin, 0.1% SDS, 10% 
methanol). A cooling jacket allowed blotting either at high current (1 A) for 1h or at low 
current (100 mA) over night. Non-specific protein binding on the membrane was blocked in 
1-2% Slim Fast (Allpharm Vertriebs GmbH, Messel, Germany) in Tween-buffer (50 mM 
TRIS (pH 7.5); 150 mM NaCl; 0.1% Tween 20) for 2h at RT and overnight at 4°C. 
 
After washing in Tween-buffer, membranes were incubated with primary antibody for 1h at 
RT, then washed again and probed for 45 min with the secondary HRP (horseradish 
peroxidase)-conjugated antibody. For quantitative results SDS-PAGE gels were loaded with 
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samples of identical total protein content and membranes were co-incubated with primary 
antibody plus anti-beta-Actin, which was used as an internal standard and detected in parallel. 
 
Primary antibodies: 
Anti-ZO-1, human, (BD Transduction Laboratories 610966, Heidelberg, Germany) 
Rat Anti-ZO-1, porcine, (Chemicon, MAB1520, Hofheim, Germany) 
Anti-Occludin (BD Transduction Laboratories 611091, Heidelberg, Germany) 
Anti-E-Cadherin (BD Transduction Laboratories 610182, Heidelberg, Germany) 
Anti-Caveolin (BD Transduction Laboratories 610059, Heidelberg, Germany) 
Rabbit Anti-Human proSP-C (Chemicon, AB3428, Hofheim, Germany) 
Anti-β-Actin, monoclonal, mouse (Sigma, A5441, Deisenhofen, Germany) 
Anti-Actin, rabbit (rabbit Anti-Actin affinity isolated antibody), (Sigma, A2066, Deisenhofen, 
Germany) 
Secondary antibodies: 
Goat Anti Rat IgG, HRP conjugated (Chemicon, AP136P, Hofheim, Germany) 
Goat Anti Rabbit IgG, HRP conjugated (Chemicon, AP132P, Hofheim, Germany) 
Goat Anti Mouse IgG, HRP conjugated (Chemicon, AP124P, Hofheim, Germany) 
 
Bound antibodies were detected by a chemiluminescent signal generated by the use of a Roti-
Lumin kit (Carl Roth GmbH, Karlsruhe, Germany), which is based on an enhanced 
chemiluminescence method (ECL). After incubating the blot with the corresponding 
substrate, the signal was autoradiographically detected on Kodak BioMax Light-1-Film 
(Amersham biosciences, Freiburg, Germany). Digital image acquisition and band 
quantification was performed via BioRad Gel Doc–Documentation System (Scanner) (Bio-
Rad, Hemel, Hempstead, UK). 
 
To quantify protein expression in pAEpC at different developmental stages, cells from two 
different cell isolations were studied and protein expression was determined on days 0, 2, 4 
and 7 after isolation. In addition to loading samples of constant total protein content onto the 
SDS-gels, beta-actin served as internal standard with its molecular weight (42 kDa) 
sufficiently distinct from that of the studied proteins. Band quantification was performed by 
densitometry. The ratio between marker protein and beta-actin (internal standard) was 
compared over time in culture. Background intensity, which was proportional to the protein 
content, was subtracted to get the real signal for the individual time points. Signals were 
captured via a rectangle-technique or by means of a “free-hand”-tool and the average mean of 
both measurements used for further evaluation. In order to exclude systematical errors, 
samples of both cell isolations were analyzed in parallel. 
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4. RESULTS 
 
 
4.1 Morphology of pAEpC 
 
Isolated porcine lung cells were plated on Transwell filters and cultivated for 13 days. The 
morphology of three cell isolations was analyzed at distinct time points of culture (2, 4, 6, 8, 
10, 13 days) using scanning and electron microscopy. The overall morphology and 
development of cultured cells in three individual preparation batches were the same, starting 
with single cells or small separated cell groups of a heterogeneous cell morphology at day 2 
and ending at day 13 with a flat monolayer of a rather uniform cell population (Fig. 3-1). 
 
Cell population at day 2 of culture comprised cells of various shape and ultrastructure. The 
cell shape varied between round and flat spread out onto the substrate. Most cells adhered to 
the substrate and formed numerous filopodia at their rims, frequently contacting other cells 
(Fig. 3-1 A). Often cells were observed which settled on other cells or cell groups. These cells 
appeared either spherical with numerous surface microvilli or more irregular with many 
filopodia and resembled lymphocytes and macrophages respectively. Erythrocytes were also 
present in the culture but disappeared during further cultivation. Ciliated cells were regularly 
intermingled between other cells and most likely derived from bronchial epithelium. In thin 
sections the typical ciliary morphology could be identified (not shown). In some flat cells but 
also occasionally in round cells on top of other cells numerous small holes were detected 
between the origins of the microvilli (compare Figure 3-2 C for similar structures in cells at 
day 13). Thin sectioning revealed the typical omega-shaped morphology of caveolae, which 
are characteristic for either endothelial cells or type I alveolar epithelial cells (not shown). The 
internal ultrastructure of the cells was as variable as their shape. In Figure 3-3 A, a cell profile 
of a round cell is shown. Frequently several vacuole-like inclusions were present which often 
included membrane lamellae and/or vesicles (compare Figure 3-3 B which shows similar 
structures in a cell at day 4). 
 
Cells grew to confluence after one week, starting from a surface coverage of 50-60% on 
day 2, over 80-90% on day 4, 96% for day 6 up to almost 100% at the age of 10 or 13 days 
(Fig. 3-1). However, even 13d-samples revealed very few but clearly visible spots of 
uncovered filter surface. In parallel to the development of confluence, the average height of 
the cells was reduced. The height declined from about 5 µm on day 2 down to about 2-2.5 µm 
from day 4 on, as measured in images taken from the block face of embedded filters after 
sectioning. 
 
Cells on culture days 10 and 13 formed a monolayer (Fig. 3-1 E,F) with few locally restricted 
multi-layered spots (Fig. 3-2 A). The monolayer was dominated by flat cells (even in their 
nuclear region) with broad cytoplasmic extensions. Cells with a protruding nucleus were 
interspersed in between these flat cells (Fig. 3-1 F). Ciliated cells or small groups of multi-
layered cells disrupt either the homogeneous surface appearance or the monolayer 
organization of the cells (Fig. 3-2 B). The internal ultrastructure of cells on days 10 and 13 
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revealed mainly two morphological forms: 1) flat cells with or without vacuole-like 
structures, which contain fragments of membrane lamellae and/or vesicles (Fig. 3-3 F), and 
2) round cells with several multilamellar bodies (Fig. 3-3 E). Fields of caveolae were only 
occasionally detected in flat cells (Fig. 3-2 C). 
 
The development of cell preparations from day 2 of culture towards days 10 and 13 was not 
only characterized by the flattening and spreading of most cells. Cellular junctions, i.e. tight 
and adherent junctions, between cells were already clearly visible in young cultures (Fig. 3-
3 D). With ongoing time of culture and confluence the presence of these epithelial cell 
contacts increased. Erythrocytes and cells with the morphology of lymphocytes, 
macrophages, endothelial cells or bronchial cells were significantly reduced in frequency or 
disappeared. Most cells showed vacuoles containing membrane fragments or vesicles in their 
cytoplasm (Fig. 3-3 B,C). Vacuoles with densely stacked membrane lamellae, like in typical 
multilamellar bodies observed in cells on days 10 and 13 (Fig. 3-3 E) were rarely detected in 
cultures up to day 8 of cultivation (Fig. 3-3 C). Some cells revealed few dispersed caveolae at 
their apical plasma membrane. 
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Fig. 3-1. 
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Fig. 3-2. 
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Fig. 3-3. 
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Fig. 3-1. Scanning electron microscopy of cultivated pAEpC at different days post plating. 
A On day 2 (2d), cells of a different shape with numerous filopodia are adhered onto the filter 
substrate. B, C With time (4d, 6d), many cells become flat, spread out onto the substrate and 
thereby covering the filter surface. Fine cytoplasmic bridges connect some cells with each 
other (arrows). D, E, F On day 8 (D, 8d) the coverage of the filter area is almost 100%. The 
monolayer appears flat with few cytoplasmic bridges between some of the cells, which 
disappear at later time points. On days 10 (E, 10d) and 13 (F, 13d) the monolayer appears 
quite homogenous. Occasionally single cells with elevated nuclei and small surface area 
(arrows in F) are inserted in between the flat cell monolayer. 
 
Fig. 3-2. Scanning electron microscopy of cultivated pAEpC at day 13 post plating. Cells 
form a flat monolayer. A Cluster of multi-layered cells (arrow) exist at rare sites. B At few 
positions in the monolayer cells with brush-like surface projections are localized (arrow). C In 
some flat cells the apical plasma membrane possesses characteristic holes of about 40–60 nm 
in diameter, which most likely represent the apical openings of caveolae. 
 
Fig. 3-3. Transmission electron microscopy of cultivated pAEpC at different time points post 
plating. A, B Typical cell forms at day 4 of culture. A round cell without particular cell 
organelles is localized on the flat extensions or filipodia of other cells (A). (n) nucleus. Many 
of the flat cells contain vacuoles (v) with some vesicles or amorphous electron dense material 
(B). (m) mitochondria. C, D On day 8, in few cells multilamellar bodies (mlb) can be detected 
besides vacuoles (asterisk) (C). The cell monolayer is already highly confluent and the cells 
display the typical epithelial cell contacts, i.e. tight junctions (tj) and desmosomes (d). 
E, F With ongoing cultivation time, two morpho-types develop. At day 13 some cells reveal a 
more round morphology with several characteristic multilamellar bodies in the apical 
cytoplasm (arrows) (E). The other cells are comparatively flat spread out on to the substrate 
and reveal no particular ultrastructure (F). 
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4.2 Bioelectrical parameters (TEER, PD) 
 
Transepithelial electrical resistance (TEER; unit: Ωcm²) was used as a standard parameter to 
quantify the tightness of the epithelial barrier. While the TEER gives information about the 
integrity of the barrier, the potential difference (PD) describes active ion transport in epithelial 
cells (unit: mV). Characteristic progressions of these parameters observed for pAEpC during 
the cultivation period are illustrated in Figure 3-4 A-C. 
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Fig. 3-4. Bioelectrical parameters monitored during culture of pAEpC monolayers. 
A, B Typical TEER-time-courses observed in different cell isolations; data are given as mean 
± SD; n=3-6. Cells of some cell isolations (type A) grow faster, i.e. they feature a steeper 
increase in TEER and confluence is reached earlier. Whereas other cell preparations (type B) 
comprise a retarded development (A). Other types of growth curves are characterized by a 
longer plateau phase (type C) or display a linear increase (type D) (B). C TEERmax (mean 
± SD; n=2-6) in different isolations of pAEpC is plotted against the time point [d] in culture at 
which this maximum is observed. In most cases (85%) batches of monolayers reach their 
maximum TEER at culture days 5-10. 
 
Cell cultures from different cell isolations showed different growth behavior and thus 
variation in the corresponding TEER and PD curves over time of culture. This seems to be a 
consequence of varying purity among the different cell isolations as indicated by microscopic 
observations. In particular, cell preparations differed in parameters, such as maximum 
transepithelial resistance (TEERmax), the time when it was reached, as well as duration of the 
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TEER plateau and the time when it started. In most cases cultured pAEpC displayed an initial 
rise in TEER after 4-5 days, which was followed by a plateau (Fig. 3-4 A, type A) lasting for 
3-4 days. More heterogeneous cell preparations usually showed a retarded development of the 
transepithelial resistance but a similar curve shape (Fig. 3-4 A, type B). Apart from that, some 
exceptional cell isolations featuring a slower but continuous increase in barrier properties 
(Fig. 3-4 B, type D) and/or an extended plateau phase (type C) were observed in a few cases. 
Regardless of the curve form, all batches of monolayers exceeded at least a TEER of 
600 Ωcm2. As depicted in Figure 3-4 C there was a positive correlation between TEERmax and 
the time of culture at which the maximum was observed, i.e. slower growing monolayers 
tended to reach higher TEERmax values than faster growing ones. 
The potential difference (PD) was monitored in parallel and gave similar results (data not 
shown). If referred to a single isolation batch, it consistently followed the development of 
TEER, reaching a maximum (PDmax) of 6-14 mV between culture days 5-10 d. At the same 
time pAEpC monolayers achieved their maximum TEER of 1200-2400 Ωcm². 
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4.3 Immunocytochemical characterization of pAEpC 
 
 
Immunostainings should identify the presence of epithelial proteins and cell markers at the 
cellular level. Since most of the used antibodies were initially not tested for their species 
reactivity in swine (apart from ZO-1), their specificity was also investigated by Western blot 
analysis (compare 3.4). 
 
Junction proteins 
Porcine alveolar epithelial cells developed an increasing transepithelial resistance with 
ongoing time of cultivation most likely by establishing functional cell-cell contacts. For a 
further characterization, pAEpC monolayers of different ages were analyzed for marker 
proteins of epithelial cell-cell contacts and for the presence of the epithelial marker 
cytoceratin. 
 
In young cultures (4d) ZO-1 immunofluorescence was distributed as small bright spots all 
over the cytoplasm and lined more or less clearly the cell border (Fig. 3-5 A). In pAEpC 
monolayers stained after 7 days in culture, the fluorescent signal in the cytoplasm had 
disappeared and the cells showed a bright and continuous immunofluorescence marking the 
circumference of the cell (Fig. 3-5 B). 
An analogous labeling pattern was obtained for occludin, another tight junction protein 
(Fig. 3-5 C,D). 
 
In addition pAEpC (6d) stained specifically for the adherent junction protein E-cadherin, as 
well as for the common epithelial cell marker cytoceratin (Fig. 3-5 E,F). In case of E-cadherin 
the observed fluorescence was distributed within the cytoplasm but especially concentrated 
close to the cell border. Staining for cytoceratin was detected as diffuse cytoplasmic 
fluorescence and in some cells as groups of small bright fluorescent dots. Qualitative 
detection of E-cadherin underlines the formation of functional cell-cell contacts in this 
primary cell culture and the presence of cytoceratin identifies pAEpC monolayers as epithelial 
cells. 
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Fig. 3-5. Confocal laser scanning microscopy of pAEpC monolayers of different age, 
immunostained for epithelial cell-cell contact markers: Monolayers after 4 days (A) and 
7 days (B) in culture are analyzed for the tight junction protein ZO-1, for occludin at the age 
of 5 days (C) and 7 days (D) and on day 6 in culture for the adherent junction protein E-
cadherin (E) and epithelial cell marker cytoceratin (F); cell nuclei are counterstained with 
propidium iodide. Scale bars represent micron (µm). A On day 4 in culture monolayers 
display ZO-1-positive cytoplasmic spots, most probably representing vesicles, and stained 
cellular borders. B At day 7 ZO-1 staining is sharply confined to the cell border, resulting in a 
circumferential labeling of cells. C, D A similar labeling pattern is obtained for the tight 
junction protein occludin. On day 5 occludin-positive cytoplasmic spots and a more or less 
continuous cell border staining are detected (C), whereas older cultures feature less 
cytoplasmic staining besides the persisting cell border staining (D). E, F E-cadherin and 
cytoceratin are present in pAEpC monolayers on day 6 in culture. The adherent junction 
protein is overall detected in the cytoplasm as well as at the cell border region, whereas 
fluorescent signals for the epithelial marker are distributed at the surface and in the cytoplasm 
of cells, but also display positive cytoplasmic spots. 
 
 
Alveolar epithelial cell marker 
Antibodies against caveolin-1, surfactant proteins and the lung resistance protein (LRP) were 
used to identify alveolar epithelial cells. Subsequent to proving that the used isolation method 
results in epithelial cells, it was important to classify different types of alveolar cells; i.e. to 
differ between type I and type II pneumocytes in particular, by applying cell-type specific 
cytochemical staining. In addition to characteristic proteins, lectin binding is also proposed to 
trace a differentiation process [2,25]. Typical markers for type II cells, the progenitor of type I 
cells, are surfactant protein-C, alkaline phosphatase and binding to Maclura pomifera 
agglutinin (MPA), while caveolin and binding to Ricinus communis agglutinin (RCA) are 
considered as markers for type I cells. The lung resistance protein (LRP) is characteristic for 
secreting cells and therefore attributed to type II pneumocytes. Characterization was mainly 
focused on 6d-old monolayers because most cell preparations achieved TEER exceeding 
600 Ωcm² within this cultivation time indicating the development of a tight epithelial barrier. 
 
Since the ultrastructural diagnosis of invaginations as caveaolae is not unequivocal, the 
biochemical presence of caveolin [26] in pAEpC monolayers was analyzed. The caveolin-1 
immunofluorescence was detected at the cell surface and in form of bright fluorescent spots in 
the cytoplasm of a subpopulation of cells. As illustrated in Figure 3-6 A not all cells within 
the population stained positive for caveolin. 
Surfactant protein-C (SP-C) is an important component of the surfactant film covering the 
alveolar epithelium and is mainly secreted by type II cells [27]. As shown in Figure 3-6 B, 
pro-surfactant protein-C (pro-SP-C), a pre-mature form of SP-C, was present in pAEpC 
monolayers (6d). However, cells of a flat, type I-like morphology gave a less intensive signal. 
Isotypic control for these antibodies (both anti-rabbit) was analyzed in parallel and did not 
show specific fluorescence (not shown). 
The lung resistance protein LRP-56 is known to be intensely expressed in epithelial cells with 
secretory and excretory functions, as well as in cells chronically exposed to xenobiotics, such 
as bronchial epithelial cells. The protein is found in vesicles and works as major vault 
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transporter protein (vaults = multi-subunit structures) [28]. In pAEpC some cells showed 
intense labeling of the cytoplasm as densely arranged spots indicating a vesicular association 
(Fig. 3-6 C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3-6. Immnunostaining for lung epithelial cell markers caveolin, pro-surfactant protein-C 
(pro-SP-C) and bronchial epithelial cell marker lung resistance protein (LRP) in pAEpC 
monolayers after 6 days in culture. Cell nuclei are counterstained with propidium iodide (red 
fluorescence). A The caveolin-1 staining (green fluorescence) is rather weak and only 
concentrated to brighter spots in the cytoplasm and to the cell surface in some cells. 
B Staining for pro-SP-C is found in all cells. The distribution is rather diffuse with a slight 
concentration around the nucleus and the cell borders. Cells, which cover a large area, 
indicative for a type I-like morphology, show a less intensive staining (arrow). C The staining 
with antibodies against LRP shows a gradual intensity among the cells of the monolayer 
ranging from strong staining to no staining. Staining appears granular, which is in accordance 
with the vesicular localization of the LRP. Scale bars represent micron (µm). 
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Alkaline phosphatase (AP) is a differentiation marker that is known to be expressed in 
alveolar type II pneumocytes, but absent in type I cells [29]. Isolation of pAEpC is supposed 
to predominantly gain type II pneumocytes, which are able to undergo differentiation into 
type I cells with time in culture. Cytochemical staining performed subsequent to isolation of 
pAEpC could detect the presence of the type II cell specific marker enzyme (AP activity) in 
freshly isolated (analyzed as soon as possible, 1d) pAEpC-cultures, whereas pAEpC 
monolayers at the age of 6d did not stain (not shown). 
 
As additional cell type marker lectin binding proved to be complementary to the change of 
expression pattern of cellular proteins in human type I- and type II-pneumocytes [2,25]. In 
tissue sections the Ricinus communis agglutinin (RCA) stains the surface of type I 
pneumocytes, while the Maclura pomifera agglutinin (MPA) binds to the surface of type II 
cells. In pAEpC, RCA and MPA stained the surface of cells and in case of MPA their nuclei 
as well (only surface labeling has a diagnostic relevance). Freshly isolated cells were air-
dried, not fixed, because fixation usually removes cells from the preparation. 
Co-incubation with both lectins at the same time in 4d-old pAEpC monolayers showed double 
labeling with both lectins in a subpopulation of cells, indicating a mixture of type I and type II 
characteristics in these cells. Besides those double-labeled (MPA+RCA) cells, single-labeled 
cells, which only bound RCA, were observed (Fig. 3-7 A). A comparison of 1 day (not 
shown) versus 7 day-old pAEpC after single-incubation with either MPA (Fig. 3-7 C) or RCA 
(Fig. 3-7 D) revealed an identical labeling pattern. The fluorescence was concentrated as 
dense, fine granulation at the cell surface and along the cell borders. At both time points many 
cells stained for MPA and only few stained strongly for RCA. Also lectin-incubation of living 
instead of fixed cells did not change this result. In summary, the lectin binding argues rather 
for a mixture of cell type specific features in pAEpC at the analyzed time of culture than for a 
clear segregation into two cell types. 
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4.4 Qualitative and semi-quantitative Western blot analysis of cell marker proteins in 
pAEpC 
 
In a qualitative Western blot analysis pAEpC were compared with two tumor-derived human 
epithelial cell lines, the bronchial Calu-3 and the intestinal Caco-2. Due to their 
morphological and functional similarity to the human airway or small intestine mucosa 
respectively, they are widely used as in vitro models of these biological barriers. To model the 
alveolar epithelium there seems to be no cell line available today, which displays sufficient 
barrier tightness as required for transport experiments. Similarities of a new primary cell 
culture to epithelial models of the same organ (Calu-3) or differences to that of other 
epithelial barriers of the human body, like the gastro-intestine (Caco-2), should help to 
evaluate a new approach. 
A semi-quantitative analysis served to monitor protein expression in pAEpC at different time 
points of culture. Analyzed proteins as well as their corresponding molecular weights are 
listed in Table 3-1. The specificity of the used antibodies was ascertained, because they 
generated autoradiographic signals at the reported molecular weights. Pro-SP-C could not be 
transferred on to the blotting membrane and therefore could not be analyzed by 
immunoblotting. Nevertheless, the immunostaining pattern obtained in case of pro-SP-C was 
comparable to that observed for a human in vitro model (hAEpC) [14] indicating specific 
labeling. The specificity of the antibody against tight junction protein ZO-1 was already 
documented by the manufacturer. 
 
Table 3-1. Proteins analyzed by immunoblotting 
 
Protein Molecular 
weight 
Localization/Purpose Method for Western 
blot analysis 
caveolin 22 kDa type I pneumocyte [14,26,30] 
pro-SP-C 21 kDa type II pneumocyte [31,32] 
occludin 65 kDa tight junction [33,34] 
E-cadherin 120 Da adherent junction [33,35] 
 
 
Qualitative detection 
 
Results are summarized in Table 3-2. Caveolin-1 was detected in pAEpC over a period of 
8 days, as well as in isolated (0d) cells. Bronchial Calu-3 cells, which were examined at the 
same age (8d), also seemed to express caveolin-1, although showing a less intensive signal. 
The tight junction protein occludin was present in both epithelial cell lines Caco-2 and Calu-
3. In pAEpC occludin could not be detected after the isolation (0d), whereas a positive signal 
was obtained for pAEpC at the age of 2, 4 or 8 days (Fig. 3-8 B). A possible explanation for 
this result is that cell-cell contacts were destroyed during the isolation process (e.g., by the 
digesting enzymes). Afterwards isolated cells have to recover and to reorganize in an 
epithelial monolayer. Therefore, a new synthesis of junction proteins would be required as a 
precondition to re-build cell-cell contacts. Expression of the adherent junction protein E-
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cadherin was proved in pAEpC at the age of 4 days and in both cell lines, suggesting the 
development of functional cell-cell contacts. 
In summary, proteins which contribute to the tightness of an epithelium (occludin and E-
cadherin) were detected in all of the three considered in vitro models, whereas caveolin was 
only found in pAEpC cultures and to a far less extent in the bronchial cell line. 
 
Table 3-2. Qualitative detection of caveolin, occludin and E-cadherin by immunoblotting, 
comparison of primary pAEpC with Caco-2 and Calu-3 cell lines 
 
 pAEpC (0d) pAEpC (8d) Calu-3 (8d) Caco-2 (8d) 
caveolin +++ +++ (+) -- 
occludin -- ++ ++ +++ 
E-cadherin + +++ ++ + 
“--“: no signal/detection; “+”: positive signal; number of symbols indicates signal intensity 
 
 
Semi-quantitative detection 
 
To get information about the development of marker protein expression in pAEpC over time 
of culture, cells from two different cell isolations were investigated. Protein expression was 
determined on days 0, 2, 4 and 7 after isolation and related to the expression of beta-actin. 
 
The alveolar epithelial cell marker caveolin-1 was detected in all analyzed cell samples at the 
same molecular weight as the positive control (Fig. 3-8 A). For some samples (pAEpC-35: 
2d; pAEpC-36: 0, 2d; positive control) an additional band appeared just beneath the caveolin 
band with the indicated molecular weight. This band was also recognized in the positive 
control, but was excluded from quantitative assessment. The time course on caveolin 
expression was different for the two analyzed cell isolations pAEpC-35 and –36 as shown by 
the protein density ratios (Fig. 3-8 A). Both passed a minimum on day 4 in culture, followed 
by an increase, which was steeper in case of isolation batch 35. 
 
Signals of the tight junction protein occludin were located between marker bands of 50 and 
75 kDa in all samples, except in those of freshly prepared cells (Fig. 3-8 B). The fact that the 
density of occludin-spots increased continuously with time in culture suggests a predominant 
expression of the protein in older cells, which is in accordance with the formation of cell-cell 
contacts. Ratios calculated in relation to beta-actin as an internal standard, which was detected 
throughout all cell lysates, showed that expression of occludin increased from day 0 to day 2, 
holding a plateau level up to day 4 before increasing again up to day 7 (Fig. 3-8 B). Both cell 
preparations developed in a similar way. 
 
Detection of E-cadherin revealed positive spots localized between marker bands of 105 and 
160 kDa, i.e. according to the positive control (Fig. 3-8 C). The internal reference beta-actin 
was observed in each lane. The examined cell isolations showed some differences in 
expression of E-cadherin. While in pAEpC-36 the protein was equally expressed at all tested 
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time points, in pAEpC-35 E-cadherin expression started at low expression levels and 
increased with time of culture (Fig. 3-8 C). Despite these differences, a considerable and 
constant expression of E-cadherin was detected for cells older than 4 days, which was 
paralleled by the formation of cell-cell contacts and a corresponding TEER development. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3-8. Quantitative detection of caveolin, occludin and E-cadherin by Western blotting, 
comparing two different cell preparations of pAEpC at the age of 0, 2, 4 and 7 days; beta-
actin serves as internal standard with 42 kDa molecular weight. The development of protein 
expression is described by density ratios: protein/internal standard and given as numerical 
values below each lane. Monolayers from 6 filter inserts are pooled for analysis of one time 
point. A Expression of caveolin is detected on all tested time points but differs for the two 
analyzed cell isolations with more intensive signals observed for pAEpC-35. Nevertheless, in 
both cases cell lysates of younger cultures (0d, 2d) feature a higher protein content than older 
ones (4d, 7d). According to densitometry both cell isolations feature a minimum in caevolin 
expression on day 4, followed by an increase. B Occludin is not found in freshly isolated cells 
(0d). Expression increases in both cell preparations with time of culture. C Expression of E-
cadherin is different in the two analyzed cell preparations. While in pAEpC-36 the expression 
level is almost constant, in pAEpC-35 it increases from low levels to a higher level than in 
pAEpC-36. 
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Fig. 3-8. 
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5. DISCUSSION 
 
The aim of the present study was the characterization of a primary porcine epithelial cell 
culture, which may serve as a model for the human alveolar epithelium. The results are 
discussed in comparison with data published for similar cell cultures of other mammalian 
species, including man [36]. The human or the porcine alveolar epithelium in situ was not 
analyzed, because the overall hallmarks in both species are the same [4,37,38] and are well 
documented [11]. 
 
 
Differentiation of porcine alveolar epithelial primary cells (pAEpC) 
 
The mammalian alveolar epithelium is a single-layered epithelium basically comprised out of 
two different cell types, type I- and type II pneumocytes, which possess a distinct 
morphology. Type I pneumocytes are flat cells with a protruding nucleus and cover a 
comparatively large area. 93% of the surface of the alveolar air space is covered by type I 
cells, although representing only 8% of the total number of alveolar cells (i.e. mean number of 
cells 19±3 ×109) [38-41]. In contrast type II pneumocytes, with their mean volume being half 
that of type I cells, comprise 16% of the total alveolar cells (number of cells 37±5 ×109) but 
cover only 7% of the alveolar surface [1,39]. The apical and the basal plasma membrane are 
characterized by caveolae, which are usually not formed by type II pneumocytes. The latter 
are of a cubical shape and bear particular intracellular structures, the multilamellar bodies, 
which form the surfactant of the lung. 
Cultivation of pAEpC starts with a morphologically heterogeneous cell population, including 
pneumocytes, endothelial cells, erythrocytes and probably macrophages as well as 
lymphocytes, which then develop a thin monolayer with time of culture. After 10 to 13 days 
the cells of the monolayer can be assigned to two different morpho-types, which resemble the 
described type I and type II pneumocytes of the alveolar epithelium in situ. Most cells are flat 
and cover a large surface of the substrate representing type I morphology, while few smaller, 
but elevated cells are intermingled between these flat cells, like the type II cells in vivo. The 
typical hallmarks of pneumocytes, i.e. multilamellar bodies and caveolae, are also present at 
least in some of the cultivated cells. 
 
The morphological analysis did not reveal cells with a clear type II morphology on day 2 of 
culture. In contrast, many cells possess vacuole-like structures in their cytoplasm, which 
contain vesicles and/or membrane lamellae. These structures might be remnants of intact 
multilamellar bodies of the isolated type II cells. It has been reported that type II cells lose 
their multilamellar bodies in the course of the isolation process and by cultivation [25,42,43]. 
During the ongoing development of the culture most of the cells flatten but retain the 
characteristic vacuole-like compartments. This decrease in the overall thickness of a cell 
monolayer was confirmed by epithelial height measurements and findings agreed with data 
reported for in vitro models of other species [2,39,42]. The other cells do not flatten and 
probably reconstruct multilamellar bodies from these vacuole-like compartments, which 
contain membrane structures similar to the lamellar material of typical type II cell 
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multilamellar bodies. At late time points some of the flat cells develop caveolae, indicative for 
a type I cell, but many cells still show the vacuole-like inclusions. Thus, the overall 
morphology seems to represent a mixture between type I and type II features. This notion is 
supported by the analysis of cell type specific marker molecule expression in the cells (i.e. 
expression of pro-SP-C, caveolin-1, sugars). While the expression of marker molecules 
showed a tendency towards a particular morphological type, in many cells an overlap of 
marker molecule expression was detectable. This mixture of cell-type specific features can be 
explained by assuming that cells pursue an ongoing differentiation process, which starts with 
the isolated but morphologically impaired type II cells (caused by the isolation process) and 
proceeds towards the two cell types. The initial phase of the differentiation is characterized by 
spreading, formation of cell contacts and establishing of cell shape. The later steps end up 
with the development of the typical hallmarks, which are important for function of the 
differentiated cells. In this scenario cells with a mixture of cell type specific features would 
represent intermediate stages, which have conserved the type II pattern from their progenitor 
and not yet fully established type I characteristics. This interpretation is in accordance with 
the theory that type II cells are the progenitor cells of type I cells [44]. Studies on primary cell 
culture models of the alveolar epithelium of other animals and man showed a comparable 
differentiation process [2,14,25,29,30,37,39,42,43]. However, further studies should 
investigate if differentiation can be fully completed, i.e. if cells with a complete segregation 
of type I and type II features develop. 
 
 
Integrity of epithelial monolayers and barrier properties of pAEpC 
 
The alveolar epithelium has a barrier and a transport function. Intercellular cell contacts 
formed by junction proteins are a pre-requisite for establishing an efficient diffusion barrier. 
In pAEpC the typical epithelial cell contacts (tight junction, adherent junction) could be 
shown by electron microscopy. In addition, the junction proteins ZO-1, occludin and E-
cadherin are expressed in pAEpC. With ongoing cultivation more occludin, a tight junction 
protein, is expressed. This development is paralleled by an increasing surface coverage of the 
cells and a rise in TEER. These features are comparable with that of other primary cell culture 
systems for the alveolar epithelium in other species [14,36,45]. Table 3-3 shows the 
bioelectrical parameters of cell culture models derived from three species (rat, swine and 
man). The values of TEER and PD are about the same, indicating similar barrier properties in 
these different culture systems. 
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Table 3-3. Comparison of bioelectrical parameters 
 
Cell culture Origin TEERmax [Ωcm²] PDmax [mV] Reference 
rAEpC rat >2000 10 [45] 
pAEpC porcine 1200-2400 6-14 own data 
hAEpC human 2100 13.5 [14] 
overview of maximal TEER and PD in primary alveolar epithelial cell cultures obtained from 
different species 
 
 
TEER values can serve as an indicator for the developmental stage of the culture in respect to 
epithelial integrity. A non-invasive measurement to determine the developmental stage of a 
culture system is necessary for its use in transport assays. Suited cultures should rest at high 
TEER levels as a consequence of a functional epithelial barrier during the time required for a 
transport experiment (usually 1.5-4 hours). In most cultures of pAEpC TEER values reach a 
plateau, lasting 2-3 days, after an initial fast rise, rendering this time span suitable for 
transport studies. Daily monitoring of the TEER and calculation of the slope (for the 
respective curve segment) may help to identify the beginning plateau. After an initial increase 
the slope remains almost constant before it declines indicating the beginning plateau. 
Cultures, which do not show this behavior, are most likely different in their growth and 
differentiation. 
 
Apart from bioelectrical measurements the determination of transepithelial permeability for 
paracellularly leaking solutes is also suited to gain information on the barrier properties of an 
in vitro model, i.e. finally about the functionality of its cell-cell junctions. The further 
characterization of this primary cell culture with respect to the transepithelial permeability as 
well as the presence or absence of active transporter systems or multidrug resistance is 
another important subject of ongoing investigations. 
 
The formation of the epithelial barrier in most cell isolations was finished around day 6 of 
culture according to the TEER values and the coverage of the substrate surface by the cells. 
At this time differentiation of cells is not fully complete because functional important 
structures, like caveolae and intact multilamellar bodies are not yet formed, although their 
molecular components are already detectable. Between days 8 and 10 the cells start to develop 
the typical morphological structures, which proceeds and is not completed until the end of the 
observation time. In this time span the further development of the TEER varies: some cell 
isolations show a further increase, others stabilize at a less high and more extended plateau, 
but usually the TEER values decrease again. Nevertheless, this decrease following the plateau 
does not mean a sudden change (values move between 1000 and 600 Ωcm² for over 4 days) 
and may be because of initiated transport processes by the cells. Thus further studies have to 
find conditions, where fully differentiated cells display suitable epithelial barrier properties 
for the use as an experimental model. 
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From the pharmaceutical point of view the described plateau phase is certainly the most 
interesting aspect. During the development of such an artificial epithelium, the presence of 
junction proteins as well as of the selected alveolar epithelial cell markers was confirmed by 
immunostaining. Results of parallel TEER measurements underline the functionality of these 
cell-cell contacts. Even if binding of specific lectins did not succeed in a clear distinction 
between type I and type II pneumocytes, the plateau phase unified the presence of 
characteristic alveolar cell markers and appropriate barrier properties for drug transport 
studies. 
 
 
Comparison to alveolar epithelial cell cultures from different species 
 
Cell lines generated from the airways of the respiratory system, e.g. Calu-3 and 16HBE14o-, 
are already available and model the airway epithelium to a certain extent [36]. In general 
immortal cell lines call for easy maintenance and avoid several difficulties, including 
reproducibility or high costs, which are commonly associated with primary culture 
approaches. In contrast there has been only limited success in generating cell lines 
representing the alveolar epithelium of the lung, which is the preferred target area for 
systemically acting drugs. This is why cultured primary pneumocytes still take priority over 
cell lines. Among the primary cultures of the alveolar epithelium the isolation from the rat has 
been described first and the model is meanwhile well established [1,42,45,46]. Primary 
culture of human alveolar cells has been described and characterized more recently [2,3,14]. 
 
While pig and man are closer related to each other than to rodents, this human cell culture 
model is certainly the most interesting comparison. Nevertheless, some species differences 
were observed, especially between the porcine and human alveolar epithelial cells in primary 
culture: in contrast to the human model lectin binding could not be used to differentiate 
porcine type II from type I pneumocytes. However, morphological analysis revealed the 
formation of these characteristic cell types. Species differences also occurred e.g., when a 
human anti-ZO-1-antibody did not work with porcine monolayers. But an anti-ZO-1-
antibody, which was also tested for species reactivity in swine, succeeded in demonstrating 
the presence of this tight junction protein. This equivalence on the structural protein level is 
also confirmed by the fact that each of the other tissue specific markers used in this study was 
detected by the same antibody as used for human cell cultures. 
 
Depending on the respective donor, larger amounts of tissue are available for the preparation 
of cells: rat < man < pig. In spite of differences in their macro-anatomy, i.e. the number of 
lobes constituting the lung organ, the same cell types and morphologies are detected on the 
cellular level. In terms of bioelectrical parameters porcine cells feature less high mean 
transepithelial resistances (Table 3-3), but single batches of monolayers generate 2000 Ωcm2 
as well. Similarities are found in the morphological development of isolated primary cells, in 
a proceeding differentiation and in the presence of type II and type I pneumocyte-like cells. 
All the three cell culture systems reveal their epithelial origin by the formation of cell-cell 
contacts and functional tight junctions, enabling an imitation of typical barrier properties. 
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According to immunocytochemical studies they commonly display alveolar epithelial cell 
markers. Electron microscopy detects a good resemblance in the ultrastructure of cells e.g., 
multilamellar bodies or caveolae. 
 
 
 
6. CONCLUSION 
 
Porcine alveolar epithelial cells in primary culture (pAEpC) differentiate into a tight 
monolayer formed by two cell types, which resemble morphologically and biochemically 
type I and type II pneumocytes. Although differentiation of the cells is not completed after 
13 days of culture (end point of observation in this study), pAEpC monolayers are similar to 
primary barrier forming cell cultures from other species, such as e.g., rat or human. Variations 
between different cell preparations, which generally occur in primary cell cultures, could be 
kept within acceptable limits. Moreover, the porcine system has relevant advantages: 1) the 
pig is closer related to man than rodents [47]; and 2) porcine tissue is easily available at high 
amounts from abattoirs without raising ethical concerns. Especially this last point makes the 
pAEpC attractive as a potential screening tool for drug development. 
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Monolayers of porcine alveolar epithelial cells in primary culture as an in vitro model 
for drug absorption studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parts of this chapter have been submitted to EJPB: 
Anne Steimer, Helmut Franke, Eleonore Haltner-Ukomado, Michael Laue, Carsten Ehrhardt, 
and Claus-Michael Lehr (2006) Monolayers of porcine alveolar epithelial cells in primary 
culture as an in vitro model for drug absorption studies. European Journal of Pharmaceutics 
and Biopharmaceutics, (submitted in June 2006) 
 175
Drug transport across porcine alveolar epithelial cell culture Chapter 4
 
1. ABSTRACT 
 
Purpose. Filter-grown monolayers of porcine alveolar epithelial cells (pAEpC) in pimary 
culture are characterized as an in vitro model for pulmonary absorption screening of 
xenobiotics, including substrates of efflux systems. 
Materials and Methods. Transepithelial electrical resistance (TEER), as well as permeability 
of marker compounds were determined to optimize experimental conditions. Since new drugs 
often feature poor water solubility, monolayer integrity in the presence of a solubilizer 
(dimethyl sulfoxide) was tested. Transport studies were carried out with budesonide and 
triamcinolone acetonide, i.e. two drugs commonly administered to the lungs. Furthermore, 
expression of P-glycoprotein (P-gp) was assessed by immunofluorescence microscopy and 
transport studies employing the substrates rhodamine 123 and digoxin. 
Results. According to permeability data of sodium fluorescein a minimal transepithelial 
resistance of 600 Ωcm2 was defined to ensure monolayer integrity. Hydrocortisone-
supplemented (0.5 µg/ml) small airway basal medium as transport buffer and a maximal 
solubilizer concentration of 1.5% dimethyl sulfoxide were found to provide suitable 
conditions for drug transport studies in pAEpC. Permeation of marker compounds was 
reproducible throughout several cell preparations and proved the model successful in 
distinguishing between low and high permeable drugs. P-gp expression was confirmed by 
immunocytochemistry (protein level), while transport studies revealed no polarity in 
transepithelial marker transport. 
Conclusion. Our results demonstrate, that filter-grown monolayers of pAEpC can be used to 
study drug transport across such artificial alveolar epithelium and may represent a suitable in 
vitro model for pulmonary drug absorption and delivery. 
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2. INTRODUCTION 
 
Today, several in vitro models, including primary cultures and cell lines, are available to 
mimic the respiratory tract. However, with respect to the alveolar airspace, the number of 
established models is still limited [1,2]. Isolation of porcine alveolar epithelial cells (pAEpC) 
and their primary culture to polarized monolayers has been described previously [3]. Hence, 
this subsequent study focuses on the suitability of the pAEpC model with regard to drug 
absorption studies. Appropriate experimental conditions are necessary to allow the 
comparability of results obtained from different cell isolations. Parameters have to be 
developed to prove and secure the reproducibility of the experimental system. In this context, 
drug development solubilizers (e.g., DMSO or alcohols) are often used to overcome solubility 
problems of test compounds, but are simultaneously known to affect cultured cells. Therefore, 
it is important to assess the effect of solubilizing agents on the integrity of a cell monolayer. 
Furthermore, analytical quantification of drug compounds is facilitated if a less complex 
matrix than featured by most of the cell culture media is used. Thus in drug absorption 
studies, the latter are often replaced by simple, chemically defined transport buffers, e.g., 
Krebs-Ringer buffer (KRB). However, the choice of a transport buffer might again prove 
crucial in terms of monolayer integrity, cell morphology and expression/induction of 
transporter proteins. Other points of interest are the robustness of such a model in 
experimental handling, as well as presence and function of active drug transport molecules 
(e.g., ABC-transporters, ABC = ATP-binding cassette). 
 
Efflux systems are often responsible for the inability of drugs or other xenobiotics to 
overcome epithelial or endothelial barriers. Numerous studies have reported the presence of 
transporter proteins in various in vitro models, such as the intestinal Caco-2 cell line, models 
of the blood-brain barrier, MDCK, A549, Calu-3, and 16HBE14o- cells [4-11]. The multidrug 
resistance (mdr) gene encoded P-glycoprotein (P-gp) is the most prominent drug efflux 
transporter and belongs to the family of ABC transporters. In order to evaluate in vitro models 
with respect to their suitability for functional studies, it is relevant to know about the presence 
of such transporter systems. 
 
The aim of this study was to assess permeability of a series of drugs, which are frequently 
administered to the lungs (i.e., budesonide and triamcinolone acetonide), in the newly 
established pAEpC model and to compare the obtained permeation data with those from other 
in vitro models, such as bronchiolar cell lines (Calu-3, 16HBE14o-), primary rat or human 
alveolar epithelial cell monolayers, the intestinal cell line Caco-2 and primary cultures of 
porcine brain endothelial cells (PBEC). 
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3. MATERIALS AND METHODS 
 
 
3.1 Cell isolation and culture conditions 
 
The methods of isolation and culture of porcine alveolar epithelial cells (pAEpC) were 
described in a preceding report [3]. The other cell types used in this study (e.g., Caco-2, Calu-
3, 16HBE14o-, primary porcine brain endothelial cells (PBEC) and human alveolar epithelial 
cells (hAEpC)) were cultivated according to established protocols [12-16]. 
 
 
3.2 Transport studies 
 
In the initial transport studies, fluorescein-Na (Flu-Na) at a final concentration of 10 µg/ml 
served as marker for passive paracellular diffusion. Due to the wide use of Flu-Na for this 
purpose, resulting data enable to compare different in vitro models (e.g., alveolar versus 
bronchial epithelial cells). SAGM (small airway growth medium, Cell Systems, St. 
Katharinen, Germany), supplemented with gentamycin, ampicillin (50 µg/ml each), and 
penicillin G (200 units/ml), served as transport buffer in these studies. Subsequent routine 
transport studies included the determination of permeability coefficients of the lipophilic 
propranolol as marker for high permeability [17] and rhodamine 123 as marker for P-gp-
mediated efflux. 
 
In order to find a suitable transport buffer for the pAEpC model, the following alternatives 
were tested: Krebs-Ringer buffer plus hydrocortisone (KRB+HC), SABM (small airway basal 
medium, Cell Systems, St. Katharinen, Germany) and SABM+HC. The cell culture medium 
used for pAEpC, SAGM, which is obtained by adding a supplement kit of various growth 
factors, hormones and also hydrocortisone, to the basal medium SABM, served as control. At 
day 8 of culture cell culture medium was replaced by the respective transport buffers. After 
removing the medium, pAEpC monolayers were transferred into new cluster plates. TEER 
was monitored over time periods of up to 48 hours, and the experiments were completed by a 
subsequent transport study using Flu-Na. 
 
Prior to transport experiments, the culture medium was replaced by SABM supplemented 
with 0.5 µg/ml hydrocortisone (HC). Experiments were conducted on days 5-8 of culture, 
when cell monolayers reached plateau values in their TEER, as measured with an electrical 
voltohmmeter (EVOM, WPI, Berlin, Germany) equipped with STX-2 “chopstick” electrodes. 
Subsequent to this exchange, cells were allowed to recover for at least 16 h (overnight). After 
equilibration, a minimum TEER value of 600 Ωcm² must be reached to warrant sufficient 
monolayer integrity for drug transport studies. 
 
To initialize a transport experiment, half the volume of the donor compartment, (i.e., 250 µl 
out of 500 µl for transport direction apical-to-basolateral (ab), and 750 µl out of 1500 µl 
basolateral-to-apical (ba)), was replaced by the respective transport buffer containing the test 
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compound in twofold of the final concentration. The initial concentrations of test molecules in 
the donor fluid were assayed by drawing 20 µl samples immediately after t = 0. Receiver 
samples (100 µl) were drawn serially from the respective downstream fluids at t = 30, 60, 90, 
and 120 min. After each sampling, fresh transport buffer of an equal volume was returned to 
the receiver side to maintain a constant volume. At the end of a transport experiment, 20 µl 
samples were drawn from the donor fluids for assay. During the study, monolayers were 
incubated in a water-saturated 5% CO2 atmosphere at 37°C. Each transport experiment was 
performed using 3 monolayers (obtained from at least 2 (up to 10)) different cell preparations 
for flux measurements in either the (ab), or (ba) direction. In order to assess the integrity of 
monolayers during the flux studies, TEER was measured before and after each transport 
experiment. 
 
Unidirectional fluxes (J) were determined from steady-state appearance rates of each 
compound accumulating in the receiver fluid. The apparent permeability coefficient, Papp, is 
calculated according to the equation 
 
 Papp = J / (A × Ci) 
 
where Ci is the initial concentration of the substance under investigation in the donor fluid and 
A the nominal surface area of cell monolayers (1.13 cm2) utilized in this study. 
 
 
3.3 Quantification of epithelial cell height and surface coverage 
 
To study the effect of transport buffer on cell morphology and barrier function, pAEpC 
monolayers were transferred from SAGM to SABM+HC. Control filters were kept in SAGM, 
which was refreshed in parallel. After an incubation time of 24 h, TEER was measured and 
monolayers were fixed and prepared for electron microscopy as described previously [3]. 
Specimens were compared with regard to the morphological ultrastructure of cells, confluence 
(covered filter surface) and height of cell monolayers. 
 
Height of cell monolayers was measured in images taken from the block face of embedded 
filters after sectioning using a scanning electron microscope (ESEM XL30 FEG, FEI Co., The 
Netherlands) [18]. The advantage of this technique is that the block face does not show 
mechanical distortions or artifacts, which usually occur in sections through cells on filter 
supports. Thus block face imaging allows undisturbed quantification. Height measurements 
were performed on the screen using the operating software of the microscope. Two different 
methods were used to measure monolayer thickness. Method 1: A grid (25 µm mesh size) 
was placed on a section profile of the monolayer. Height of the cells or cellular processes was 
measured perpendicular to the filter surface at all positions where the grid crosses the filter 
(monolayer side). This procedure allows equidistant cell height measurements. Free filter area 
was defined as zero in height, but ignored for median calculation. Method 2: Height 
measurements were only taken at all cell nuclei visible in a section. The region of the cell 
nucleus represents usually the maximal height of a cell. 
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Analysis of the filter area covered by cells (surface coverage) was based on two randomized 
samples of pAEpC incubated in the different transport buffers. During scanning electron 
microscopy of cell surfaces digital images were taken at a magnification of 800 x and overlaid 
with a lattice-grid (2.5 × 2.5 µm). The number of points lying over free filter surface was 
determined (point-counting method of basic stereology). Included in this evaluation were 44 
different images in case of culture medium SAGM and 30 for the transport buffer 
SABM+HC. 
 
 
3.4 Tolerance to dimethyl sulfoxide (DMSO) 
 
As already described above, pAEpC monolayers were switched from culture medium to 
transport buffer and allowed to equilibrate for at least 16 hours. Subsequently, DMSO was 
applied at final concentrations of 0, 0.25, 0.5, 1, 2 and 3% to the apical or basolateral sides of 
the cell monolayers. Flu-Na, administered in parallel (at 10 µg/ml) served as marker to test 
monolayer integrity. Permeability was analyzed for (ab) and (ba) transport directions to 
distinguish DMSO impact on both aspects of the epithelium. Receiver samples were drawn 
serially from the respective downstream fluids at t = 30, 60, 90, and 120 min. After each 
sampling, fresh transport buffer of an equal volume was returned to the receiver side to 
maintain a constant volume. Each transport experiment was performed using 3 monolayers 
(obtained from 4 cell preparations). In order to assess the integrity of monolayers during the 
flux studies, TEER was measured before and after each transport experiment. Changes in 
TEER were expressed as [%] of the initial value. 
 
 
3.5 Expression and functionality of P-glycoprotein 
 
Immunofluorescence microscopy 
The anti-P-glycoprotein antibody (clone F4, Sigma, Deisenhofen, Germany) was diluted 
1:100 in PBS containing 1% (w/v) bovine serum albumin (BSA). Mouse IgG1 was used as an 
isotypic control. Transwell-grown pAEpC monolayers were stained on days 5 and 6 after cell 
plating. Cells were fixed for 10 min with 2% (w/v) paraformaldehyde and blocked for 10 min 
in 50 mM NH4Cl, followed by permeabilization for 8 min with 0.1% (w/v) Triton X-100. 
After a 60-min incubation with 100 µl of the diluted primary antibody, the cell monolayers 
were washed three times with PBS before incubation with 100 µl of a 1:100 dilution of an 
FITC-labeled goat anti-mouse F(ab’)2 fragment (Dako, F 0479, Hamburg, Germany) in PBS 
containing 1% (w/v) BSA. Propidium iodide (PI; 1 µg/ml) was then added to counterstain cell 
nuclei. After 30 min incubation, the specimens were washed three times with PBS and 
embedded in FluorSave anti-fade medium (Calbiochem, Bad Soden, Germany). Images were 
obtained with a confocal laser scanning microscope (MRC-1024, Bio-Rad, Hemel, 
Hempstead, UK) with the instrument settings adjusted, so that no positive signal was 
observed in the channel corresponding to the green fluorescence of the isotypic controls. 
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Transport of efflux markers 
A mdr-(multidrug resistance)-phenomenon reveals itself as a polarized transport of substrates 
across a biological barrier; for apically-localized efflux systems the (ab)-permeation is 
exceeded by the (ba)-permeation. Addition of specific inhibitors will compensate this effect 
and may help to identify such efflux systems. The quotient of permeability coefficients for 
both transport directions Papp(ba)/Papp(ab) is referred to as the transport ratio. In absence of 
any active transport or efflux this ratio is typically observed between 1 and 2, whereas in case 
of the presence of an efflux system, a ratio of five and more is found. Thus, a transport ratio 
significantly exceeding 2 describes a net secretion flux, indicating an active transport. 
Functionality of the efflux pump P-glycoprotein (P-gp/MDR1) has been tested using the 
substrates rhodamine 123 [19] and 3H-digoxin [20]. Verapamil (at 40 µM) and ritonavir (at 
7 µM) are frequently used as inhibitors of P-gp function [4,21]. Inhibitors were present in 
both, donor and receiver solutions, to guarantee continued inhibition. 
In addition, bi-directional fluxes of further substances across pAEpC monolayers were 
investigated: doxorubicin (a more selective P-gp-substrate than rhodamine 123) [6], 
sulforhodamine 101 (a MRP-(multidrug resistance related protein)-substrate) [22], and the 
MRP2-substrate, furosemide [23]. 
 
 
3.6 Compound analytics 
 
Fluorescence of samples was analyzed in 96-well plates using a fluorescence plate reader 
(Victor², Wallac Perkin Elmer, Rodgau, Germany) at excitation and emission wavelengths of 
485 and 553 nm, respectively. Radio-labeled compounds were measured by liquid 
scintillation counting (Wallac 1450 Microbeta, Wallac Perkin Elmer, Rodgau, Germany). All 
other compounds were analyzed by HPLC (Waters, Eschborn, Germany) applying validated 
protocols. If necessary, samples were diluted with the respective transport buffer. 
 
 
3.7 Statistics 
 
Results are expressed as mean ± SD Significance (p < 0.05) of differences in the group mean 
values for TEER and Papp was determined by one-way analysis of variances (ANOVA), 
followed by Student-Newman-Keuls post-hoc tests. 
Electron microscopy results for surface coverage and epithelial cell height are expressed as 
median and corresponding IQR (interquartial range). Significance (p < 0.01 for analysis of 
surface coverage and p < 0.05 in case of monolayer thickness) of differences in the total 
populations for the respective distributions was determined by test for homogeneity according 
to Kolmogoroff and Smirnoff. 
 181
Drug transport across porcine alveolar epithelial cell culture Chapter 4
 
4. RESULTS 
 
 
4.1 Barrier properties and integrity of pAEpC monolayers 
 
In addition to measuring TEER values, the paracellular integrity of pAEpC monolayers was 
assessed by transport studies using the hydrophilic marker Flu-Na in absorptive (ab) direction. 
The average permeability coefficient Papp for pAEpC was calculated as 3.49±1.66 × 10-7 cm/s 
(n=39 filters, obtained from 14 independent cell preparations, transport buffer SAGM). As 
expected, an inverse correlation between permeability coefficient and TEER was observed. 
Figure 4-1 illustrates that Papp(Flu-Na) declined with increasing TEER values. According to 
these data no further significant decline in permeability was detected for cell monolayers with 
TEER values < 600 Ωcm², which therefore was defined as a limit for monolayer integrity in 
drug absorption experiments. 
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Fig. 4-1. Correlation between Papp of Flu-Na (10 µg/ml) across pAEpC monolayers, and 
initial TEER values. Each data point represents the result obtained from a single filter. The 
observed inverse correlation (rising TEER values paralleled by a decrease in permeability) 
suggests a threshold of 600 Ωcm2. 
 
Flu-Na was chosen, because of the vast amount of data available from transport studies using 
the substance across other in vitro cell culture models; an intestinal cell line (Caco-2), 
bronchial cell lines (Calu-3, 16HBE14o-), primary porcine brain endothelial cells (PBEC), 
and primary human alveolar epithelial cells (hAEpC). Figure 4-2 compares permeability 
values across these barrier-forming models (data either generated at Across Barriers GmbH or 
at Saarland University (*)). Permeability coefficients for Flu-Na in all models ranged between 
1.04 and 8.50 ×10-7 cm/s. Considering variations reported in literature for cells cultured in 
different laboratories, the paracellular tightness of pAEpC monolayers was similar to the 
other models, indicating comparable barrier properties. 
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Fig. 4-2. Comparison of epithelial barrier properties quantified for different in vitro models, 
including cell lines and primary cells. Absorptive permeability coefficients (mean ± SD) were 
determined for the hydrophilic marker compound Flu-Na. *(Asterisk) indicates data from 
Saarland University (n = 12 except for pAEpC: n = 39 and Caco-2: n = 57). Despite the 
differences in cell type and donor species, the passive paracellular diffusion across the 
monolayers was within the same order of magnitude (×10-7 cm/s). 
 
 
4.2 Selection of suitable transport buffer 
 
An ideal transport buffer should be complex enough to maintain the epithelial barrier function 
of cell monolayers (indicated by stable transepithelial electrical resistances) and simple 
enough to enable analysis by HPLC. Krebs-Ringer buffer plus hydrocortisone (KRB+HC), 
SABM, and SABM+HC were tested in this regard. Control monolayers were kept in SAGM, 
the culture medium used for pAEpC (also containing HC). Thus in total, three of the test 
solutions were supplemented with hydrocortisone (0.5 µg/ml). The influence of selected 
transport buffers on the TEER is illustrated in Figure 4-3. 
Transfer of pAEpC monolayers from culture medium to any other liquid, or exchange of 
culture medium always caused a decline in TEER of about 50% (measured approx. 2 h after 
replacement), which was followed by a slow recovery. Therefore, an equilibration time of 
16 hours was chosen after each medium change prior to a later transport experiment. One-way 
analysis of variance revealed a statistically significantly (p ≤ 0.001) lower TEER value for 
KRB compared to the other test solutions. Permeability coefficients for Flu-Na were also 
determined and gave similar results (data not shown). According to these data KRB is not 
suited to transport buffer for pAEpC monolayers, whereas SABM and SABM+HC seemed 
appropriate and comparable. 
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Fig. 4-3. Influence of different transport buffers on the transepithelial electrical resistance 
(TEER) of pAEpC monolayers. TEER values prior to replacement of culture medium were 
assumed as 100%. TEER was monitored over 25 hours. Changes were expressed as decline 
[%] ± SEM from n = 12 monolayers obtained from 4 different cell isolations. *(Asterisks) 
mark statistical significance to other test buffers (culture medium SAGM = control). 
 
Cell morphology 
After 24 hours incubation with either SAGM (culture medium) or SABM+HC (transport 
buffer), the morphology of pAEpC monolayers differed only slightly. At day 6, most of the 
filter surface was covered by a tight confluent monolayer, which was dominated by flat cells 
with broad cytoplasmic extensions and interspersed by cells with protruding nuclei (Fig. 4-
4 A,B). Functional cellular junctions were already present, as confirmed by TEER 
measurements, which revealed comparable resistance values for both treatments. The fraction 
of flat, extended cells seemed higher in case of the hydrocortisone containing SABM (Fig. 4-
5 A,B). 
 
 
Fig. 4-4. Shape and internal ultrastructure of cells incubated in transport buffer SABM+HC 
by block-face imaging. Two representative cells, one with a more round sectioning profile (A) 
and one with a flatter profile (B), are shown. Both cells contain vacuole-like structures (*) 
filled with membraneous material (arrows). n = nucleus. 
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Fig. 4-5. Influence of transport buffers on cell morphology. Representative scanning electron 
microscopy of pAEpC monolayers (on day 6) incubated with culture medium SAGM (A) or 
transport buffer SABM+HC (B), respectively. The monolayer incubated with SABM+HC 
shows cells of a more flattened morphology covering the surface of the filter. 
 
Cell surface area 
SAGM and SABM+HC were assessed for their influence on pAEpC filter coverage (two 
randomized samples for each treatment). A mean coverage of 98% (IQR=2.4%) resulted after 
24 hours incubation with the transport buffer, and a 96% (IQR=3.1%) of coverage was 
determined when the culture medium was used. 
 
Height of monolayers 
A slight impact on epithelial height was observed between cell monolayers incubated in either 
SAGM or SABM+HC (Table 4-1). Because of the high IQR of the height values, the relative 
difference between culture medium and transport buffer indicates just a trend: Cells in the 
nuclear region, as well as peripheral extensions are more flat (16-17%) when grown in 
SABM+HC in comparison to cells kept in SAGM. However, apart from the monolayer 
height, growth and development of cells was similar for the compared test liquids within an 
observation time of 24 hours. 
 
Table 4-1. Survey of epithelial cell height in pAEpC monolayers quantified by two different 
methods 
 
SAGM SABM+HC  
height IQR n height IQR n 
Relative 
difference
method 1 2.7 µm 5 123 2.3 µm 2.6 147 16% 
method 2 7.8 µm 4.5 78 6.45 µm 3.9 85 17% 
height is given as median value with corresponding interquartial range (IQR), 
n indicates the number of measurements 
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Concluding from these results, the hydrocortisone-supplemented basal medium was chosen as 
routine transport buffer, because of its close resemblance to the culture medium and at the 
same time lower complexity. Moreover, pAEpC monolayers transferred into SABM+HC 
flatten out faster and thus reach a higher surface coverage. 
 
 
4.3 Tolerance to DMSO 
 
Effects of the solubility enhancer DMSO on the integrity of pAEpC monolayers were 
compared by monitoring TEER and the permeation of Flu-Na. Figure 4-6 illustrates changes 
in TEER (A) and in flux of Flu-Na (B) caused by the tested DMSO concentrations. The 
solvent was applied from either side of pAEpC monolayers. 
Only at highest concentration of DMSO (3%), the monitored parameters differed significantly 
from values obtained without DMSO. Concentrations up to 1.5% of DMSO did not affect the 
integrity of cultured pAEpC monolayers. Nevertheless, effects of DMSO on active transport 
processes were not tested and thus, cannot be completely excluded. 
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Fig. 4-6. Influence of the solubility enhancer DMSO on epithelial barrier properties of 
pAEpC monolayers (asterisks mark statistical significance of differences to other DMSO 
concentrations according to analysis of variance). A Effect of varied DMSO concentrations 
on the development of TEER (mean ± SD, n = 6). B Changes in monolayer integrity caused 
by different DMSO concentrations assessed by permeability of 10 µg/ml Flu-Na (mean ± SD, 
n = 6) for both transport directions (ab) and (ba). A statistically significant difference in 
TEER and in permeability was observed at the highest concentration of 3% DMSO. 
 
 
 186
Drug transport across porcine alveolar epithelial cell culture Chapter 4
 
4.4 Expression and functionality of P-glycoprotein 
 
Immunofluorescence microscopy 
A positive signal for P-glycoprotein/MDR1 was detected in pAEpC monolayers at days 5 and 
6 of culture by immunocytochemistry, as illustrated in Figure 4-7. The functionality of the 
protein, to act as an active efflux system was investigated in the following transport studies. 
 
 
Fig. 4-7. Confocal laser scanning microscopy of Transwell-grown pAEpC monolayers 
immunolabeled for P-glycoprotein. Cell nuclei were counterstained with propidium iodide 
(red). At days 5 and 6 of culture, pAEpC displayed a positive signal for P-gp (green) at the 
apical aspects of the cell membranes, as well as P-gp positive spots in the cytoplasm. Scale 
bar represents micron (µm). 
 
Transport of efflux markers 
Several known substrates of drug transporters were studied in both, absorptive and secretory 
direction across monolayers of pAEpC. The determined permeability coefficients and 
transport ratios are summarized in Table 4-2. 
The (ba)/(ab) transport ratio of the P-gp-substrates, rhodamin 123 and 3H-digoxin, was 
calculated as approximately 1 (i.e., no net secretion was observed). The result did not change 
in presence of the P-gp-inibitors, verapamil and ritonavir. A polarized P-gp-mediated 
transport across such epithelial cell monolayer could therefore be excluded for pAEpC in 
vitro (at the investigated time of culture, days 5-8). The transport ratios of other ABC-
transporter substrates, sulforhodamine 101 and furosemide, also did not exhibit any 
transporter activity. Doxorubicin, another mdr-substrate, proved cytotoxic at the used 
concentration and was therefore not included into these considerations. 
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Table 4-2. Permeability coefficients and calculated transport ratios of mdr-substrates across 
pAEpC monolayers 
 
Substrate Concen-
tration 
n Papp(ab) 
 
Papp(ba) 
 
Ratio 
(ba)/(ab)
rhodamine 123 10 µM 8 0.77±0.27 0.89±0.19 1.2 
3H-digoxin 2.5 µCi/ml 2 1.91±0.27 2.12±0.25 1.1 
3H-digoxin 
+ 7µM ritonavir 
2.6 µCi/ml 2 1.90±0.27 1.83±0.42 1.0 
sulforhodamine 101 100 µM 2 0.39±0.13 0.45±0.15 1.2 
doxorubicin 100 µM 2 toxicity problems -- 
furosemide 200 µM 3 0.66±0.11 0.83±0.19 1.3 
n represents the number of tested cell isolations (triplicates each); 
mean Papp [×10-6 cm/s] values ± SD for bi-directional transport 
 
 
4.5 Quality control and acceptance criteria 
 
When using a cell culture system for the assessment of drug permeability, certain exclusion 
limits and acceptance criteria have to be introduced. For this purpose, Flu-Na ((ab)-direction) 
was chosen as low permeability marker and propranolol ((ab)-direction) as high permeability 
marker. Rhodamine 123 ((ab)- and (ba)-direction) served as marker for P-gp activity. Papp 
values of these selected compounds were routinely determined throughout several cell 
isolations. 
 
According to the data presented in Figure 4-8 A, permeability of both, high and low 
permeability markers, was reproducible across independent cell preparations. The mean 
permeability coefficients were: 0.38±0.11 × 10-6 cm/s for Flu-Na and 25.31±5.03 × 10-6 cm/s 
for propranolol. The number of tested cell isolations was 10 (Flu-Na) and 7 (propranolol) 
respectively (triplicates each, transport buffer SABM+HC). Bi-directional transport studies 
with rhodamine 123 also showed a consistency over several cell isolations (Fig. 4-8 B), 
confirming the absence of a functional P-gp-mediated efflux. 
 
Based on these results and considering the variations attributed to primary cell culture, the 
following acceptance criteria were defined: Papp(propranolol) ≥ 2.0 × 10-5 cm/s and Papp(Flu-
Na) ≤ 5.0 × 10-7 cm/s. With respect to efflux systems, the calculated Papp(ba)/Papp(ab) 
transport ratio should not exceed 1.5 for rhodamine 123. Cell monolayers, which did not meet 
these criteria, were excluded from use in subsequent transport studies. 
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Fig. 4-8. Permeability coefficients (mean ± SD, n = 3) observed throughout a series of pAEpC 
isolations. A High permeability marker propranolol (■) and low permeability marker Flu-Na 
(▲) determined for transport direction (ab); log scale. Data confirm reproducible permeation 
characteristics for different cell isolations. B Papp values of the efflux marker rhodamine 123 
(Rh123), determined for transport directions (ab) (●) and (ba) (○). 
 
 
4.6 Transepithelial permeability of drug substances relevant to pulmonary drug 
delivery 
 
Budesonide and triamcinolone acetonide, which are commonly administered by oral 
inhalation for the treatment of acute and chronic airway diseases, were tested for their 
permeability across pAEpC monolayers. Permeability coefficients are summarized in Table 4-
3. 
 
Table 4-3. Permeability coefficients and calculated transport ratios of pulmonary 
administered drug substances across pAEpC monolayers 
 
Compound Concentration Papp(ab) 
 
Papp(ba) 
 
Ratio 
(ba)/(ab) 
budesonide 30 µM 2.65±0.49 2.80±0.20 1.1 
triamcinolone acetonide 60 µM 1.97±0.63 1.49±0.01 0.8 
mean Papp [×10-5 cm/s] values ± SD for bi-directional transport 
 
The results found across pAEpC monolayers were well comparable to data obtained from 
other in vitro models of respiratory epithelia, such as human alveolar epithelial primary cells 
(hAEpC) and two human bronchial epithelial cell lines Calu-3 and 16HBE14o- (Fig. 4-9). In 
detail, pAEpC monolayers showed a slightly higher permeability for budesonide if compared 
to the other three in vitro models, whereas permeation in case of triamcinolone acetonide was 
similar. No net directionality was observed for any substance across cell monolayers of any in 
vitro model. 
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Fig. 4-9. Permeability coefficients (mean ± SD, n = 8; n = 3 for pAEpC) of pulmonary 
delivered drug compounds, budesonide (A) and triamcinolon acetonide (B), were compared in 
bi-directional transport studies across pAEpC and hAEpC in primary culture, as well as the 
bronchial cell lines Calu-3 and 16HBE14o-. Open columns represent (ab)-, hatched columns 
indicate (ba)-transport direction. 
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5. DISCUSSION 
 
In the presented study, a robust and easily accessible model for in vitro drug transport across 
the alveolar epithelial barrier was established. Porcine alveolar epithelial cells were grown to 
confluent monolayers with functional cell junctions, which are responsible for the tightness 
and the passive barrier properties of the epithelium. Experimental conditions were defined to 
use pAEpC monolayers for the assessment of drug permeability. We found that 
hydrocortisone-supplemented SABM is the optimal transport buffer of the tested alternatives; 
a maximum final concentration of 1.5% DMSO can be tolerated; 16 h of equilibration time 
after transfer of cells to transport buffer are necessary; and a minimum TEER of 600 Ωcm2 
ensures a tight monolayer. No functionally active mdr-related efflux systems were detected, 
although P-gp was found to be expressed along the apical aspect of cultured monolayers by 
immunofluorescence microscopy. Electron microscopy revealed that cell differentiation was 
not complete at day 6 of culture. Despite the characteristic type I and type II morphology, the 
inner structure of cells (e.g., vacuoles filled with membraneous material) indicated an 
intermediate mixture of pneumocyte features. Nevertheless, the plateau phase in TEER 
development (culture days 5-8) [3] unified the presence of characteristic alveolar cell markers 
and appropriate barrier properties for drug transport studies. 
With regard to the alveolar airspaces of the lung, one still has to rely on primary cultured 
pneumocyte monolayers. Currently available cell lines (e.g., A549, L2, AK-D) lack the ability 
to form tight monolayers due to their missing or incomplete expression of functional tight 
junctions. Although exhibiting some phenotypic features of alveolar epithelial cells, they 
generally appear not capable to imitate permeation properties of intact alveolar epithelium. 
Due to this confined imitation of barrier properties, these cell lines should not be used for in 
vitro drug absorption studies [24]. Instead, primary culture of isolated pneumocytes seems to 
be the only reasonable alternative for research on alveolar epithelial transport processes and 
cell biology. A human system [18,25,26] is certainly preferable, but due to the lack of 
availability of human tissue and some ethical issues pertaining to use of human tissues in 
certain countries, most studies are based on isolation and culture of cells from the lungs of 
small laboratory animals including mouse [27,28], rat [29,30], and rabbit [31,32]. An 
interspecies comparison of characteristics of cells from the alveolar regions of normal lungs 
(including humans, baboons and rats) showed relatively constant numbers of cell types in the 
alveolar region and in their average thickness, size and surface areas [33]. These results 
justify the use of animal derived in vitro models and speak in favor of the establishment of a 
porcine derived model. 
Several efflux transporters, including the well-known P-gp, have been discovered and 
localized in various in vitro models as well as in native tissues: Focusing the human 
respiratory tract, a study comparing expression and distribution of P-gp in normal and tumor 
human tissues detected the protein in normal human bronchial epithelium, less clearly in 
alveolar macrophages, but not at all in pneumocytes [34]. This result was confirmed by 
Western blot analysis using the alveolar epithelial cell line A549, where no P-gp or 
multidrug-resistance related protein (MRP) was found [9]. During examination of bronchial 
epithelium derived from lung carcinoma patients, the MDR1 glycoprotein was detected i) at 
the apical surface of ciliated epithelial cells (from surface epithelium) or ciliated collecting 
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ducts, ii) on apical and lateral surfaces of serous cells from bronchial glands and iii) at the 
luminal surface of endothelial cells in bronchial capillaries. In contrast, no staining of mucus 
secreting cells was observed [35]. In case of MRP minimal or no expression was found in 
normal alveolar type I and type II cells [36]. But the Calu-3 cell line, which is representative 
for bronchial airway epithelium, was suggested to possess MRP1 functional activity that is 
subordinate to P-gp efflux [10]. 
The fact that most data generated in pAEpC monolayers are comparable to those reported for 
the human hAEpC model recommends the porcine model as an interesting alternative. The 
differences regarding functionality of MDR-proteins between the two models are 
compensated by the easy availability of tissue material, without ethical approval. The lowest 
(ba)/(ab) transport ratio of 1.2 for rhodamine 123 was found in pAEpC monolayers (Fig. 4-10, 
Table 4-4). Nevertheless hAEpC monolayers, as the next closely related approach to pAEpC, 
also showed a comparatively low transport ratio of 3.1. More distinct efflux phenomena could 
be detected in the Caco-2 model featuring a ratio of 13.2. The highest transport ratio (1.3) 
determined in the pAEpC model, was that of the MRP2-substrate furosemide, which in 
contrast to the corresponding ratio of 42.2, as measured in Caco-2 cells (unpublished data, on 
file at Across Barriers GmbH), does not seem relevant. 
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Fig. 4-10. Comparison of permeability coefficients (mean ± SD, n = 12; n = 24 for pAEpC) 
for the P-gp substrate, rhodamine 123, determined in bi-directional transport studies across 
different in vitro models: porcine (pAEpC) and human (hAEpC) alveolar epithelial cells, the 
bronchial cell lines Calu-3 and 16HBE14o-, the intestinal cell line Caco-2 and porcine 
primary brain endothelial cells (PBEC). The most apparent efflux was observed across Caco-
2 monolayers (data generated at Across Barriers GmbH, or at * = Saarland University) 
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Table 4-4. In vitro cell culture models and their reported transport ratios for the P-gp-substrate 
rhodamine 123 
 
Model Ratio Papp(ba)/Papp(ab) for rhodamine 123 
pAEpC 1.2 
hAEpC 3.1* 
Calu-3 4.9 
16HBE14o- 2.9* 
Caco-2 13.2 
PBEC 2.4 
(unpublished data of Across Barriers GmbH; except * = Saarland University) 
 
 
With regard to morphological characterization and transepithelial permeability, results 
obtained with pAEpC were similar to those reported for related cell culture models and the 
native tissue in vivo [1,11,18,19,26,29,33,37-42]. In total there was a good correspondence to 
other in vitro models and to the human alveolar model in particular. Nevertheless, in studies 
on the absorption of human proteins (e.g., insulin, calcitonin, and growth hormone) species 
differences could become relevant. Likewise, active transport processes, which may be of 
importance for the pulmonary application of low molecular weight compounds, are not 
considered so far. 
 
 
6. CONCLUSION 
 
Porcine alveolar epithelial cells in primary culture appear as an attractive in vitro model for 
drug absorption studies of the lower lungs. The cells have the ability to form polarized 
monolayers of characteristic alveolar epithelial type-I-like phenotype, which are able to 
distinguish between high and low permeability markers. In this study, the baseline parameters 
have been put down to use the pAEpC model as a screen in the routine assessment of drug 
permeability. 
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1. SUMMARY 
 
A new in vitro cell culture approach to model the alveolar epithelial level of the respiratory 
tract was developed, characterized and established in the present thesis. Due to acknowledged 
similarities to the human physiology, porcine tissue was chosen as starting material for cell 
cultures. The isolation process and culture conditions of cells, as well as the definition of 
experimental conditions were optimized with respect to a later use of the in vitro model in 
drug transport studies. Subsequent topics were dealt with in detail: 
 
1) Review on currently available in vitro models for the respiratory tract and assessment of 
their suitability in drug transport studies or other application fields of pharmaceutical 
research. 
An important aspect to discuss was the imitation of the in vivo situation in terms of occurring 
cell types, their morphology, epithelial barrier characteristics, as well as ion transport and 
other specific transport processes. Biochemical barrier properties, caused by metabolic 
enzymes or active efflux systems, represent further points of interest. In vitro models, which 
are generally accepted in scientific research, as indicated by frequency and incidence of 
publications or by the number of projects and scientists concentrating on their further 
characterization and evaluation, were selected and described in more detail. Pulmonary cell 
lines in comparison with primary culture approaches and their present limitations, as well as 
promising perspectives of current in vitro models represent important points of discussion. 
Nevertheless there is still a need for in vitro models of the distal lung region. The resulting 
survey provides a data pool, which allows a realistic assessment of the newly developed cell 
culture models for further research. 
 
2) Development of an appropriate method to isolate alveolar epithelial cells from porcine 
tissue and establishment of suitable culture conditions. 
For this purpose an isolation procedure that was previously described for human alveolar 
epithelial primary cells was slightly modified, adapted to larger amounts of tissue and refined 
for requirements of a different species. Occurring infections in either the native tissue or in 
resulting cell cultures, were another challenge to face. But analysis of the slaughtering 
process, investigation of respective literature data and identification of the infectious 
pathogens lead to a selection of antibiotics, which minimize the risk of contamination and 
thus guarantee an appropriate protection. In order to establish culture conditions suited for the 
expression of functional barrier properties, transepithelial electrical resistance (TEER) was 
chosen as bioelectrical parameter to decide on which method or condition should be preferred. 
Standard protocols were defined for the isolation procedure as well as for cultivation 
conditions (temperature, humidified atmosphere), plating density, coating and material of 
growth supports, culture medium composition and feeding intervals. Finally separation of 
alveolar epithelial primary cells out of porcine tissue was proven feasible; porcine alveolar 
epithelial cells obtained at the end of this purification process (termed pAEpC) grew to 
confluence and generated high transepithelial resistances under optimized culture conditions. 
Subsequently the epithelial and alveolar origin of these cells had to be verified. 
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3) Morphology and cytochemistry of porcine alveolar epithelial cells in primary culture. 
The pAEpC as a new in vitro cell culture approach for the respiratory tract were characterized 
by a detailed morphological, bioelectrical and immunocytochemical analysis. Light and 
electron microscopic techniques allowed documentation of the growth and differentiation 
process and the morphological identification of characteristic cell types, such as type I and 
type II pneumocytes. Quantification of epithelial cell height and surface coverage throughout 
a cultivation period completed this documentation. Microscopic techniques also served to 
visualize other ultrastructural features of respiratory epithelium like multilamellar bodies, 
microvilli, ciliated cells, caveolae, and also the formation of cell-cell contacts. 
The presence of junction proteins, such as zonula-occludens protein-1, occludin and E-
cadherin, as well as the epithelial marker cytoceratin was demonstrated by immunostaining 
and partly by western blot analysis. Furthermore, immunocytochemical characterization 
identified the alveolar epithelial cell markers caveolin, pro-surfactant-protein-C and lung 
resistance protein and, in addition, the enzyme alkaline phosphatase as an indicator of 
alveolar epithelial differentiation. In contrast to what is known from human alveolar epithelial 
primary cells (hAEpC), cell-type-specific binding of lectins did not proof suitable as 
differentiation markers for pAEpC. Semi-quantitative analysis of junction or marker proteins 
in pAEpC monolayers at different time points of culture revealed changes in their expression. 
In parallel, distribution patterns observed in immunostainings varied with the age of pAEpC 
monolayers. Whereas in young cultures fluorescent signals of tight junction proteins were 
distributed allover the cytoplasm and lined more or less clearly the cell border, at day 7 in 
culture the fluorescent signal in the cytoplasm had disappeared and the cells showed a bright 
and continuous immunofluorescence marking the circumference of the cell. In accordance 
with the localization of junction proteins at the cell border region, as found in mature cell 
cultures, the development of barrier properties was confirmed by the monitored bioelectrical 
parameters: TEER and potential difference (PD). 
Presented data show that on account of suited culture conditions pAEpC display typical 
characteristics of alveolar epithelium in terms of identified cell types (type I and type II 
pneumocytes), protein expression and differentiation; they form polarized tight and confluent 
monolayers, which are suitable as model for drug transport studies. 
 
4) Quality control parameters and use of pAEpC as in vitro model for drug transport studies. 
Intending a later use in studies of pulmonary drug absorption an important point of interest 
was to evaluate the model’s capability to form functional cell-cell contacts and to generate 
significant barrier function as quantified by the transepithelial electrical resistance. 
Paracellular integrity of pAEpC monolayers was assessed in absorptive transport studies 
using the hydrophilic marker fluorescein-Na. Comparison to other in vitro models (primary 
and cell lines) proved the paracellular tightness of pAEpC monolayers as of comparable scale. 
In order to obtain reproducible conditions a minimal TEER was selected, qualifying each 
culture for utilization in an experiment. Growth medium was replaced by an appropriate 
transport buffer, i.e. a less complex matrix, which facilitates sample analysis in HPLC. 
Because of the poor water solubility of most drug candidates for permeability screening, cell 
monolayers were tested for their integrity in the presence of frequently used co-solvents, such 
as dimethyl sulfoxide. Obtained results recommended the following experimental conditions 
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for drug transport studies in pAEpC: a hydrocortisone-supplemented basal medium as 
transport buffer, a maximum concentration of 1.5% dimethyl sulfoxide and an equilibration 
time of 16 h after transfer of cells to the transport buffer. A minimum resistance of 600 Ωcm² 
was defined as minimal quality limit. 
Because of the typical variability in cell quality of primary cell cultures, the acceptance of the 
pAEpC in vitro model for its use in drug transport studies requires reliable quality control 
parameters. These could warrant results from studies using cells of different cell isolations. 
Such a quality control system was developed and limit values were defined, which qualify a 
certain batch of cell monolayers for drug transport studies. Since the permeability coefficients 
of high and low permeability markers were reproducible throughout several cell preparations, 
the pAEpC model enables the classification of unknown test compounds as either high or low 
permeable. 
Budesonide and triamcinolon acetonide are substances relevant for pulmonary drug delivery, 
and were selected to study their permeability across the alveolar epithelial barrier in pAEpC. 
Resulting permeability coefficients were compared to those obtained in other in vitro models 
of respiratory epithelia, including human alveolar epithelial primary cells (hAEpC) and two 
human bronchial epithelial cell lines Calu-3 and 16HBE14o-, and turned out to be similar. 
 
5) Efflux systems and multidrug resistance in pAEpC. 
The expression of functional transport systems is another important feature of in vitro models. 
Efflux systems are capable to influence drug absorption and thus may affect the 
bioavailability of a drug. Apart from this active barrier against drug absorption, transport 
proteins like P-glycoprotein (P-gp) or the lung resistance-related protein (LRP) are also 
responsible for resistance of cancer cells to chemotherapeutics. 
Expression of both proteins could be proven in pAEpC monolayers by immunofluorescence 
staining and confocal laser scanning microscopy. Moreover, electron microscopy helped to 
detect endosomal transport vehicles, called caveolae, which are discussed to play an important 
role in active absorption of proteins across the pulmonary epithelium. 
Although polarized pAEpC monolayers immunostained positive for P-glycoprotein, there was 
no evidence for the presence of a mdr-related efflux mechanism in vitro. Cell monolayers out 
of different cell isolations showed no directional transport for P-gp-substrates rhodamine 123, 
3H-digoxin, sulforhodamine 101, doxorubicine and furosemide. The presence of an inhibitor 
did not influence these findings, confirming the lack of P-gp-mediated efflux in the pAEpC-
model. A regularly performed quality control (transport experiment) proved that pAEpC 
monolayers out of different cell isolations reproducibly featured constant transepithelial 
permeation rates for rhodamine 123, being the same for both transport directions. 
Comparison of respiratory epithelia and intestinal- or blood-brain barrier models could clearly 
illustrate differences in terms of P-gp-mediated efflux. Nevertheless human alveolar epithelial 
primary cells as the next close approach to pAEpC also showed a relatively low transport 
ratio of 3.1, in contrast to distinct efflux phenomena as reported for the intestinal cell line 
Caco-2 showing a ratio of 13.2. 
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2. ZUSAMMENFASSUNG 
 
In der vorliegenden Arbeit wurde ein neues Zellkulturmodell für das Alveolarepithel des 
Respirationstraktes etabliert. Im Zentrum stand dabei die Entwicklung einer Methode zur 
Isolierung und Kultivierung porciner Alveolarepithelzellen sowie deren Charakterisierung. 
Auf Grund der bekannten Parallelen zur menschlichen Physiologie und der guten 
Verfügbarkeit von Gewebe, eignet sich das Schwein in besonderem Maße als 
Ausgangsspezies für die Erstellung von Zellkulturen. Im Hinblick auf eine spätere 
Verwendung des in-vitro-Modells für Transportstudien sollten spezielle Vorschriften zur 
Durchführung dieser Experimente entwickelt werden. Im Einzelnen wurden folgende Themen 
behandelt: 
 
1) Übersicht über in vitro-Modelle für den Respirationstrakt und deren Bewertung im 
Hinblick auf ihre Eignung zu Arzneistoff-Transportstudien oder anderen Anwendungsgebieten 
der pharmazeutischen Forschung. 
Einen wichtigen Aspekt dieser Recherche stellte die Qualität der Imitation einer in-vivo-
Situation durch das entsprechende Zellkulturmodell dar. Diese ergibt sich aus den in vitro 
auftretenden Zelltypen, deren Morphologie, den Barriereeigenschaften des Epithels, sowie 
dem Ionentransport oder anderen spezifischen Transportprozessen. Biochemische 
Barriereeigenschaften, die durch metabolische Prozesse (Stoffwechsel-Enzyme) oder aktive 
Effluxsysteme verursacht werden, stellen weitere interessante Themen dar. In-vitro-Modelle, 
die gemessen an Häufigkeit und Vorkommen fachlicher Veröffentlichungen oder an der 
Anzahl von in-vitro-Projekten und daran beteiligten Wissenschaftlern als in der 
wissenschaftlichen Forschung akzeptiert gelten, wurden ausgewählt und mit Blick auf ihre 
weitere Charakterisierung und Bewertung im Detail beschrieben. Insbesondere der Vergleich 
von pulmonalen Zelllinien mit Primärkulturen, ihre gegenwärtigen Grenzen aber auch 
vielversprechenden Perspektiven standen hier im Vordergrund der Diskussion. Letztlich 
resultiert ein klarer Bedarf an in-vitro-Modellen für die distale Lungenregion. Der hier 
gezeigte Überblick liefert Daten, auf deren Grundlage eine realistische Bewertung neu 
entwickelter Zellkulturmodelle für die zukünftige Forschung möglich ist. 
 
2) Entwicklung einer Methode zur Isolation alveolarer Epithelzellen aus Schweinelunge und 
Etablierung geeigneter Kulturbedingungen. 
Zu diesem Zweck wurde ein zuvor für menschliche, primäre Alveolarepithelzellen 
beschriebener Isolationsprozess modifiziert, an größere Gewebemengen angepasst und auf die 
veränderten Anforderungen der Zellkultur aus einer anderen Spezies hin optimiert. Das 
Auftreten von Infektionen, sowohl im Ursprungsgewebe als auch in den resultierenden 
Zellkulturen, stellte eine weitere Herausforderung dar. Durch eine genaue Analyse des 
Schlachtprozesses, das Studium entsprechender Literaturdaten und Identifikation der 
infektiösen Erreger konnte eine Auswahl an Antibiotika getroffen werden, welche das 
Kontaminationsrisiko auf ein erträgliches Maß minimieren. Es wurden Kulturbedingungen 
herausgearbeitet, die die Ausbildung funktioneller Barriereeigenschaften begünstigen. Als 
Entscheidungskriterium zur Bewertung der verglichenen Methoden oder Bedingungen diente 
der bioelektrische Parameter transepithelialer, elektrischer Widerstand (TEER). Zudem 
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wurden Standard-Protokolle für die Isolation und die anschließende Kulivierung alveolarer 
Epithelzellen definiert. Wichtige Parameter waren hier insbesondere die Aussaatdichte, 
Beschichtung und Material der Wachstumsunterlage, die Zusammensetzung des 
Kulturmediums und die Frequenz des Mediumwechsels. Es konnte gezeigt werden, dass die 
Gewinnung primärer, alveolarer Epithelzellen aus Schweinelunge (genannt pAEpC) 
prinzipiell möglich ist: Die isolierten Zellen bilden einen konfluenten Zellrasen und unter 
optimierten Kulturbedingungen eine dichte epitheliale Barriere, was sich mit entsprechend 
hohen transepithelialen Widerständen belegen ließ. Nachfolgend wurde die epitheliale und 
alveolare Herkunft dieser Zellen bestätigt. 
 
3) Morphologie und Zytochemie porciner alveolarer Epithelzellen in Primärkultur. 
Ein neues Zellkulturmodell für den Respirationstrakt, pAEpC, wurde im Rahmen einer 
detailierten morphologischen, bioelektrischen und immunozytochemischen Analyse 
charakterisiert. Licht- und Elektronenmikroskopie dokumentierten das Zellwachstum und den 
Differenzierungsprozess; zusätzlich wurden diese Techniken zur morphologischen 
Identifizierung charakteristischer Zelltypen, beispielsweise Typ I- und Typ II-Pneumozyten, 
herangezogen. Die Quantifizierung von Epithelhöhe und Oberflächenbedeckung im Verlauf 
einer solchen Kulturperiode vervollständigten diese Untersuchungen. Desweiteren konnten 
auch ultrastrukturelle Merkmale des Respirationsepithels sichtbar gemacht werden, wie z. B. 
multilammellare Einschlüsse, Microvilli, zilienbesetzte Zellen und Caveolae, aber auch die 
Ausbildung interzellulärer Kontakte. 
Die Expression von tight junction assoziierten Proteinen, wie etwa des Zonula-Occludens-
Proteins-1 und Occludin, des Zonula-Adherens-Proteins E-Cadherin, und des Epithel-Markers 
Zytokeratin, konnte durch Immunfärbungen und teilweise auch in Western Blot Analysen 
belegt werden. Darüber hinaus wurden im Rahmen einer immunozytochemischen 
Charakterisierung weitere Marker für alveolares Epithel, wie Caveolin, Pro-Surfactant-
Protein-C und das Lung-Resistance-Protein identifiziert. Zusätzlich konnte das Enzym 
alkalische Phosphatase nachgewiesen werden, das als Indikator für die Differenzierung 
alveolarer Epithelzellen gilt. Im Gegensatz zu Beobachtungen an primären, humanen 
Alveolarepithelzellen (hAEpC), erwies sich die zelltyp-spezifische Bindung von Lektinen im 
porcinen Modell (pAEpC) zumindest im Rahmen der Beobachtungsdauer nicht als 
brauchbarer Differenzierungsmarker. Eine semiquantitative Analyse von Junction- oder 
Alveolarepithel-Marker-Proteinen zu unterschiedlichen Zeitpunkten der Kultur zeigte 
Veränderungen in deren Expression. Parallel dazu veränderte sich das in Immunfärbungen 
beobachtete Verteilungsmuster in Abhängigkeit vom Alter der Zell-Monolayer. In jungen 
Zell-Kulturen waren die Fluoreszenzsignale tight-junction assoziierter Proteine im gesamten 
Zytoplasma verteilt zu finden und zeichneten mehr oder weniger deutlich die Zell-Grenzen 
nach. Ab dem 7. Kulturtag dagegen waren keine dieser hell scheinenden Regionen mehr im 
Zytoplasma zu sehen, statt dessen markierte ein kontinuierliches, scharfes Fluoreszenzsignal 
die Kontur der einzelnen Zellen. In Übereinstimmung mit dieser erwarteten Lokalisation 
junctionaler Proteine an den Zellgrenzen konnte die Ausbildung von Barriere-Eigenschaften 
anhand des transepithelialen Widerstandes (TEER) und der Potential-Differenz (PD) bestätigt 
werden. 
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Unter geeigneten Kulturbedingungen prägen pAEpC typische Merkmale des Alveolarepithels 
aus. Die in der Kultur identifizierten Typ-I- und Typ-II-Pneumozyten exprimieren für das 
Alveolarepithel charakteristische Proteine und zeigen eine typische Differenzierung. Sie 
bilden einen dichten, konfluenten, einschichtigen Zellrasen aus und eignen sich somit für 
Transportstudien in-vitro. 
 
4) Parameter zur Qualitätskontrolle und Verwendung von pAEpC als in-vitro-Modell in 
Transportstudien. 
Im Hinblick auf eine Verwendung in Studien auf dem Gebiet der pulmonalen Arzneistoff-
Absorption war es sehr wichtig, die Fähigkeit der pAEpC Monolayer zur Bildung 
funktionaler Zell-Zell-Kontakte und somit zur Ausbildung einer Barriere zu verifizieren. 
Quantifiziert wurde diese Barrierebildung mit Hilfe des Parameters TEER (s.o.). Ergänzend 
wurde die parazelluläre Permeabilität des hydrophilen Markers Fluorescein-Na bestimmt. Ein 
Vergleich dieser Daten mit denen aus anderen barrierebildenden Zellkultursystemen (primäre 
Zellen und Zelllinien) belegte die Ausbildung einer Permeationsbarriere durch pAEpC in 
vergleichbarer Größenordung. 
Um einzelne Zellkulturen für den Gebrauch in einem Experiment zu qualifizieren wurden zur 
Gewährleistung reproduzierbarer Bedingungen 600 Ωcm² als limitierender (minimaler) TEER 
festgelegt. Da eine weniger komplexe Matrix die Analyse von Proben mittels HPLC 
vereinfacht, wurde das Kulturmedium durch hydrocortison-supplementiertes Basalmedium 
(Transportpuffer) ersetzt. Die einzuhaltende Äquilibrationszeit nach diesem Mediumwechsel 
betrug 16 h. 
Die schlechte Wasserlöslichkeit einer Vielzahl potentieller Arzneistoff-Kandidaten erfordert 
für das Permeabilitäts-Screening häufig den Einsatz von Lösungsvermittlern, wie z. B. 
Dimethylsulfoxid (DMSO). Bis zu einer Konzentration von maximal 1,5% konnte eine 
Toleranz der pAEpC-Barriere gegenüber DMSO belegt werden. 
Die für primäre Zellkultur-Systeme typische, variable Qualität erfordert eine verlässliche 
Qualitätskontrolle, um Zellen aus unterschiedlichen Präparationen (also verschiedenen 
„Zellchargen“) im gleichen Experiment oder innerhalb einer Versuchsreihe nutzen zu können. 
Im Rahmen der Entwicklung entsprechender Qualitätskontrollparameter wurden daher 
Grenzwerte definiert, die eine Zell-„Charge“ zur Verwendung in Transportstudien 
qualifizieren. Da die Permeabilitäts-Koeffizienten sowohl hoch- als auch niedrig-permeabler 
Marker-Substanzen verschiedener Zell-„Chargen“ reproduzierbar waren, ermöglicht das 
pAEpC Modell die Klassifizierung von Testsubstanzen als hoch- oder niedrigpermeabel. 
Exemplarisch für die pulmonale Applikationsroute wurden die Arzneistoffe Budesonid und 
Triamcinolonacetonid ausgewählt und ihre Permeabilität über die alveolare Epithelbarriere im 
pAEpC Modell untersucht. Die dabei bestimmten Permeabilitätskoeffizienten stimmten 
grundsätzlich mit in anderen in-vitro-Modellen des Respirationsepithels ermittelten 
Permeationsdaten überein, darunter humane alveolare primäre Epithelzellen (hAEpC) und 
zwei menschliche Bronchialepithelzelllinien, Calu-3 und 16HBE14o-. 
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5) Efflux-Systeme und Multidrug Resistance in pAEpC. 
Die Expression funktionaler Transport-Systeme ist ein weiteres wichtiges Merkmal von 
Epithelien in vivo und sollte daher auch im in-vitro-Modell untersucht werden. Efflux-
Systeme beeinflussen die Absorption von Arzneistoffen und auf diese Weise letztlich auch 
ihre Bioverfügbarkeit. So sind z.B. Transporter wie das P-Glycoprotein (P-gp) oder das Lung 
Resistance-related Protein (LRP) verantwortlich für die Resistenz von Krebszellen gegenüber 
Chemotherapeutika. 
Die Expression dieser beiden Proteine konnte in pAEpC Monolayern mittels 
immunozytochemischer Anfärbung und konfokaler Laser Scanning Mikroskopie 
nachgewiesen werden. Darüber hinaus wurden in elektronenmikroskopischen Aufnahmen 
(SEM) endosomale Transport-Vehikel, sogenannte Caveolae, detektiert. Diese spielen 
vermutlich eine wichtige Rolle bei der aktiven Absorption von Proteinen über das 
Pulmonalepithel. 
Obwohl der Nachweis von P-gp in pAEpC Monolayern gelang (positive Immunfärbung), 
konnte in Transportstudien mit den P-gp-Substraten Rhodamin 123, 3H-Digoxin, 
Sulforhodamin 101, Doxorubizin und Furosemid kein direktionaler Fluss gefunden werden. 
Weitere Untersuchungen in Anwesenheit eines P-gp-Inhibitors bestätigten das Fehlen eines P-
gp-vermittelten Efflux im pAEpC Modell. 
Ein Vergleich mit anderen respiratorischen Epithelien und intestinalen oder Blut-Hirn-
Schranke Modellen konnte klare Unterschiede im Bezug auf P-gp-vermittelten Efflux 
demonstrieren. Allerdings wiesen primäre humane Alveolarepithelzellen, als 
nächstverwandtes Modellsystem zu pAEpC, nur einen relativ niedrigen Transport-Quotienten 
von 3,1 auf. Ein ausgeprägtes Efflux-Phänomenen zeigte dagegen die intestinale Zelllinie 
Caco-2 mit einem Quotienten von 13,2. 
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3. OUTLOOK 
 
A cell culture model for the alveolar region of the respiratory tract was established in this 
thesis. A detailed characterization by microscopic and immunocytochemical techniques 
revealed its good resemblance to typical features found in the native human epithelium or 
other in vitro models of lung epithelia. Subsequent investigations focused on the feasibility of 
studies for pulmonary drug absorption or targeting in pAEpC. Obtained results proved the 
model’s suitability as a screening tool in pulmonary drug delivery as well as in inhalation 
toxicology. In addition, it may also help to clarify transport mechanisms and the way, how 
potential drug candidates overcome an epithelial barrier. 
Certainly a further screening of pAEpC monolayers for active transport processes, which are 
involved in absorption and secretion of therapeutic drugs, should complete the 
characterization. Knowledge of trafficking processes, uptake mechanisms and factors 
influencing both could help to improve future therapies. The model does also offer the chance 
to imitate a clinical picture, or to support the development of sophisticated drug targeting 
techniques by formulation screening. Other challenging perspectives may focus on the 
improvement of application techniques and the realization of a quantitative drug dosing, to 
better simulate aerosol or powder inhalation onto cell monolayers. A further point of interest 
will be to check for the interaction of drug-loaded particles with a cell monolayer. Aiming at a 
closer imitation of in vivo conditions, a current trend in scientific research tries to combine 
different cell types as co-cultures composed of endothelial, epithelial and cells of the immune 
system. 
Cell culture-based in vitro models will help to identify possible application sites for 
therapeutic drugs and to understand the mechanisms responsible for absorption and metabolic 
degradation. 
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1. LIST OF ABBREVIATIONS 
 
(ab)   transport direction from apical to basolateral 
(ba)   transport direction from basolateral to apical 
AIC   air-interface culture 
ATCC   american type culture collection 
AP   alkaline phosphatase 
BSSA   balanced salt solution A 
BSSB   balanced salt solution B 
Ca2+   calcium ion 
Cat.No.  catalogue number 
CFU   colony forming unit 
Col   collagen 
DMEM  Dulbecco’s minimum essential medium 
DMSO  dimethyl sulfoxide 
DNA   deoxyribonucleic acid 
DNase   deoxyribonuclease 
FCS   fetal calf serum 
FITC   fluoresceinisothiocyanate 
Flu-Na   fluorescein-Na 
Fn   fibronectin 
GK-A   total count of microorganisms (“Gesamtkeimzahl allgemein”) 
GK-C   total count of coliform bacteria 
GK-HS  total count of yeasts and moulds (fungi) 
hAEpC  human alveolar epithelial cells in primary culture 
IQR   interquartial range 
IU   international units 
kDa   kilo dalton 
KRB   Krebs-Ringer buffer 
LCC   liquid-covered culture 
mdr   multi-drug resistance 
Mg2+   magnesium ion 
MPA   maclura pomifera lectin 
MRP   multidrug resistance-associated protein 
pAEpC-n  pAEpC isolation number n (isolation batch) 
pAEpC  porcine alveolar epithelial cells in primary culture 
Papp   apparent permeability coefficient 
PBEC   porcine brain endothelial cells 
PBS   phosphate buffered saline 
PC   polycarbonate 
PD   potential difference 
PDA   photodiode array 
PE   polyester 
P-gp   P-glycoprotein 
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Ph. Eur. 3rd edition European Pharmacopoeia third edition 
Pro   propranolol 
rAEpC   rat alveolar epithelial cells in primary culture 
RCA   ricinus communis lectin 
Rh123   rhodamine 123 
rpm   revolutions per minute 
SDS   sodium dodecyl sufate 
SABM   small airway basal medium 
SAGM  small airway growth medium 
SL   stock solution 
TEER   transepithelial electrical resistance 
TEERmax  maximum transepithelial electrical resistance 
TJ   tight junction 
TRIS   Tris(hydroxymethyl)methylamine (buffer) 
VIT   vitrogen 
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